<!DOCTYPE us-patent-grant SYSTEM "us-patent-grant-v44-2013-05-16.dtd" [ ]>
<us-patent-grant lang="EN" dtd-version="v4.4 2013-05-16" file="US08626300-20140107.XML" status="PRODUCTION" id="us-patent-grant" country="US" date-produced="20131224" date-publ="20140107">
<us-bibliographic-data-grant>
<publication-reference>
<document-id>
<country>US</country>
<doc-number>08626300</doc-number>
<kind>B2</kind>
<date>20140107</date>
</document-id>
</publication-reference>
<application-reference appl-type="utility">
<document-id>
<country>US</country>
<doc-number>13046595</doc-number>
<date>20110311</date>
</document-id>
</application-reference>
<us-application-series-code>13</us-application-series-code>
<us-term-of-grant>
<disclaimer>
<text>This patent is subject to a terminal disclaimer.</text>
</disclaimer>
</us-term-of-grant>
<classifications-ipcr>
<classification-ipcr>
<ipc-version-indicator><date>20060101</date></ipc-version-indicator>
<classification-level>A</classification-level>
<section>A</section>
<class>61</class>
<subclass>F</subclass>
<main-group>7</main-group>
<subgroup>12</subgroup>
<symbol-position>F</symbol-position>
<classification-value>I</classification-value>
<action-date><date>20140107</date></action-date>
<generating-office><country>US</country></generating-office>
<classification-status>B</classification-status>
<classification-data-source>H</classification-data-source>
</classification-ipcr>
<classification-ipcr>
<ipc-version-indicator><date>20060101</date></ipc-version-indicator>
<classification-level>A</classification-level>
<section>A</section>
<class>61</class>
<subclass>N</subclass>
<main-group>1</main-group>
<subgroup>18</subgroup>
<symbol-position>L</symbol-position>
<classification-value>I</classification-value>
<action-date><date>20140107</date></action-date>
<generating-office><country>US</country></generating-office>
<classification-status>B</classification-status>
<classification-data-source>H</classification-data-source>
</classification-ipcr>
</classifications-ipcr>
<classification-national>
<country>US</country>
<main-classification>607 44</main-classification>
<further-classification>607  2</further-classification>
<further-classification>607117</further-classification>
<further-classification>607118</further-classification>
<further-classification>607 96</further-classification>
</classification-national>
<invention-title id="d2e51">Methods and apparatus for thermally-induced renal neuromodulation</invention-title>
<us-references-cited>
<us-citation>
<patcit num="00001">
<document-id>
<country>US</country>
<doc-number>2130758</doc-number>
<kind>A</kind>
<name>Rose</name>
<date>19380900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00002">
<document-id>
<country>US</country>
<doc-number>2276995</doc-number>
<kind>A</kind>
<name>Milinowski</name>
<date>19420300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00003">
<document-id>
<country>US</country>
<doc-number>2276996</doc-number>
<kind>A</kind>
<name>Milinowski</name>
<date>19420300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00004">
<document-id>
<country>US</country>
<doc-number>3043310</doc-number>
<kind>A</kind>
<name>Milinowski</name>
<date>19620700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00005">
<document-id>
<country>US</country>
<doc-number>3127895</doc-number>
<kind>A</kind>
<name>Kendall et al.</name>
<date>19640400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00006">
<document-id>
<country>US</country>
<doc-number>3181535</doc-number>
<kind>A</kind>
<name>Milinowski</name>
<date>19650500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00007">
<document-id>
<country>US</country>
<doc-number>3270746</doc-number>
<kind>A</kind>
<name>Kendall et al.</name>
<date>19660900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00008">
<document-id>
<country>US</country>
<doc-number>3329149</doc-number>
<kind>A</kind>
<name>Kendall et al.</name>
<date>19670700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00009">
<document-id>
<country>US</country>
<doc-number>3522811</doc-number>
<kind>A</kind>
<name>Schwartz et al.</name>
<date>19700800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00010">
<document-id>
<country>US</country>
<doc-number>3563246</doc-number>
<kind>A</kind>
<name>Puharich et al.</name>
<date>19710200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00011">
<document-id>
<country>US</country>
<doc-number>3650277</doc-number>
<kind>A</kind>
<name>Sjostrand et al.</name>
<date>19720300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00012">
<document-id>
<country>US</country>
<doc-number>3670737</doc-number>
<kind>A</kind>
<name>Pearo</name>
<date>19720600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00013">
<document-id>
<country>US</country>
<doc-number>3760812</doc-number>
<kind>A</kind>
<name>Timm et al.</name>
<date>19730900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00014">
<document-id>
<country>US</country>
<doc-number>3774620</doc-number>
<kind>A</kind>
<name>Hansjurgens</name>
<date>19731100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00015">
<document-id>
<country>US</country>
<doc-number>3794022</doc-number>
<kind>A</kind>
<name>Nawracaj et al.</name>
<date>19740200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00016">
<document-id>
<country>US</country>
<doc-number>3800802</doc-number>
<kind>A</kind>
<name>Berry et al.</name>
<date>19740400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00017">
<document-id>
<country>US</country>
<doc-number>3803463</doc-number>
<kind>A</kind>
<name>Cover</name>
<date>19740400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00018">
<document-id>
<country>US</country>
<doc-number>3894532</doc-number>
<kind>A</kind>
<name>Morey</name>
<date>19750700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00019">
<document-id>
<country>US</country>
<doc-number>3895639</doc-number>
<kind>A</kind>
<name>Rodler et al.</name>
<date>19750700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00020">
<document-id>
<country>US</country>
<doc-number>3897789</doc-number>
<kind>A</kind>
<name>Blanchard</name>
<date>19750800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00021">
<document-id>
<country>US</country>
<doc-number>3911930</doc-number>
<kind>A</kind>
<name>Hagfors et al.</name>
<date>19751000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00022">
<document-id>
<country>US</country>
<doc-number>3952751</doc-number>
<kind>A</kind>
<name>Yarger</name>
<date>19760400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00023">
<document-id>
<country>US</country>
<doc-number>3987790</doc-number>
<kind>A</kind>
<name>Eckenhoff et al.</name>
<date>19761000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00024">
<document-id>
<country>US</country>
<doc-number>4011861</doc-number>
<kind>A</kind>
<name>Enger</name>
<date>19770300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00025">
<document-id>
<country>US</country>
<doc-number>4026300</doc-number>
<kind>A</kind>
<name>DeLuca et al.</name>
<date>19770500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00026">
<document-id>
<country>US</country>
<doc-number>4055190</doc-number>
<kind>A</kind>
<name>Tany</name>
<date>19771000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00027">
<document-id>
<country>US</country>
<doc-number>4071033</doc-number>
<kind>A</kind>
<name>Nawracaj et al.</name>
<date>19780100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00028">
<document-id>
<country>US</country>
<doc-number>4105017</doc-number>
<kind>A</kind>
<name>Ryaby et al.</name>
<date>19780800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00029">
<document-id>
<country>US</country>
<doc-number>4141365</doc-number>
<kind>A</kind>
<name>Fischell et al.</name>
<date>19790200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00030">
<document-id>
<country>US</country>
<doc-number>4266532</doc-number>
<kind>A</kind>
<name>Ryaby et al.</name>
<date>19810500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00031">
<document-id>
<country>US</country>
<doc-number>4266533</doc-number>
<kind>A</kind>
<name>Ryaby et al.</name>
<date>19810500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00032">
<document-id>
<country>US</country>
<doc-number>4305115</doc-number>
<kind>A</kind>
<name>Armitage</name>
<date>19811200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00033">
<document-id>
<country>US</country>
<doc-number>4315503</doc-number>
<kind>A</kind>
<name>Ryaby et al.</name>
<date>19820200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00034">
<document-id>
<country>US</country>
<doc-number>4360019</doc-number>
<kind>A</kind>
<name>Portner et al.</name>
<date>19821100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00035">
<document-id>
<country>US</country>
<doc-number>4379462</doc-number>
<kind>A</kind>
<name>Borkan et al.</name>
<date>19830400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00036">
<document-id>
<country>US</country>
<doc-number>4405305</doc-number>
<kind>A</kind>
<name>Stephen et al.</name>
<date>19830900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00037">
<document-id>
<country>US</country>
<doc-number>4454883</doc-number>
<kind>A</kind>
<name>Fellus</name>
<date>19840600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00038">
<document-id>
<country>US</country>
<doc-number>4467808</doc-number>
<kind>A</kind>
<name>Brighton et al.</name>
<date>19840800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00039">
<document-id>
<country>US</country>
<doc-number>4487603</doc-number>
<kind>A</kind>
<name>Harris</name>
<date>19841200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00040">
<document-id>
<country>US</country>
<doc-number>4530840</doc-number>
<kind>A</kind>
<name>Tice et al.</name>
<date>19850700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00041">
<document-id>
<country>US</country>
<doc-number>4587975</doc-number>
<kind>A</kind>
<name>Salo et al.</name>
<date>19860500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00042">
<document-id>
<country>US</country>
<doc-number>4602624</doc-number>
<kind>A</kind>
<name>Naples et al.</name>
<date>19860700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00043">
<document-id>
<country>US</country>
<doc-number>4608985</doc-number>
<kind>A</kind>
<name>Crish et al.</name>
<date>19860900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00044">
<document-id>
<country>US</country>
<doc-number>4649936</doc-number>
<kind>A</kind>
<name>Ungar et al.</name>
<date>19870300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00045">
<document-id>
<country>US</country>
<doc-number>4671286</doc-number>
<kind>A</kind>
<name>Renault</name>
<date>19870600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00046">
<document-id>
<country>US</country>
<doc-number>4674482</doc-number>
<kind>A</kind>
<name>Waltonen et al.</name>
<date>19870600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00047">
<document-id>
<country>US</country>
<doc-number>4692147</doc-number>
<kind>A</kind>
<name>Duggan</name>
<date>19870900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00048">
<document-id>
<country>US</country>
<doc-number>4715852</doc-number>
<kind>A</kind>
<name>Reinicke et al.</name>
<date>19871200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00049">
<document-id>
<country>US</country>
<doc-number>4764504</doc-number>
<kind>A</kind>
<name>Johnson et al.</name>
<date>19880800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00050">
<document-id>
<country>US</country>
<doc-number>4774967</doc-number>
<kind>A</kind>
<name>Zanakis</name>
<date>19881000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00051">
<document-id>
<country>US</country>
<doc-number>4791931</doc-number>
<kind>A</kind>
<name>Slate</name>
<date>19881200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00052">
<document-id>
<country>US</country>
<doc-number>4816016</doc-number>
<kind>A</kind>
<name>Schulte et al.</name>
<date>19890300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00053">
<document-id>
<country>US</country>
<doc-number>4852573</doc-number>
<kind>A</kind>
<name>Kennedy</name>
<date>19890800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00054">
<document-id>
<country>US</country>
<doc-number>4865845</doc-number>
<kind>A</kind>
<name>Eckenhoff et al.</name>
<date>19890900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00055">
<document-id>
<country>US</country>
<doc-number>4976711</doc-number>
<kind>A</kind>
<name>Parins et al.</name>
<date>19901200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00056">
<document-id>
<country>US</country>
<doc-number>4979511</doc-number>
<kind>A</kind>
<name>Terry, Jr.</name>
<date>19901200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00057">
<document-id>
<country>US</country>
<doc-number>4981146</doc-number>
<kind>A</kind>
<name>Bertolucci</name>
<date>19910100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00058">
<document-id>
<country>US</country>
<doc-number>4998532</doc-number>
<kind>A</kind>
<name>Griffith</name>
<date>19910300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00059">
<document-id>
<country>US</country>
<doc-number>5006119</doc-number>
<kind>A</kind>
<name>Acker et al.</name>
<date>19910400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00060">
<document-id>
<country>US</country>
<doc-number>5014699</doc-number>
<kind>A</kind>
<name>Pollack et al.</name>
<date>19910500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00061">
<document-id>
<country>US</country>
<doc-number>5019034</doc-number>
<kind>A</kind>
<name>Weaver et al.</name>
<date>19910500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00062">
<document-id>
<country>US</country>
<doc-number>5057318</doc-number>
<kind>A</kind>
<name>Magruder et al.</name>
<date>19911000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00063">
<document-id>
<country>US</country>
<doc-number>5058584</doc-number>
<kind>A</kind>
<name>Bourgeois</name>
<date>19911000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00064">
<document-id>
<country>US</country>
<doc-number>5059423</doc-number>
<kind>A</kind>
<name>Magruder et al.</name>
<date>19911000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00065">
<document-id>
<country>US</country>
<doc-number>5061492</doc-number>
<kind>A</kind>
<name>Okada et al.</name>
<date>19911000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00066">
<document-id>
<country>US</country>
<doc-number>5094242</doc-number>
<kind>A</kind>
<name>Gleason et al.</name>
<date>19920300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00067">
<document-id>
<country>US</country>
<doc-number>5111815</doc-number>
<kind>A</kind>
<name>Mower</name>
<date>19920500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00068">
<document-id>
<country>US</country>
<doc-number>5112614</doc-number>
<kind>A</kind>
<name>Magruder et al.</name>
<date>19920500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00069">
<document-id>
<country>US</country>
<doc-number>5125928</doc-number>
<kind>A</kind>
<name>Parins et al.</name>
<date>19920600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00070">
<document-id>
<country>US</country>
<doc-number>5131409</doc-number>
<kind>A</kind>
<name>Lobarev et al.</name>
<date>19920700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00071">
<document-id>
<country>US</country>
<doc-number>5137727</doc-number>
<kind>A</kind>
<name>Eckenhoff</name>
<date>19920800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00072">
<document-id>
<country>US</country>
<doc-number>5188837</doc-number>
<kind>A</kind>
<name>Domb</name>
<date>19930200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00073">
<document-id>
<country>US</country>
<doc-number>5193048</doc-number>
<kind>A</kind>
<name>Kaufman et al.</name>
<date>19930300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00074">
<document-id>
<country>US</country>
<doc-number>5193539</doc-number>
<kind>A</kind>
<name>Schulman et al.</name>
<date>19930300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00075">
<document-id>
<country>US</country>
<doc-number>5193540</doc-number>
<kind>A</kind>
<name>Schulman et al.</name>
<date>19930300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00076">
<document-id>
<country>US</country>
<doc-number>5199428</doc-number>
<kind>A</kind>
<name>Obel et al.</name>
<date>19930400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00077">
<document-id>
<country>US</country>
<doc-number>5203326</doc-number>
<kind>A</kind>
<name>Collins et al.</name>
<date>19930400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00078">
<document-id>
<country>US</country>
<doc-number>5213098</doc-number>
<kind>A</kind>
<name>Bennett et al.</name>
<date>19930500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00079">
<document-id>
<country>US</country>
<doc-number>5215086</doc-number>
<kind>A</kind>
<name>Terry, Jr. et al.</name>
<date>19930600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00080">
<document-id>
<country>US</country>
<doc-number>5231988</doc-number>
<kind>A</kind>
<name>Wernicke et al.</name>
<date>19930800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00081">
<document-id>
<country>US</country>
<doc-number>5234692</doc-number>
<kind>A</kind>
<name>Magruder et al.</name>
<date>19930800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00082">
<document-id>
<country>US</country>
<doc-number>5234693</doc-number>
<kind>A</kind>
<name>Magruder et al.</name>
<date>19930800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00083">
<document-id>
<country>US</country>
<doc-number>5251634</doc-number>
<kind>A</kind>
<name>Weinberg</name>
<date>19931000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00084">
<document-id>
<country>US</country>
<doc-number>5251643</doc-number>
<kind>A</kind>
<name>Osypka</name>
<date>19931000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00085">
<document-id>
<country>US</country>
<doc-number>5263480</doc-number>
<kind>A</kind>
<name>Wernicke et al.</name>
<date>19931100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00086">
<document-id>
<country>US</country>
<doc-number>5269303</doc-number>
<kind>A</kind>
<name>Wernicke et al.</name>
<date>19931200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00087">
<document-id>
<country>US</country>
<doc-number>5282468</doc-number>
<kind>A</kind>
<name>Klepinski</name>
<date>19940200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00088">
<document-id>
<country>US</country>
<doc-number>5282785</doc-number>
<kind>A</kind>
<name>Shapland et al.</name>
<date>19940200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00089">
<document-id>
<country>US</country>
<doc-number>5286254</doc-number>
<kind>A</kind>
<name>Shapland et al.</name>
<date>19940200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00090">
<document-id>
<country>US</country>
<doc-number>5299569</doc-number>
<kind>A</kind>
<name>Wernicke et al.</name>
<date>19940400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00091">
<document-id>
<country>US</country>
<doc-number>5300068</doc-number>
<kind>A</kind>
<name>Rosar et al.</name>
<date>19940400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00092">
<document-id>
<country>US</country>
<doc-number>5304120</doc-number>
<kind>A</kind>
<name>Crandell et al.</name>
<date>19940400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00093">
<document-id>
<country>US</country>
<doc-number>5304206</doc-number>
<kind>A</kind>
<name>Baker</name>
<date>19940400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00094">
<document-id>
<country>US</country>
<doc-number>5317155</doc-number>
<kind>A</kind>
<name>King</name>
<date>19940500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00095">
<document-id>
<country>US</country>
<doc-number>5324255</doc-number>
<kind>A</kind>
<name>Passafaro et al.</name>
<date>19940600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00096">
<document-id>
<country>US</country>
<doc-number>5324316</doc-number>
<kind>A</kind>
<name>Schulman et al.</name>
<date>19940600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00097">
<document-id>
<country>US</country>
<doc-number>5334193</doc-number>
<kind>A</kind>
<name>Nardella</name>
<date>19940800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00098">
<document-id>
<country>US</country>
<doc-number>5335657</doc-number>
<kind>A</kind>
<name>Terry, Jr. et al.</name>
<date>19940800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00099">
<document-id>
<country>US</country>
<doc-number>5338662</doc-number>
<kind>A</kind>
<name>Sadri</name>
<date>19940800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00100">
<document-id>
<country>US</country>
<doc-number>5351394</doc-number>
<kind>A</kind>
<name>Weinberg</name>
<date>19941000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00101">
<document-id>
<country>US</country>
<doc-number>5358514</doc-number>
<kind>A</kind>
<name>Schulman et al.</name>
<date>19941000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00102">
<document-id>
<country>US</country>
<doc-number>5368591</doc-number>
<kind>A</kind>
<name>Lennox et al.</name>
<date>19941100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00103">
<document-id>
<country>US</country>
<doc-number>5370680</doc-number>
<kind>A</kind>
<name>Proctor</name>
<date>19941200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00104">
<document-id>
<country>US</country>
<doc-number>5389069</doc-number>
<kind>A</kind>
<name>Weaver</name>
<date>19950200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00105">
<document-id>
<country>US</country>
<doc-number>5397308</doc-number>
<kind>A</kind>
<name>Ellis et al.</name>
<date>19950300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00106">
<document-id>
<country>US</country>
<doc-number>5397338</doc-number>
<kind>A</kind>
<name>Grey et al.</name>
<date>19950300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00107">
<document-id>
<country>US</country>
<doc-number>5400784</doc-number>
<kind>A</kind>
<name>Durand et al.</name>
<date>19950300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00108">
<document-id>
<country>US</country>
<doc-number>5405367</doc-number>
<kind>A</kind>
<name>Schulman et al.</name>
<date>19950400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00109">
<document-id>
<country>US</country>
<doc-number>5423744</doc-number>
<kind>A</kind>
<name>Gencheff et al.</name>
<date>19950600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00110">
<document-id>
<country>US</country>
<doc-number>5429634</doc-number>
<kind>A</kind>
<name>Narciso, Jr.</name>
<date>19950700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00111">
<document-id>
<country>US</country>
<doc-number>5433739</doc-number>
<kind>A</kind>
<name>Sluijter et al.</name>
<date>19950700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00112">
<document-id>
<country>US</country>
<doc-number>5439440</doc-number>
<kind>A</kind>
<name>Hofmann</name>
<date>19950800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00113">
<document-id>
<country>US</country>
<doc-number>5454782</doc-number>
<kind>A</kind>
<name>Perkins</name>
<date>19951000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00114">
<document-id>
<country>US</country>
<doc-number>5454809</doc-number>
<kind>A</kind>
<name>Janssen</name>
<date>19951000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00115">
<document-id>
<country>US</country>
<doc-number>5458568</doc-number>
<kind>A</kind>
<name>Racchini et al.</name>
<date>19951000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00116">
<document-id>
<country>US</country>
<doc-number>5458626</doc-number>
<kind>A</kind>
<name>Krause</name>
<date>19951000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00117">
<document-id>
<country>US</country>
<doc-number>5458631</doc-number>
<kind>A</kind>
<name>Xavier</name>
<date>19951000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00118">
<document-id>
<country>US</country>
<doc-number>5470352</doc-number>
<kind>A</kind>
<name>Rappaport</name>
<date>19951100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00119">
<document-id>
<country>US</country>
<doc-number>5472406</doc-number>
<kind>A</kind>
<name>de la Torre et al.</name>
<date>19951200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00120">
<document-id>
<country>US</country>
<doc-number>5478303</doc-number>
<kind>A</kind>
<name>Foley-Nolan et al.</name>
<date>19951200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00121">
<document-id>
<country>US</country>
<doc-number>5484400</doc-number>
<kind>A</kind>
<name>Edwards et al.</name>
<date>19960100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00122">
<document-id>
<country>US</country>
<doc-number>5494822</doc-number>
<kind>A</kind>
<name>Sadri</name>
<date>19960200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00123">
<document-id>
<country>US</country>
<doc-number>5498238</doc-number>
<kind>A</kind>
<name>Shapland et al.</name>
<date>19960300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00124">
<document-id>
<country>US</country>
<doc-number>5499971</doc-number>
<kind>A</kind>
<name>Shapland et al.</name>
<date>19960300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00125">
<document-id>
<country>US</country>
<doc-number>5505700</doc-number>
<kind>A</kind>
<name>Leone et al.</name>
<date>19960400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00126">
<document-id>
<country>US</country>
<doc-number>5507724</doc-number>
<kind>A</kind>
<name>Hofmann et al.</name>
<date>19960400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00127">
<document-id>
<country>US</country>
<doc-number>5507791</doc-number>
<kind>A</kind>
<name>Sit'ko</name>
<date>19960400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00128">
<document-id>
<country>US</country>
<doc-number>5531778</doc-number>
<kind>A</kind>
<name>Maschino et al.</name>
<date>19960700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00129">
<document-id>
<country>US</country>
<doc-number>5540730</doc-number>
<kind>A</kind>
<name>Terry, Jr. et al.</name>
<date>19960700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00130">
<document-id>
<country>US</country>
<doc-number>5540734</doc-number>
<kind>A</kind>
<name>Zabara</name>
<date>19960700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00131">
<document-id>
<country>US</country>
<doc-number>5553611</doc-number>
<kind>A</kind>
<name>Budd et al.</name>
<date>19960900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00132">
<document-id>
<country>US</country>
<doc-number>5560360</doc-number>
<kind>A</kind>
<name>Filler et al.</name>
<date>19961000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00133">
<document-id>
<country>US</country>
<doc-number>5569198</doc-number>
<kind>A</kind>
<name>Racchini</name>
<date>19961000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00134">
<document-id>
<country>US</country>
<doc-number>5571147</doc-number>
<kind>A</kind>
<name>Sluijter et al.</name>
<date>19961100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00135">
<document-id>
<country>US</country>
<doc-number>5571150</doc-number>
<kind>A</kind>
<name>Wernicke et al.</name>
<date>19961100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00136">
<document-id>
<country>US</country>
<doc-number>5573552</doc-number>
<kind>A</kind>
<name>Hansjurgens</name>
<date>19961100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00137">
<document-id>
<country>US</country>
<doc-number>5584863</doc-number>
<kind>A</kind>
<name>Rauch et al.</name>
<date>19961200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00138">
<document-id>
<country>US</country>
<doc-number>5589192</doc-number>
<kind>A</kind>
<name>Okabe et al.</name>
<date>19961200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00139">
<document-id>
<country>US</country>
<doc-number>5599345</doc-number>
<kind>A</kind>
<name>Edwards et al.</name>
<date>19970200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00140">
<document-id>
<country>US</country>
<doc-number>5618563</doc-number>
<kind>A</kind>
<name>Berde et al.</name>
<date>19970400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00141">
<document-id>
<country>US</country>
<doc-number>5626576</doc-number>
<kind>A</kind>
<name>Janssen</name>
<date>19970500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00142">
<document-id>
<country>US</country>
<doc-number>5626862</doc-number>
<kind>A</kind>
<name>Brem et al.</name>
<date>19970500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00143">
<document-id>
<country>US</country>
<doc-number>5628730</doc-number>
<kind>A</kind>
<name>Shapland et al.</name>
<date>19970500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00144">
<document-id>
<country>US</country>
<doc-number>5634462</doc-number>
<kind>A</kind>
<name>Tyler et al.</name>
<date>19970600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00145">
<document-id>
<country>US</country>
<doc-number>5634899</doc-number>
<kind>A</kind>
<name>Shapland et al.</name>
<date>19970600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00146">
<document-id>
<country>US</country>
<doc-number>5672174</doc-number>
<kind>A</kind>
<name>Gough et al.</name>
<date>19970900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00147">
<document-id>
<country>US</country>
<doc-number>5688266</doc-number>
<kind>A</kind>
<name>Edwards et al.</name>
<date>19971100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00148">
<document-id>
<country>US</country>
<doc-number>5689877</doc-number>
<kind>A</kind>
<name>Grill, Jr. et al.</name>
<date>19971100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00149">
<document-id>
<country>US</country>
<doc-number>5690691</doc-number>
<kind>A</kind>
<name>Chen et al.</name>
<date>19971100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00150">
<document-id>
<country>US</country>
<doc-number>5700282</doc-number>
<kind>A</kind>
<name>Zabara</name>
<date>19971200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00151">
<document-id>
<country>US</country>
<doc-number>5700485</doc-number>
<kind>A</kind>
<name>Berde et al.</name>
<date>19971200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00152">
<document-id>
<country>US</country>
<doc-number>5704908</doc-number>
<kind>A</kind>
<name>Hofmann et al.</name>
<date>19980100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00153">
<document-id>
<country>US</country>
<doc-number>5707400</doc-number>
<kind>A</kind>
<name>Terry, Jr. et al.</name>
<date>19980100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00154">
<document-id>
<country>US</country>
<doc-number>5711326</doc-number>
<kind>A</kind>
<name>Thies et al.</name>
<date>19980100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00155">
<document-id>
<country>US</country>
<doc-number>5713847</doc-number>
<kind>A</kind>
<name>Howard, III et al.</name>
<date>19980200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00156">
<document-id>
<country>US</country>
<doc-number>5722401</doc-number>
<kind>A</kind>
<name>Pietroski et al.</name>
<date>19980300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00157">
<document-id>
<country>US</country>
<doc-number>5723001</doc-number>
<kind>A</kind>
<name>Pilla et al.</name>
<date>19980300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00158">
<document-id>
<country>US</country>
<doc-number>5725563</doc-number>
<kind>A</kind>
<name>Klotz et al.</name>
<date>19980300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00159">
<document-id>
<country>US</country>
<doc-number>5728396</doc-number>
<kind>A</kind>
<name>Peery et al.</name>
<date>19980300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00160">
<document-id>
<country>US</country>
<doc-number>5747060</doc-number>
<kind>A</kind>
<name>Sackler et al.</name>
<date>19980500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00161">
<document-id>
<country>US</country>
<doc-number>5755750</doc-number>
<kind>A</kind>
<name>Petruska et al.</name>
<date>19980500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00162">
<document-id>
<country>US</country>
<doc-number>5756115</doc-number>
<kind>A</kind>
<name>Moo-Young et al.</name>
<date>19980500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00163">
<document-id>
<country>US</country>
<doc-number>5772590</doc-number>
<kind>A</kind>
<name>Webster, Jr.</name>
<date>19980600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00164">
<document-id>
<country>US</country>
<doc-number>5792187</doc-number>
<kind>A</kind>
<name>Adams</name>
<date>19980800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00165">
<document-id>
<country>US</country>
<doc-number>5800464</doc-number>
<kind>A</kind>
<name>Kieval</name>
<date>19980900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00166">
<document-id>
<country>US</country>
<doc-number>5807306</doc-number>
<kind>A</kind>
<name>Shapland et al.</name>
<date>19980900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00167">
<document-id>
<country>US</country>
<doc-number>5810802</doc-number>
<kind>A</kind>
<name>Panescu et al.</name>
<date>19980900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00168">
<document-id>
<country>US</country>
<doc-number>5814079</doc-number>
<kind>A</kind>
<name>Kieval</name>
<date>19980900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00169">
<document-id>
<country>US</country>
<doc-number>5824087</doc-number>
<kind>A</kind>
<name>Aspden et al.</name>
<date>19981000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00170">
<document-id>
<country>US</country>
<doc-number>5836935</doc-number>
<kind>A</kind>
<name>Ashton et al.</name>
<date>19981100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00171">
<document-id>
<country>US</country>
<doc-number>RE35987</doc-number>
<kind>E</kind>
<name>Harris et al.</name>
<date>19981200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00172">
<document-id>
<country>US</country>
<doc-number>5843069</doc-number>
<kind>A</kind>
<name>Butler et al.</name>
<date>19981200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00173">
<document-id>
<country>US</country>
<doc-number>5861021</doc-number>
<kind>A</kind>
<name>Thome et al.</name>
<date>19990100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00174">
<document-id>
<country>US</country>
<doc-number>5865787</doc-number>
<kind>A</kind>
<name>Shapland et al.</name>
<date>19990200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00175">
<document-id>
<country>US</country>
<doc-number>5871449</doc-number>
<kind>A</kind>
<name>Brown</name>
<date>19990200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00176">
<document-id>
<country>US</country>
<doc-number>5891181</doc-number>
<kind>A</kind>
<name>Zhu</name>
<date>19990400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00177">
<document-id>
<country>US</country>
<doc-number>5893885</doc-number>
<kind>A</kind>
<name>Webster et al.</name>
<date>19990400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00178">
<document-id>
<country>US</country>
<doc-number>5906636</doc-number>
<kind>A</kind>
<name>Casscells, III et al.</name>
<date>19990500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00179">
<document-id>
<country>US</country>
<doc-number>5906817</doc-number>
<kind>A</kind>
<name>Moullier et al.</name>
<date>19990500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00180">
<document-id>
<country>US</country>
<doc-number>5913876</doc-number>
<kind>A</kind>
<name>Taylor et al.</name>
<date>19990600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00181">
<document-id>
<country>US</country>
<doc-number>5916154</doc-number>
<kind>A</kind>
<name>Hobbs et al.</name>
<date>19990600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00182">
<document-id>
<country>US</country>
<doc-number>5916239</doc-number>
<kind>A</kind>
<name>Geddes et al.</name>
<date>19990600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00183">
<document-id>
<country>US</country>
<doc-number>5919187</doc-number>
<kind>A</kind>
<name>Guglielmi et al.</name>
<date>19990700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00184">
<document-id>
<country>US</country>
<doc-number>5924997</doc-number>
<kind>A</kind>
<name>Campbell</name>
<date>19990700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00185">
<document-id>
<country>US</country>
<doc-number>5928272</doc-number>
<kind>A</kind>
<name>Adkins et al.</name>
<date>19990700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00186">
<document-id>
<country>US</country>
<doc-number>5935075</doc-number>
<kind>A</kind>
<name>Casscells et al.</name>
<date>19990800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00187">
<document-id>
<country>US</country>
<doc-number>5944710</doc-number>
<kind>A</kind>
<name>Dev et al.</name>
<date>19990800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00188">
<document-id>
<country>US</country>
<doc-number>5954719</doc-number>
<kind>A</kind>
<name>Chen et al.</name>
<date>19990900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00189">
<document-id>
<country>US</country>
<doc-number>5983131</doc-number>
<kind>A</kind>
<name>Weaver et al.</name>
<date>19991100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00190">
<document-id>
<country>US</country>
<doc-number>5983141</doc-number>
<kind>A</kind>
<name>Sluijter et al.</name>
<date>19991100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00191">
<document-id>
<country>US</country>
<doc-number>6004269</doc-number>
<kind>A</kind>
<name>Crowley et al.</name>
<date>19991200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00192">
<document-id>
<country>US</country>
<doc-number>6006134</doc-number>
<kind>A</kind>
<name>Hill et al.</name>
<date>19991200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00193">
<document-id>
<country>US</country>
<doc-number>6009877</doc-number>
<kind>A</kind>
<name>Edwards</name>
<date>20000100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00194">
<document-id>
<country>US</country>
<doc-number>6010613</doc-number>
<kind>A</kind>
<name>Walters et al.</name>
<date>20000100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00195">
<document-id>
<country>US</country>
<doc-number>6026326</doc-number>
<kind>A</kind>
<name>Bardy</name>
<date>20000200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00196">
<document-id>
<country>US</country>
<doc-number>6041252</doc-number>
<kind>A</kind>
<name>Walker et al.</name>
<date>20000300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00197">
<document-id>
<country>US</country>
<doc-number>6051017</doc-number>
<kind>A</kind>
<name>Loeb et al.</name>
<date>20000400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00198">
<document-id>
<country>US</country>
<doc-number>6058328</doc-number>
<kind>A</kind>
<name>Levine et al.</name>
<date>20000500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00199">
<document-id>
<country>US</country>
<doc-number>6058331</doc-number>
<kind>A</kind>
<name>King</name>
<date>20000500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00200">
<document-id>
<country>US</country>
<doc-number>6066134</doc-number>
<kind>A</kind>
<name>Eggers et al.</name>
<date>20000500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00201">
<document-id>
<country>US</country>
<doc-number>6073048</doc-number>
<kind>A</kind>
<name>Kieval et al.</name>
<date>20000600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00202">
<document-id>
<country>US</country>
<doc-number>6077227</doc-number>
<kind>A</kind>
<name>Miesel et al.</name>
<date>20000600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00203">
<document-id>
<country>US</country>
<doc-number>6086527</doc-number>
<kind>A</kind>
<name>Talpade</name>
<date>20000700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00204">
<document-id>
<country>US</country>
<doc-number>6099524</doc-number>
<kind>A</kind>
<name>Lipson et al.</name>
<date>20000800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00205">
<document-id>
<country>US</country>
<doc-number>6117101</doc-number>
<kind>A</kind>
<name>Diederich et al.</name>
<date>20000900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00206">
<document-id>
<country>US</country>
<doc-number>6122548</doc-number>
<kind>A</kind>
<name>Starkebaum et al.</name>
<date>20000900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00207">
<document-id>
<country>US</country>
<doc-number>6123718</doc-number>
<kind>A</kind>
<name>Tu et al.</name>
<date>20000900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00208">
<document-id>
<country>US</country>
<doc-number>6135999</doc-number>
<kind>A</kind>
<name>Fanton et al.</name>
<date>20001000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00209">
<document-id>
<country>US</country>
<doc-number>6146380</doc-number>
<kind>A</kind>
<name>Racz et al.</name>
<date>20001100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00210">
<document-id>
<country>US</country>
<doc-number>6149620</doc-number>
<kind>A</kind>
<name>Baker et al.</name>
<date>20001100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00211">
<document-id>
<country>US</country>
<doc-number>6161048</doc-number>
<kind>A</kind>
<name>Sluijter et al.</name>
<date>20001200</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607100</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00212">
<document-id>
<country>US</country>
<doc-number>6171306</doc-number>
<kind>B1</kind>
<name>Swanson</name>
<date>20010100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00213">
<document-id>
<country>US</country>
<doc-number>6178349</doc-number>
<kind>B1</kind>
<name>Kieval</name>
<date>20010100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00214">
<document-id>
<country>US</country>
<doc-number>6190353</doc-number>
<kind>B1</kind>
<name>Makower et al.</name>
<date>20010200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00215">
<document-id>
<country>US</country>
<doc-number>6192889</doc-number>
<kind>B1</kind>
<name>Morrish</name>
<date>20010200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00216">
<document-id>
<country>US</country>
<doc-number>6205361</doc-number>
<kind>B1</kind>
<name>Kuzma et al.</name>
<date>20010300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00217">
<document-id>
<country>US</country>
<doc-number>6208894</doc-number>
<kind>B1</kind>
<name>Schulman et al.</name>
<date>20010300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00218">
<document-id>
<country>US</country>
<doc-number>6214032</doc-number>
<kind>B1</kind>
<name>Loeb et al.</name>
<date>20010400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00219">
<document-id>
<country>US</country>
<doc-number>6219577</doc-number>
<kind>B1</kind>
<name>Brown, III et al.</name>
<date>20010400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00220">
<document-id>
<country>US</country>
<doc-number>6224592</doc-number>
<kind>B1</kind>
<name>Eggers et al.</name>
<date>20010500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00221">
<document-id>
<country>US</country>
<doc-number>6238702</doc-number>
<kind>B1</kind>
<name>Berde et al.</name>
<date>20010500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00222">
<document-id>
<country>US</country>
<doc-number>6245026</doc-number>
<kind>B1</kind>
<name>Campbell et al.</name>
<date>20010600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00223">
<document-id>
<country>US</country>
<doc-number>6246912</doc-number>
<kind>B1</kind>
<name>Sluijter</name>
<date>20010600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00224">
<document-id>
<country>US</country>
<doc-number>6251130</doc-number>
<kind>B1</kind>
<name>Dobak, III et al.</name>
<date>20010600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00225">
<document-id>
<country>US</country>
<doc-number>6254598</doc-number>
<kind>B1</kind>
<name>Edwards et al.</name>
<date>20010700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00226">
<document-id>
<country>US</country>
<doc-number>6258087</doc-number>
<kind>B1</kind>
<name>Edwards et al.</name>
<date>20010700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00227">
<document-id>
<country>US</country>
<doc-number>6259952</doc-number>
<kind>B1</kind>
<name>Sluijter et al.</name>
<date>20010700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00228">
<document-id>
<country>US</country>
<doc-number>6269269</doc-number>
<kind>B1</kind>
<name>Ottenhoff et al.</name>
<date>20010700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00229">
<document-id>
<country>US</country>
<doc-number>6272377</doc-number>
<kind>B1</kind>
<name>Sweeney et al.</name>
<date>20010800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00230">
<document-id>
<country>US</country>
<doc-number>6272383</doc-number>
<kind>B1</kind>
<name>Grey et al.</name>
<date>20010800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00231">
<document-id>
<country>US</country>
<doc-number>6273886</doc-number>
<kind>B1</kind>
<name>Edwards et al.</name>
<date>20010800</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>606 34</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00232">
<document-id>
<country>US</country>
<doc-number>6280377</doc-number>
<kind>B1</kind>
<name>Talpade</name>
<date>20010800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00233">
<document-id>
<country>US</country>
<doc-number>6283951</doc-number>
<kind>B1</kind>
<name>Flaherty et al.</name>
<date>20010900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00234">
<document-id>
<country>US</country>
<doc-number>6287304</doc-number>
<kind>B1</kind>
<name>Eggers et al.</name>
<date>20010900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00235">
<document-id>
<country>US</country>
<doc-number>6287608</doc-number>
<kind>B1</kind>
<name>Levin et al.</name>
<date>20010900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00236">
<document-id>
<country>US</country>
<doc-number>6292695</doc-number>
<kind>B1</kind>
<name>Webster et al.</name>
<date>20010900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00237">
<document-id>
<country>US</country>
<doc-number>6304777</doc-number>
<kind>B1</kind>
<name>Ben-Haim et al.</name>
<date>20011000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00238">
<document-id>
<country>US</country>
<doc-number>6304787</doc-number>
<kind>B1</kind>
<name>Kuzma et al.</name>
<date>20011000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00239">
<document-id>
<country>US</country>
<doc-number>6306423</doc-number>
<kind>B1</kind>
<name>Donovan et al.</name>
<date>20011000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00240">
<document-id>
<country>US</country>
<doc-number>6314325</doc-number>
<kind>B1</kind>
<name>Fitz</name>
<date>20011100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00241">
<document-id>
<country>US</country>
<doc-number>6322558</doc-number>
<kind>B1</kind>
<name>Taylor et al.</name>
<date>20011100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00242">
<document-id>
<country>US</country>
<doc-number>6322559</doc-number>
<kind>B1</kind>
<name>Daulton et al.</name>
<date>20011100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00243">
<document-id>
<country>US</country>
<doc-number>6326020</doc-number>
<kind>B1</kind>
<name>Kohane et al.</name>
<date>20011200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00244">
<document-id>
<country>US</country>
<doc-number>6326177</doc-number>
<kind>B1</kind>
<name>Schoenbach et al.</name>
<date>20011200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00245">
<document-id>
<country>US</country>
<doc-number>6328699</doc-number>
<kind>B1</kind>
<name>Eigler et al.</name>
<date>20011200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00246">
<document-id>
<country>US</country>
<doc-number>6334069</doc-number>
<kind>B1</kind>
<name>George et al.</name>
<date>20011200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00247">
<document-id>
<country>US</country>
<doc-number>6347247</doc-number>
<kind>B1</kind>
<name>Dev et al.</name>
<date>20020200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00248">
<document-id>
<country>US</country>
<doc-number>6353763</doc-number>
<kind>B1</kind>
<name>George et al.</name>
<date>20020300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00249">
<document-id>
<country>US</country>
<doc-number>6356786</doc-number>
<kind>B1</kind>
<name>Rezai et al.</name>
<date>20020300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00250">
<document-id>
<country>US</country>
<doc-number>6356787</doc-number>
<kind>B1</kind>
<name>Rezai et al.</name>
<date>20020300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00251">
<document-id>
<country>US</country>
<doc-number>6366808</doc-number>
<kind>B1</kind>
<name>Schroeppel et al.</name>
<date>20020400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00252">
<document-id>
<country>US</country>
<doc-number>6366815</doc-number>
<kind>B1</kind>
<name>Haugland et al.</name>
<date>20020400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00253">
<document-id>
<country>US</country>
<doc-number>6393324</doc-number>
<kind>B2</kind>
<name>Gruzdowich et al.</name>
<date>20020500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00254">
<document-id>
<country>US</country>
<doc-number>6400982</doc-number>
<kind>B2</kind>
<name>Sweeney et al.</name>
<date>20020600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00255">
<document-id>
<country>US</country>
<doc-number>6405079</doc-number>
<kind>B1</kind>
<name>Ansarinia</name>
<date>20020600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00256">
<document-id>
<country>US</country>
<doc-number>6405732</doc-number>
<kind>B1</kind>
<name>Edwards et al.</name>
<date>20020600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00257">
<document-id>
<country>US</country>
<doc-number>6413255</doc-number>
<kind>B1</kind>
<name>Stern</name>
<date>20020700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00258">
<document-id>
<country>US</country>
<doc-number>6415183</doc-number>
<kind>B1</kind>
<name>Scheiner et al.</name>
<date>20020700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00259">
<document-id>
<country>US</country>
<doc-number>6415187</doc-number>
<kind>B1</kind>
<name>Kuzma et al.</name>
<date>20020700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00260">
<document-id>
<country>US</country>
<doc-number>6438423</doc-number>
<kind>B1</kind>
<name>Rezai et al.</name>
<date>20020800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00261">
<document-id>
<country>US</country>
<doc-number>6442424</doc-number>
<kind>B1</kind>
<name>Ben-Haim et al.</name>
<date>20020800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00262">
<document-id>
<country>US</country>
<doc-number>6449507</doc-number>
<kind>B1</kind>
<name>Hill et al.</name>
<date>20020900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00263">
<document-id>
<country>US</country>
<doc-number>6450942</doc-number>
<kind>B1</kind>
<name>Lapanashvili et al.</name>
<date>20020900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00264">
<document-id>
<country>US</country>
<doc-number>6461314</doc-number>
<kind>B1</kind>
<name>Pant et al.</name>
<date>20021000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00265">
<document-id>
<country>US</country>
<doc-number>6464687</doc-number>
<kind>B1</kind>
<name>Ishikawa et al.</name>
<date>20021000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00266">
<document-id>
<country>US</country>
<doc-number>6473644</doc-number>
<kind>B1</kind>
<name>Terry, Jr. et al.</name>
<date>20021000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00267">
<document-id>
<country>US</country>
<doc-number>6482619</doc-number>
<kind>B1</kind>
<name>Rubinsky et al.</name>
<date>20021100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00268">
<document-id>
<country>US</country>
<doc-number>6488679</doc-number>
<kind>B1</kind>
<name>Swanson et al.</name>
<date>20021200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00269">
<document-id>
<country>US</country>
<doc-number>6506189</doc-number>
<kind>B1</kind>
<name>Rittman et al.</name>
<date>20030100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00270">
<document-id>
<country>US</country>
<doc-number>6508774</doc-number>
<kind>B1</kind>
<name>Acker et al.</name>
<date>20030100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00271">
<document-id>
<country>US</country>
<doc-number>6514226</doc-number>
<kind>B1</kind>
<name>Levin et al.</name>
<date>20030200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00272">
<document-id>
<country>US</country>
<doc-number>6516211</doc-number>
<kind>B1</kind>
<name>Acker et al.</name>
<date>20030200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00273">
<document-id>
<country>US</country>
<doc-number>6517811</doc-number>
<kind>B2</kind>
<name>John et al.</name>
<date>20030200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00274">
<document-id>
<country>US</country>
<doc-number>6522926</doc-number>
<kind>B1</kind>
<name>Kieval et al.</name>
<date>20030200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00275">
<document-id>
<country>US</country>
<doc-number>6522932</doc-number>
<kind>B1</kind>
<name>Kuzma et al.</name>
<date>20030200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00276">
<document-id>
<country>US</country>
<doc-number>6524607</doc-number>
<kind>B1</kind>
<name>Goldenheim et al.</name>
<date>20030200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00277">
<document-id>
<country>US</country>
<doc-number>6534081</doc-number>
<kind>B2</kind>
<name>Goldenheim et al.</name>
<date>20030300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00278">
<document-id>
<country>US</country>
<doc-number>6536949</doc-number>
<kind>B1</kind>
<name>Heuser</name>
<date>20030300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00279">
<document-id>
<country>US</country>
<doc-number>6562034</doc-number>
<kind>B2</kind>
<name>Edwards et al.</name>
<date>20030500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00280">
<document-id>
<country>US</country>
<doc-number>6564096</doc-number>
<kind>B2</kind>
<name>Mest</name>
<date>20030500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00281">
<document-id>
<country>US</country>
<doc-number>6571127</doc-number>
<kind>B1</kind>
<name>Ben-Haim et al.</name>
<date>20030500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00282">
<document-id>
<country>US</country>
<doc-number>6592567</doc-number>
<kind>B1</kind>
<name>Levin et al.</name>
<date>20030700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00283">
<document-id>
<country>US</country>
<doc-number>6599256</doc-number>
<kind>B1</kind>
<name>Acker et al.</name>
<date>20030700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00284">
<document-id>
<country>US</country>
<doc-number>6600954</doc-number>
<kind>B2</kind>
<name>Cohen et al.</name>
<date>20030700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00285">
<document-id>
<country>US</country>
<doc-number>6600956</doc-number>
<kind>B2</kind>
<name>Maschino et al.</name>
<date>20030700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00286">
<document-id>
<country>US</country>
<doc-number>6601459</doc-number>
<kind>B1</kind>
<name>Jenni et al.</name>
<date>20030800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00287">
<document-id>
<country>US</country>
<doc-number>6605084</doc-number>
<kind>B2</kind>
<name>Acker et al.</name>
<date>20030800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00288">
<document-id>
<country>US</country>
<doc-number>6613045</doc-number>
<kind>B1</kind>
<name>Laufer et al.</name>
<date>20030900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00289">
<document-id>
<country>US</country>
<doc-number>6615071</doc-number>
<kind>B1</kind>
<name>Casscells, III et al.</name>
<date>20030900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00290">
<document-id>
<country>US</country>
<doc-number>6616624</doc-number>
<kind>B1</kind>
<name>Kieval</name>
<date>20030900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00291">
<document-id>
<country>US</country>
<doc-number>6620151</doc-number>
<kind>B2</kind>
<name>Blischak et al.</name>
<date>20030900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00292">
<document-id>
<country>US</country>
<doc-number>6622041</doc-number>
<kind>B2</kind>
<name>Terry, Jr. et al.</name>
<date>20030900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00293">
<document-id>
<country>US</country>
<doc-number>6622731</doc-number>
<kind>B2</kind>
<name>Daniel et al.</name>
<date>20030900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00294">
<document-id>
<country>US</country>
<doc-number>6635054</doc-number>
<kind>B2</kind>
<name>Fjield et al.</name>
<date>20031000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00295">
<document-id>
<country>US</country>
<doc-number>6654636</doc-number>
<kind>B1</kind>
<name>Dev et al.</name>
<date>20031100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00296">
<document-id>
<country>US</country>
<doc-number>6666845</doc-number>
<kind>B2</kind>
<name>Hooper et al.</name>
<date>20031200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00297">
<document-id>
<country>US</country>
<doc-number>6669655</doc-number>
<kind>B1</kind>
<name>Acker et al.</name>
<date>20031200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00298">
<document-id>
<country>US</country>
<doc-number>6671556</doc-number>
<kind>B2</kind>
<name>Osorio et al.</name>
<date>20031200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00299">
<document-id>
<country>US</country>
<doc-number>6672312</doc-number>
<kind>B2</kind>
<name>Acker</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00300">
<document-id>
<country>US</country>
<doc-number>6676657</doc-number>
<kind>B2</kind>
<name>Wood</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00301">
<document-id>
<country>US</country>
<doc-number>6681136</doc-number>
<kind>B2</kind>
<name>Schuler et al.</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00302">
<document-id>
<country>US</country>
<doc-number>6684105</doc-number>
<kind>B2</kind>
<name>Cohen et al.</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00303">
<document-id>
<country>US</country>
<doc-number>6685648</doc-number>
<kind>B2</kind>
<name>Flaherty et al.</name>
<date>20040200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00304">
<document-id>
<country>US</country>
<doc-number>6690971</doc-number>
<kind>B2</kind>
<name>Schauerte et al.</name>
<date>20040200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00305">
<document-id>
<country>US</country>
<doc-number>6692738</doc-number>
<kind>B2</kind>
<name>MacLaughlin et al.</name>
<date>20040200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00306">
<document-id>
<country>US</country>
<doc-number>6697670</doc-number>
<kind>B2</kind>
<name>Chomenky et al.</name>
<date>20040200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00307">
<document-id>
<country>US</country>
<doc-number>6718208</doc-number>
<kind>B2</kind>
<name>Hill et al.</name>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00308">
<document-id>
<country>US</country>
<doc-number>6735471</doc-number>
<kind>B2</kind>
<name>Hill et al.</name>
<date>20040500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00309">
<document-id>
<country>US</country>
<doc-number>6736835</doc-number>
<kind>B2</kind>
<name>Pellegrino et al.</name>
<date>20040500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00310">
<document-id>
<country>US</country>
<doc-number>6738663</doc-number>
<kind>B2</kind>
<name>Schroeppel et al.</name>
<date>20040500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00311">
<document-id>
<country>US</country>
<doc-number>6749598</doc-number>
<kind>B1</kind>
<name>Keren et al.</name>
<date>20040600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00312">
<document-id>
<country>US</country>
<doc-number>6786904</doc-number>
<kind>B2</kind>
<name>Doscher et al.</name>
<date>20040900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00313">
<document-id>
<country>US</country>
<doc-number>6795728</doc-number>
<kind>B2</kind>
<name>Chornenky et al.</name>
<date>20040900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00314">
<document-id>
<country>US</country>
<doc-number>6845267</doc-number>
<kind>B2</kind>
<name>Harrison et al.</name>
<date>20050100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00315">
<document-id>
<country>US</country>
<doc-number>6850801</doc-number>
<kind>B2</kind>
<name>Kieval et al.</name>
<date>20050200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00316">
<document-id>
<country>US</country>
<doc-number>6862479</doc-number>
<kind>B1</kind>
<name>Whitehurst et al.</name>
<date>20050300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00317">
<document-id>
<country>US</country>
<doc-number>6865416</doc-number>
<kind>B2</kind>
<name>Dev et al.</name>
<date>20050300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00318">
<document-id>
<country>US</country>
<doc-number>6885888</doc-number>
<kind>B2</kind>
<name>Rezai</name>
<date>20050400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00319">
<document-id>
<country>US</country>
<doc-number>6893436</doc-number>
<kind>B2</kind>
<name>Woodard et al.</name>
<date>20050500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00320">
<document-id>
<country>US</country>
<doc-number>6916656</doc-number>
<kind>B2</kind>
<name>Walters et al.</name>
<date>20050700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00321">
<document-id>
<country>US</country>
<doc-number>6927049</doc-number>
<kind>B2</kind>
<name>Rubinsky et al.</name>
<date>20050800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00322">
<document-id>
<country>US</country>
<doc-number>6936047</doc-number>
<kind>B2</kind>
<name>Nasab et al.</name>
<date>20050800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00323">
<document-id>
<country>US</country>
<doc-number>6939345</doc-number>
<kind>B2</kind>
<name>KenKnight et al.</name>
<date>20050900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00324">
<document-id>
<country>US</country>
<doc-number>6939346</doc-number>
<kind>B2</kind>
<name>Kannenberg et al.</name>
<date>20050900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00325">
<document-id>
<country>US</country>
<doc-number>6958060</doc-number>
<kind>B2</kind>
<name>Mathiesen et al.</name>
<date>20051000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00326">
<document-id>
<country>US</country>
<doc-number>6969388</doc-number>
<kind>B2</kind>
<name>Goldman et al.</name>
<date>20051100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00327">
<document-id>
<country>US</country>
<doc-number>6972013</doc-number>
<kind>B1</kind>
<name>Zhang et al.</name>
<date>20051200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00328">
<document-id>
<country>US</country>
<doc-number>6978174</doc-number>
<kind>B2</kind>
<name>Gelfand et al.</name>
<date>20051200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00329">
<document-id>
<country>US</country>
<doc-number>6985774</doc-number>
<kind>B2</kind>
<name>Kieval et al.</name>
<date>20060100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00330">
<document-id>
<country>US</country>
<doc-number>6994700</doc-number>
<kind>B2</kind>
<name>Elkins et al.</name>
<date>20060200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00331">
<document-id>
<country>US</country>
<doc-number>6994706</doc-number>
<kind>B2</kind>
<name>Chornenky et al.</name>
<date>20060200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00332">
<document-id>
<country>US</country>
<doc-number>7004911</doc-number>
<kind>B1</kind>
<name>Tu et al.</name>
<date>20060200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00333">
<document-id>
<country>US</country>
<doc-number>7054685</doc-number>
<kind>B2</kind>
<name>Dimmer et al.</name>
<date>20060500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00334">
<document-id>
<country>US</country>
<doc-number>7063679</doc-number>
<kind>B2</kind>
<name>Maguire et al.</name>
<date>20060600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00335">
<document-id>
<country>US</country>
<doc-number>7081114</doc-number>
<kind>B2</kind>
<name>Rashidi</name>
<date>20060700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00336">
<document-id>
<country>US</country>
<doc-number>7081115</doc-number>
<kind>B2</kind>
<name>Taimisto</name>
<date>20060700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00337">
<document-id>
<country>US</country>
<doc-number>7083614</doc-number>
<kind>B2</kind>
<name>Fjield et al.</name>
<date>20060800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00338">
<document-id>
<country>US</country>
<doc-number>7122019</doc-number>
<kind>B1</kind>
<name>Kesten et al.</name>
<date>20061000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00339">
<document-id>
<country>US</country>
<doc-number>7149574</doc-number>
<kind>B2</kind>
<name>Yun et al.</name>
<date>20061200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00340">
<document-id>
<country>US</country>
<doc-number>7155284</doc-number>
<kind>B1</kind>
<name>Whitehurst et al.</name>
<date>20061200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00341">
<document-id>
<country>US</country>
<doc-number>7162303</doc-number>
<kind>B2</kind>
<name>Levin et al.</name>
<date>20070100</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00342">
<document-id>
<country>US</country>
<doc-number>7191015</doc-number>
<kind>B2</kind>
<name>Lamson et al.</name>
<date>20070300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00343">
<document-id>
<country>US</country>
<doc-number>7221979</doc-number>
<kind>B2</kind>
<name>Zhou et al.</name>
<date>20070500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00344">
<document-id>
<country>US</country>
<doc-number>7373204</doc-number>
<kind>B2</kind>
<name>Gelfand et al.</name>
<date>20080500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00345">
<document-id>
<country>US</country>
<doc-number>7381200</doc-number>
<kind>B2</kind>
<name>Katoh et al.</name>
<date>20080600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00346">
<document-id>
<country>US</country>
<doc-number>7444183</doc-number>
<kind>B2</kind>
<name>Knudson et al.</name>
<date>20081000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00347">
<document-id>
<country>US</country>
<doc-number>7617005</doc-number>
<kind>B2</kind>
<name>Demarais et al.</name>
<date>20091100</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607116</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00348">
<document-id>
<country>US</country>
<doc-number>7620451</doc-number>
<kind>B2</kind>
<name>Demarais et al.</name>
<date>20091100</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607  3</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00349">
<document-id>
<country>US</country>
<doc-number>7647115</doc-number>
<kind>B2</kind>
<name>Levin et al.</name>
<date>20100100</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00350">
<document-id>
<country>US</country>
<doc-number>7653438</doc-number>
<kind>B2</kind>
<name>Deem et al.</name>
<date>20100100</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00351">
<document-id>
<country>US</country>
<doc-number>7717948</doc-number>
<kind>B2</kind>
<name>Demarais et al.</name>
<date>20100500</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 96</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00352">
<document-id>
<country>US</country>
<doc-number>7756583</doc-number>
<kind>B2</kind>
<name>Demarais et al.</name>
<date>20100700</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00353">
<document-id>
<country>US</country>
<doc-number>7778703</doc-number>
<kind>B2</kind>
<name>Gross et al.</name>
<date>20100800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00354">
<document-id>
<country>US</country>
<doc-number>8131371</doc-number>
<kind>B2</kind>
<name>Demarals et al.</name>
<date>20120300</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00355">
<document-id>
<country>US</country>
<doc-number>8131372</doc-number>
<kind>B2</kind>
<name>Levin et al.</name>
<date>20120300</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00356">
<document-id>
<country>US</country>
<doc-number>8140170</doc-number>
<kind>B2</kind>
<name>Rezai et al.</name>
<date>20120300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00357">
<document-id>
<country>US</country>
<doc-number>8145316</doc-number>
<kind>B2</kind>
<name>Deem et al.</name>
<date>20120300</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00358">
<document-id>
<country>US</country>
<doc-number>8145317</doc-number>
<kind>B2</kind>
<name>Demarais et al.</name>
<date>20120300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00359">
<document-id>
<country>US</country>
<doc-number>8150518</doc-number>
<kind>B2</kind>
<name>Levin et al.</name>
<date>20120400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00360">
<document-id>
<country>US</country>
<doc-number>8150519</doc-number>
<kind>B2</kind>
<name>Demarais et al.</name>
<date>20120400</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00361">
<document-id>
<country>US</country>
<doc-number>8150520</doc-number>
<kind>B2</kind>
<name>Demarais et al.</name>
<date>20120400</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00362">
<document-id>
<country>US</country>
<doc-number>8175711</doc-number>
<kind>B2</kind>
<name>Demarais et al.</name>
<date>20120500</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00363">
<document-id>
<country>US</country>
<doc-number>2001/0044596</doc-number>
<kind>A1</kind>
<name>Jaafar</name>
<date>20011100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00364">
<document-id>
<country>US</country>
<doc-number>2002/0002329</doc-number>
<kind>A1</kind>
<name>Avitall</name>
<date>20020100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00365">
<document-id>
<country>US</country>
<doc-number>2002/0026222</doc-number>
<kind>A1</kind>
<name>Schauerte et al.</name>
<date>20020200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00366">
<document-id>
<country>US</country>
<doc-number>2002/0026228</doc-number>
<kind>A1</kind>
<name>Schauerte</name>
<date>20020200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00367">
<document-id>
<country>US</country>
<doc-number>2002/0032468</doc-number>
<kind>A1</kind>
<name>Hill et al.</name>
<date>20020300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00368">
<document-id>
<country>US</country>
<doc-number>2002/0038137</doc-number>
<kind>A1</kind>
<name>Stein</name>
<date>20020300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00369">
<document-id>
<country>US</country>
<doc-number>2002/0040204</doc-number>
<kind>A1</kind>
<name>Dev et al.</name>
<date>20020400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00370">
<document-id>
<country>US</country>
<doc-number>2002/0045853</doc-number>
<kind>A1</kind>
<name>Dev et al.</name>
<date>20020400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00371">
<document-id>
<country>US</country>
<doc-number>2002/0065541</doc-number>
<kind>A1</kind>
<name>Fredricks et al.</name>
<date>20020500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00372">
<document-id>
<country>US</country>
<doc-number>2002/0072782</doc-number>
<kind>A1</kind>
<name>Osorio et al.</name>
<date>20020600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00373">
<document-id>
<country>US</country>
<doc-number>2002/0107553</doc-number>
<kind>A1</kind>
<name>Hill et al.</name>
<date>20020800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00374">
<document-id>
<country>US</country>
<doc-number>2002/0116030</doc-number>
<kind>A1</kind>
<name>Rezai</name>
<date>20020800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00375">
<document-id>
<country>US</country>
<doc-number>2002/0120304</doc-number>
<kind>A1</kind>
<name>Mest</name>
<date>20020800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00376">
<document-id>
<country>US</country>
<doc-number>2002/0165532</doc-number>
<kind>A1</kind>
<name>Hill et al.</name>
<date>20021100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00377">
<document-id>
<country>US</country>
<doc-number>2002/0165586</doc-number>
<kind>A1</kind>
<name>Hill et al.</name>
<date>20021100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00378">
<document-id>
<country>US</country>
<doc-number>2002/0169413</doc-number>
<kind>A1</kind>
<name>Keren et al.</name>
<date>20021100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00379">
<document-id>
<country>US</country>
<doc-number>2002/0177846</doc-number>
<kind>A1</kind>
<name>Mulier et al.</name>
<date>20021100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00380">
<document-id>
<country>US</country>
<doc-number>2002/0183682</doc-number>
<kind>A1</kind>
<name>Darvish</name>
<date>20021200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00381">
<document-id>
<country>US</country>
<doc-number>2002/0183684</doc-number>
<kind>A1</kind>
<name>Dev et al.</name>
<date>20021200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00382">
<document-id>
<country>US</country>
<doc-number>2002/0188325</doc-number>
<kind>A1</kind>
<name>Hill et al.</name>
<date>20021200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00383">
<document-id>
<country>US</country>
<doc-number>2002/0198512</doc-number>
<kind>A1</kind>
<name>Seward</name>
<date>20021200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00384">
<document-id>
<country>US</country>
<doc-number>2003/0004549</doc-number>
<kind>A1</kind>
<name>Hill et al.</name>
<date>20030100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00385">
<document-id>
<country>US</country>
<doc-number>2003/0009145</doc-number>
<kind>A1</kind>
<name>Struijker-Boudier et al.</name>
<date>20030100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00386">
<document-id>
<country>US</country>
<doc-number>2003/0018367</doc-number>
<kind>A1</kind>
<name>DiLorenzo</name>
<date>20030100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00387">
<document-id>
<country>US</country>
<doc-number>2003/0040774</doc-number>
<kind>A1</kind>
<name>Terry, Jr. et al.</name>
<date>20030200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00388">
<document-id>
<country>US</country>
<doc-number>2003/0045909</doc-number>
<kind>A1</kind>
<name>Gross et al.</name>
<date>20030300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00389">
<document-id>
<country>US</country>
<doc-number>2003/0050681</doc-number>
<kind>A1</kind>
<name>Pianca et al.</name>
<date>20030300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00390">
<document-id>
<country>US</country>
<doc-number>2003/0060848</doc-number>
<kind>A1</kind>
<name>Kieval et al.</name>
<date>20030300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00391">
<document-id>
<country>US</country>
<doc-number>2003/0060857</doc-number>
<kind>A1</kind>
<name>Perrson et al.</name>
<date>20030300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00392">
<document-id>
<country>US</country>
<doc-number>2003/0060858</doc-number>
<kind>A1</kind>
<name>Kieval et al.</name>
<date>20030300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00393">
<document-id>
<country>US</country>
<doc-number>2003/0100924</doc-number>
<kind>A1</kind>
<name>Foreman et al.</name>
<date>20030500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00394">
<document-id>
<country>US</country>
<doc-number>2003/0120270</doc-number>
<kind>A1</kind>
<name>Acker</name>
<date>20030600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00395">
<document-id>
<country>US</country>
<doc-number>2003/0125790</doc-number>
<kind>A1</kind>
<name>Fastovsky et al.</name>
<date>20030700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00396">
<document-id>
<country>US</country>
<doc-number>2003/0150464</doc-number>
<kind>A1</kind>
<name>Casscells</name>
<date>20030800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00397">
<document-id>
<country>US</country>
<doc-number>2003/0158584</doc-number>
<kind>A1</kind>
<name>Cates et al.</name>
<date>20030800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00398">
<document-id>
<country>US</country>
<doc-number>2003/0181897</doc-number>
<kind>A1</kind>
<name>Thomas et al.</name>
<date>20030900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00399">
<document-id>
<country>US</country>
<doc-number>2003/0181963</doc-number>
<kind>A1</kind>
<name>Pellegrino et al.</name>
<date>20030900</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 96</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00400">
<document-id>
<country>US</country>
<doc-number>2003/0199747</doc-number>
<kind>A1</kind>
<name>Michlitsch et al.</name>
<date>20031000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00401">
<document-id>
<country>US</country>
<doc-number>2003/0199767</doc-number>
<kind>A1</kind>
<name>Cespedes et al.</name>
<date>20031000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00402">
<document-id>
<country>US</country>
<doc-number>2003/0199768</doc-number>
<kind>A1</kind>
<name>Cespedes et al.</name>
<date>20031000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00403">
<document-id>
<country>US</country>
<doc-number>2003/0199806</doc-number>
<kind>A1</kind>
<name>Kieval</name>
<date>20031000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00404">
<document-id>
<country>US</country>
<doc-number>2003/0199863</doc-number>
<kind>A1</kind>
<name>Swanson et al.</name>
<date>20031000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00405">
<document-id>
<country>US</country>
<doc-number>2003/0204161</doc-number>
<kind>A1</kind>
<name>Ferek-Petric</name>
<date>20031000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00406">
<document-id>
<country>US</country>
<doc-number>2003/0216792</doc-number>
<kind>A1</kind>
<name>Levin et al.</name>
<date>20031100</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 48</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00407">
<document-id>
<country>US</country>
<doc-number>2003/0220521</doc-number>
<kind>A1</kind>
<name>Reitz et al.</name>
<date>20031100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00408">
<document-id>
<country>US</country>
<doc-number>2003/0236443</doc-number>
<kind>A1</kind>
<name>Cespedes et al.</name>
<date>20031200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00409">
<document-id>
<country>US</country>
<doc-number>2004/0010289</doc-number>
<kind>A1</kind>
<name>Biggs et al.</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00410">
<document-id>
<country>US</country>
<doc-number>2004/0010303</doc-number>
<kind>A1</kind>
<name>Bolea et al.</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00411">
<document-id>
<country>US</country>
<doc-number>2004/0019364</doc-number>
<kind>A1</kind>
<name>Kieval et al.</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00412">
<document-id>
<country>US</country>
<doc-number>2004/0019371</doc-number>
<kind>A1</kind>
<name>Jaafar et al.</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00413">
<document-id>
<country>US</country>
<doc-number>2004/0064090</doc-number>
<kind>A1</kind>
<name>Keren et al.</name>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00414">
<document-id>
<country>US</country>
<doc-number>2004/0064091</doc-number>
<kind>A1</kind>
<name>Keren et al.</name>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00415">
<document-id>
<country>US</country>
<doc-number>2004/0065615</doc-number>
<kind>A1</kind>
<name>Hooper et al.</name>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00416">
<document-id>
<country>US</country>
<doc-number>2004/0073238</doc-number>
<kind>A1</kind>
<name>Makower</name>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00417">
<document-id>
<country>US</country>
<doc-number>2004/0082978</doc-number>
<kind>A1</kind>
<name>Harrison et al.</name>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 48</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00418">
<document-id>
<country>US</country>
<doc-number>2004/0101523</doc-number>
<kind>A1</kind>
<name>Reitz et al.</name>
<date>20040500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00419">
<document-id>
<country>US</country>
<doc-number>2004/0106953</doc-number>
<kind>A1</kind>
<name>Yomtov et al.</name>
<date>20040600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00420">
<document-id>
<country>US</country>
<doc-number>2004/0111080</doc-number>
<kind>A1</kind>
<name>Harper et al.</name>
<date>20040600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00421">
<document-id>
<country>US</country>
<doc-number>2004/0127942</doc-number>
<kind>A1</kind>
<name>Yomtov et al.</name>
<date>20040700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00422">
<document-id>
<country>US</country>
<doc-number>2004/0162590</doc-number>
<kind>A1</kind>
<name>Whitehurst et al.</name>
<date>20040800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00423">
<document-id>
<country>US</country>
<doc-number>2004/0163655</doc-number>
<kind>A1</kind>
<name>Gelfand et al.</name>
<date>20040800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00424">
<document-id>
<country>US</country>
<doc-number>2004/0167415</doc-number>
<kind>A1</kind>
<name>Gelfand et al.</name>
<date>20040800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00425">
<document-id>
<country>US</country>
<doc-number>2004/0176699</doc-number>
<kind>A1</kind>
<name>Walker et al.</name>
<date>20040900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00426">
<document-id>
<country>US</country>
<doc-number>2004/0176757</doc-number>
<kind>A1</kind>
<name>Sinelnikov et al.</name>
<date>20040900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00427">
<document-id>
<country>US</country>
<doc-number>2004/0193228</doc-number>
<kind>A1</kind>
<name>Gerber</name>
<date>20040900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00428">
<document-id>
<country>US</country>
<doc-number>2004/0215186</doc-number>
<kind>A1</kind>
<name>Cornelius et al.</name>
<date>20041000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00429">
<document-id>
<country>US</country>
<doc-number>2004/0220511</doc-number>
<kind>A1</kind>
<name>Scott et al.</name>
<date>20041100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00430">
<document-id>
<country>US</country>
<doc-number>2004/0243102</doc-number>
<kind>A1</kind>
<name>Berg et al.</name>
<date>20041200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00431">
<document-id>
<country>US</country>
<doc-number>2004/0243206</doc-number>
<kind>A1</kind>
<name>Tadlock</name>
<date>20041200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00432">
<document-id>
<country>US</country>
<doc-number>2004/0249416</doc-number>
<kind>A1</kind>
<name>Yun et al.</name>
<date>20041200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00433">
<document-id>
<country>US</country>
<doc-number>2004/0254616</doc-number>
<kind>A1</kind>
<name>Rossing et al.</name>
<date>20041200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00434">
<document-id>
<country>US</country>
<doc-number>2005/0010263</doc-number>
<kind>A1</kind>
<name>Schauerte</name>
<date>20050100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00435">
<document-id>
<country>US</country>
<doc-number>2005/0021092</doc-number>
<kind>A1</kind>
<name>Yun et al.</name>
<date>20050100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00436">
<document-id>
<country>US</country>
<doc-number>2005/0038409</doc-number>
<kind>A1</kind>
<name>Segal et al.</name>
<date>20050200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00437">
<document-id>
<country>US</country>
<doc-number>2005/0049542</doc-number>
<kind>A1</kind>
<name>Sigg et al.</name>
<date>20050300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00438">
<document-id>
<country>US</country>
<doc-number>2005/0065562</doc-number>
<kind>A1</kind>
<name>Rezai</name>
<date>20050300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00439">
<document-id>
<country>US</country>
<doc-number>2005/0065573</doc-number>
<kind>A1</kind>
<name>Rezai</name>
<date>20050300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00440">
<document-id>
<country>US</country>
<doc-number>2005/0065574</doc-number>
<kind>A1</kind>
<name>Rezai</name>
<date>20050300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00441">
<document-id>
<country>US</country>
<doc-number>2005/0075681</doc-number>
<kind>A1</kind>
<name>Rezai et al.</name>
<date>20050400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00442">
<document-id>
<country>US</country>
<doc-number>2005/0080409</doc-number>
<kind>A1</kind>
<name>Young et al.</name>
<date>20050400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00443">
<document-id>
<country>US</country>
<doc-number>2005/0080459</doc-number>
<kind>A1</kind>
<name>Jacobson et al.</name>
<date>20050400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00444">
<document-id>
<country>US</country>
<doc-number>2005/0096710</doc-number>
<kind>A1</kind>
<name>Kieval</name>
<date>20050500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00445">
<document-id>
<country>US</country>
<doc-number>2005/0153885</doc-number>
<kind>A1</kind>
<name>Yun et al.</name>
<date>20050700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00446">
<document-id>
<country>US</country>
<doc-number>2005/0154418</doc-number>
<kind>A1</kind>
<name>Kieval et al.</name>
<date>20050700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00447">
<document-id>
<country>US</country>
<doc-number>2005/0171523</doc-number>
<kind>A1</kind>
<name>Rubinsky et al.</name>
<date>20050800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00448">
<document-id>
<country>US</country>
<doc-number>2005/0171574</doc-number>
<kind>A1</kind>
<name>Rubinsky et al.</name>
<date>20050800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00449">
<document-id>
<country>US</country>
<doc-number>2005/0171575</doc-number>
<kind>A1</kind>
<name>Dev et al.</name>
<date>20050800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00450">
<document-id>
<country>US</country>
<doc-number>2005/0187579</doc-number>
<kind>A1</kind>
<name>Danek et al.</name>
<date>20050800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00451">
<document-id>
<country>US</country>
<doc-number>2005/0197624</doc-number>
<kind>A1</kind>
<name>Goodson et al.</name>
<date>20050900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00452">
<document-id>
<country>US</country>
<doc-number>2005/0209548</doc-number>
<kind>A1</kind>
<name>Dev et al.</name>
<date>20050900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00453">
<document-id>
<country>US</country>
<doc-number>2005/0209642</doc-number>
<kind>A1</kind>
<name>Palti</name>
<date>20050900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00454">
<document-id>
<country>US</country>
<doc-number>2005/0228460</doc-number>
<kind>A1</kind>
<name>Levin et al.</name>
<date>20051000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00455">
<document-id>
<country>US</country>
<doc-number>2005/0234523</doc-number>
<kind>A1</kind>
<name>Levin et al.</name>
<date>20051000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00456">
<document-id>
<country>US</country>
<doc-number>2005/0240126</doc-number>
<kind>A1</kind>
<name>Foley et al.</name>
<date>20051000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00457">
<document-id>
<country>US</country>
<doc-number>2005/0240173</doc-number>
<kind>A1</kind>
<name>Palti</name>
<date>20051000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00458">
<document-id>
<country>US</country>
<doc-number>2005/0240228</doc-number>
<kind>A1</kind>
<name>Palti</name>
<date>20051000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00459">
<document-id>
<country>US</country>
<doc-number>2005/0240241</doc-number>
<kind>A1</kind>
<name>Yun et al.</name>
<date>20051000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00460">
<document-id>
<country>US</country>
<doc-number>2005/0245882</doc-number>
<kind>A1</kind>
<name>Elkins et al.</name>
<date>20051100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00461">
<document-id>
<country>US</country>
<doc-number>2005/0245892</doc-number>
<kind>A1</kind>
<name>Elkins et al.</name>
<date>20051100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00462">
<document-id>
<country>US</country>
<doc-number>2005/0251212</doc-number>
<kind>A1</kind>
<name>Kieval et al.</name>
<date>20051100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00463">
<document-id>
<country>US</country>
<doc-number>2005/0261672</doc-number>
<kind>A1</kind>
<name>Deem et al.</name>
<date>20051100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00464">
<document-id>
<country>US</country>
<doc-number>2005/0267010</doc-number>
<kind>A1</kind>
<name>Goodson et al.</name>
<date>20051200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00465">
<document-id>
<country>US</country>
<doc-number>2005/0282284</doc-number>
<kind>A1</kind>
<name>Rubinsky et al.</name>
<date>20051200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00466">
<document-id>
<country>US</country>
<doc-number>2006/0004417</doc-number>
<kind>A1</kind>
<name>Rossing et al.</name>
<date>20060100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00467">
<document-id>
<country>US</country>
<doc-number>2006/0004430</doc-number>
<kind>A1</kind>
<name>Rossing et al.</name>
<date>20060100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00468">
<document-id>
<country>US</country>
<doc-number>2006/0025821</doc-number>
<kind>A1</kind>
<name>Gelfand et al.</name>
<date>20060200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00469">
<document-id>
<country>US</country>
<doc-number>2006/0030814</doc-number>
<kind>A1</kind>
<name>Valencia et al.</name>
<date>20060200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00470">
<document-id>
<country>US</country>
<doc-number>2006/0036218</doc-number>
<kind>A1</kind>
<name>Goodson et al.</name>
<date>20060200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00471">
<document-id>
<country>US</country>
<doc-number>2006/0041277</doc-number>
<kind>A1</kind>
<name>Deem et al.</name>
<date>20060200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00472">
<document-id>
<country>US</country>
<doc-number>2006/0041283</doc-number>
<kind>A1</kind>
<name>Gelfand et al.</name>
<date>20060200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00473">
<document-id>
<country>US</country>
<doc-number>2006/0067972</doc-number>
<kind>A1</kind>
<name>Kesten et al.</name>
<date>20060300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00474">
<document-id>
<country>US</country>
<doc-number>2006/0069323</doc-number>
<kind>A1</kind>
<name>Elkins et al.</name>
<date>20060300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00475">
<document-id>
<country>US</country>
<doc-number>2006/0074453</doc-number>
<kind>A1</kind>
<name>Kieval et al.</name>
<date>20060400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00476">
<document-id>
<country>US</country>
<doc-number>2006/0079859</doc-number>
<kind>A1</kind>
<name>Elkins et al.</name>
<date>20060400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00477">
<document-id>
<country>US</country>
<doc-number>2006/0085046</doc-number>
<kind>A1</kind>
<name>Rezai et al.</name>
<date>20060400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00478">
<document-id>
<country>US</country>
<doc-number>2006/0089674</doc-number>
<kind>A1</kind>
<name>Walters et al.</name>
<date>20060400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00479">
<document-id>
<country>US</country>
<doc-number>2006/0095029</doc-number>
<kind>A1</kind>
<name>Young et al.</name>
<date>20060500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00480">
<document-id>
<country>US</country>
<doc-number>2006/0100667</doc-number>
<kind>A1</kind>
<name>Machado et al.</name>
<date>20060500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00481">
<document-id>
<country>US</country>
<doc-number>2006/0106429</doc-number>
<kind>A1</kind>
<name>Libbus et al.</name>
<date>20060500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00482">
<document-id>
<country>US</country>
<doc-number>2006/0111754</doc-number>
<kind>A1</kind>
<name>Rezai et al.</name>
<date>20060500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00483">
<document-id>
<country>US</country>
<doc-number>2006/0116720</doc-number>
<kind>A1</kind>
<name>Knoblich</name>
<date>20060600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00484">
<document-id>
<country>US</country>
<doc-number>2006/0121016</doc-number>
<kind>A1</kind>
<name>Lee</name>
<date>20060600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00485">
<document-id>
<country>US</country>
<doc-number>2006/0121610</doc-number>
<kind>A1</kind>
<name>Rubinsky et al.</name>
<date>20060600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00486">
<document-id>
<country>US</country>
<doc-number>2006/0135998</doc-number>
<kind>A1</kind>
<name>Libbus et al.</name>
<date>20060600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00487">
<document-id>
<country>US</country>
<doc-number>2006/0136004</doc-number>
<kind>A1</kind>
<name>Cowan et al.</name>
<date>20060600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00488">
<document-id>
<country>US</country>
<doc-number>2006/0149350</doc-number>
<kind>A1</kind>
<name>Patel et al.</name>
<date>20060700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00489">
<document-id>
<country>US</country>
<doc-number>2006/0155344</doc-number>
<kind>A1</kind>
<name>Rezai et al.</name>
<date>20060700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00490">
<document-id>
<country>US</country>
<doc-number>2006/0167437</doc-number>
<kind>A1</kind>
<name>Valencia</name>
<date>20060700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00491">
<document-id>
<country>US</country>
<doc-number>2006/0167498</doc-number>
<kind>A1</kind>
<name>DiLorenzo</name>
<date>20060700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00492">
<document-id>
<country>US</country>
<doc-number>2006/0167499</doc-number>
<kind>A1</kind>
<name>Palti</name>
<date>20060700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00493">
<document-id>
<country>US</country>
<doc-number>2006/0189941</doc-number>
<kind>A1</kind>
<name>Seward et al.</name>
<date>20060800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00494">
<document-id>
<country>US</country>
<doc-number>2006/0189960</doc-number>
<kind>A1</kind>
<name>Kesten et al.</name>
<date>20060800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00495">
<document-id>
<country>US</country>
<doc-number>2006/0190044</doc-number>
<kind>A1</kind>
<name>Libbus et al.</name>
<date>20060800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00496">
<document-id>
<country>US</country>
<doc-number>2006/0206149</doc-number>
<kind>A1</kind>
<name>Yun</name>
<date>20060900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00497">
<document-id>
<country>US</country>
<doc-number>2006/0206150</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20060900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00498">
<document-id>
<country>US</country>
<doc-number>2006/0212076</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20060900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00499">
<document-id>
<country>US</country>
<doc-number>2006/0212078</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20060900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00500">
<document-id>
<country>US</country>
<doc-number>2006/0229677</doc-number>
<kind>A1</kind>
<name>Moffitt et al.</name>
<date>20061000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00501">
<document-id>
<country>US</country>
<doc-number>2006/0235474</doc-number>
<kind>A1</kind>
<name>Demarais</name>
<date>20061000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00502">
<document-id>
<country>US</country>
<doc-number>2006/0265014</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20061100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00503">
<document-id>
<country>US</country>
<doc-number>2006/0265015</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20061100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00504">
<document-id>
<country>US</country>
<doc-number>2006/0271111</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20061100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00505">
<document-id>
<country>US</country>
<doc-number>2006/0276852</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20061200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00506">
<document-id>
<country>US</country>
<doc-number>2007/0066957</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20070300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00507">
<document-id>
<country>US</country>
<doc-number>2007/0066972</doc-number>
<kind>A1</kind>
<name>Ormsby et al.</name>
<date>20070300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00508">
<document-id>
<country>US</country>
<doc-number>2007/0083239</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20070400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00509">
<document-id>
<country>US</country>
<doc-number>2007/0129720</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20070600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00510">
<document-id>
<country>US</country>
<doc-number>2007/0129760</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20070600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00511">
<document-id>
<country>US</country>
<doc-number>2007/0129761</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20070600</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607  3</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00512">
<document-id>
<country>US</country>
<doc-number>2007/0135875</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20070600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00513">
<document-id>
<country>US</country>
<doc-number>2007/0142864</doc-number>
<kind>A1</kind>
<name>Libbus et al.</name>
<date>20070600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00514">
<document-id>
<country>US</country>
<doc-number>2007/0156200</doc-number>
<kind>A1</kind>
<name>Kornet et al.</name>
<date>20070700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00515">
<document-id>
<country>US</country>
<doc-number>2007/0173899</doc-number>
<kind>A1</kind>
<name>Levin et al.</name>
<date>20070700</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 40</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00516">
<document-id>
<country>US</country>
<doc-number>2007/0208382</doc-number>
<kind>A1</kind>
<name>Yun</name>
<date>20070900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00517">
<document-id>
<country>US</country>
<doc-number>2007/0265687</doc-number>
<kind>A1</kind>
<name>Deem et al.</name>
<date>20071100</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 72</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00518">
<document-id>
<country>US</country>
<doc-number>2007/0282376</doc-number>
<kind>A1</kind>
<name>Shuros et al.</name>
<date>20071200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00519">
<document-id>
<country>US</country>
<doc-number>2007/0288070</doc-number>
<kind>A1</kind>
<name>Libbus et al.</name>
<date>20071200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00520">
<document-id>
<country>US</country>
<doc-number>2008/0004673</doc-number>
<kind>A1</kind>
<name>Rossing et al.</name>
<date>20080100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00521">
<document-id>
<country>US</country>
<doc-number>2008/0015659</doc-number>
<kind>A1</kind>
<name>Zhang et al.</name>
<date>20080100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00522">
<document-id>
<country>US</country>
<doc-number>2008/0039904</doc-number>
<kind>A1</kind>
<name>Bulkes et al.</name>
<date>20080200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00523">
<document-id>
<country>US</country>
<doc-number>2008/0091255</doc-number>
<kind>A1</kind>
<name>Caparso et al.</name>
<date>20080400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00524">
<document-id>
<country>US</country>
<doc-number>2008/0140150</doc-number>
<kind>A1</kind>
<name>Zhou et al.</name>
<date>20080600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00525">
<document-id>
<country>US</country>
<doc-number>2008/0213331</doc-number>
<kind>A1</kind>
<name>Gelfand et al.</name>
<date>20080900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00526">
<document-id>
<country>US</country>
<doc-number>2008/0255642</doc-number>
<kind>A1</kind>
<name>Zarins et al.</name>
<date>20081000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00527">
<document-id>
<country>US</country>
<doc-number>2008/0319513</doc-number>
<kind>A1</kind>
<name>Pu et al.</name>
<date>20081200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00528">
<document-id>
<country>US</country>
<doc-number>2009/0024195</doc-number>
<kind>A1</kind>
<name>Rezai et al.</name>
<date>20090100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00529">
<document-id>
<country>US</country>
<doc-number>2009/0036948</doc-number>
<kind>A1</kind>
<name>Levin et al.</name>
<date>20090200</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 44</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00530">
<document-id>
<country>US</country>
<doc-number>2009/0062873</doc-number>
<kind>A1</kind>
<name>Wu et al.</name>
<date>20090300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00531">
<document-id>
<country>US</country>
<doc-number>2009/0076409</doc-number>
<kind>A1</kind>
<name>Wu et al.</name>
<date>20090300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00532">
<document-id>
<country>US</country>
<doc-number>2010/0010567</doc-number>
<kind>A1</kind>
<name>Deem et al.</name>
<date>20100100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00533">
<document-id>
<country>US</country>
<doc-number>2010/0057150</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20100300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00534">
<document-id>
<country>US</country>
<doc-number>2010/0137860</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20100600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00535">
<document-id>
<country>US</country>
<doc-number>2010/0137952</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20100600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00536">
<document-id>
<country>US</country>
<doc-number>2010/0168731</doc-number>
<kind>A1</kind>
<name>Wu et al.</name>
<date>20100700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00537">
<document-id>
<country>US</country>
<doc-number>2010/0168739</doc-number>
<kind>A1</kind>
<name>Wu et al.</name>
<date>20100700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00538">
<document-id>
<country>US</country>
<doc-number>2010/0174282</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20100700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00539">
<document-id>
<country>US</country>
<doc-number>2010/0191112</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20100700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00540">
<document-id>
<country>US</country>
<doc-number>2010/0222851</doc-number>
<kind>A1</kind>
<name>Deem et al.</name>
<date>20100900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00541">
<document-id>
<country>US</country>
<doc-number>2010/0222854</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20100900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00542">
<document-id>
<country>US</country>
<doc-number>2010/0249773</doc-number>
<kind>A1</kind>
<name>Clark et al.</name>
<date>20100900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00543">
<document-id>
<country>US</country>
<doc-number>2010/0268307</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20101000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00544">
<document-id>
<country>US</country>
<doc-number>2011/0137298</doc-number>
<kind>A1</kind>
<name>Nguyen et al.</name>
<date>20110600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00545">
<document-id>
<country>US</country>
<doc-number>2011/0307034</doc-number>
<kind>A1</kind>
<name>Hastings et al.</name>
<date>20111200</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>607 61</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00546">
<document-id>
<country>US</country>
<doc-number>2012/0130289</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20120500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00547">
<document-id>
<country>US</country>
<doc-number>2012/0130345</doc-number>
<kind>A1</kind>
<name>Levin et al.</name>
<date>20120500</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>604506</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00548">
<document-id>
<country>US</country>
<doc-number>2012/0143181</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20120600</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>606 41</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00549">
<document-id>
<country>US</country>
<doc-number>2012/0172837</doc-number>
<kind>A1</kind>
<name>Demarais et al.</name>
<date>20120700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00550">
<document-id>
<country>US</country>
<doc-number>2013/0012866</doc-number>
<kind>A1</kind>
<name>Deem et al.</name>
<date>20130100</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>604 21</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00551">
<document-id>
<country>DE</country>
<doc-number>3151180</doc-number>
<date>19820800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00552">
<document-id>
<country>EP</country>
<doc-number>0811395</doc-number>
<date>19970600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00553">
<document-id>
<country>EP</country>
<doc-number>2092957</doc-number>
<date>20090800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00554">
<document-id>
<country>WO</country>
<doc-number>WO/85/01213</doc-number>
<date>19850300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00555">
<document-id>
<country>WO</country>
<doc-number>WO/91/04725</doc-number>
<date>19910400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00556">
<document-id>
<country>WO</country>
<doc-number>WO/92/20291</doc-number>
<date>19921100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00557">
<document-id>
<country>WO</country>
<doc-number>WO/93/02740</doc-number>
<date>19930200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00558">
<document-id>
<country>WO</country>
<doc-number>WO/93/07803</doc-number>
<date>19930400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00559">
<document-id>
<country>WO</country>
<doc-number>WO/94/00188</doc-number>
<date>19940100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00560">
<document-id>
<country>WO</country>
<doc-number>WO/94/11057</doc-number>
<date>19940500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00561">
<document-id>
<country>WO</country>
<doc-number>WO/95/25472</doc-number>
<date>19950900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00562">
<document-id>
<country>WO</country>
<doc-number>WO-9525472</doc-number>
<date>19950900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00563">
<document-id>
<country>WO</country>
<doc-number>WO/95/33514</doc-number>
<date>19951200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00564">
<document-id>
<country>WO</country>
<doc-number>WO/96/00039</doc-number>
<date>19960100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00565">
<document-id>
<country>WO</country>
<doc-number>WO/96/04957</doc-number>
<date>19960200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00566">
<document-id>
<country>WO</country>
<doc-number>WO/96/11723</doc-number>
<date>19960400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00567">
<document-id>
<country>WO</country>
<doc-number>WO/97/13463</doc-number>
<date>19970400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00568">
<document-id>
<country>WO</country>
<doc-number>WO/97/13550</doc-number>
<date>19970400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00569">
<document-id>
<country>WO</country>
<doc-number>WO-9736548</doc-number>
<kind>A1</kind>
<date>19971000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00570">
<document-id>
<country>WO</country>
<doc-number>WO/97/49453</doc-number>
<date>19971200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00571">
<document-id>
<country>WO</country>
<doc-number>WO/98/37926</doc-number>
<date>19980900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00572">
<document-id>
<country>WO</country>
<doc-number>WO/98/42403</doc-number>
<date>19981000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00573">
<document-id>
<country>WO</country>
<doc-number>WO/98/43700</doc-number>
<date>19981000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00574">
<document-id>
<country>WO</country>
<doc-number>WO/98/43701</doc-number>
<date>19981000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00575">
<document-id>
<country>WO</country>
<doc-number>WO/98/48888</doc-number>
<date>19981100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00576">
<document-id>
<country>WO</country>
<doc-number>WO/99/33407</doc-number>
<date>19990700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00577">
<document-id>
<country>WO</country>
<doc-number>WO/99/51286</doc-number>
<date>19991000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00578">
<document-id>
<country>WO</country>
<doc-number>WO/99/52424</doc-number>
<date>19991000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00579">
<document-id>
<country>WO</country>
<doc-number>WO-0122897</doc-number>
<kind>A1</kind>
<date>20010400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00580">
<document-id>
<country>WO</country>
<doc-number>WO0126729</doc-number>
<date>20010400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00581">
<document-id>
<country>WO</country>
<doc-number>WO0170114</doc-number>
<date>20010900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00582">
<document-id>
<country>WO</country>
<doc-number>WO-0170114</doc-number>
<kind>A1</kind>
<date>20010900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00583">
<document-id>
<country>WO</country>
<doc-number>WO/02/09808</doc-number>
<date>20020200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00584">
<document-id>
<country>WO</country>
<doc-number>WO/02/26314</doc-number>
<date>20020400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00585">
<document-id>
<country>WO</country>
<doc-number>WO/02/053207</doc-number>
<date>20020700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00586">
<document-id>
<country>WO</country>
<doc-number>WO/02/070039</doc-number>
<date>20020900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00587">
<document-id>
<country>WO</country>
<doc-number>WO/02/070047</doc-number>
<date>20020900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00588">
<document-id>
<country>WO</country>
<doc-number>WO/02/085448</doc-number>
<date>20021000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00589">
<document-id>
<country>WO</country>
<doc-number>WO/2002085192</doc-number>
<date>20021000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00590">
<document-id>
<country>WO</country>
<doc-number>WO/03/018108</doc-number>
<date>20030300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00591">
<document-id>
<country>WO</country>
<doc-number>WO/03/028802</doc-number>
<date>20030400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00592">
<document-id>
<country>WO</country>
<doc-number>WO/03/063692</doc-number>
<date>20030800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00593">
<document-id>
<country>WO</country>
<doc-number>WO/03/071140</doc-number>
<date>20030800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00594">
<document-id>
<country>WO</country>
<doc-number>WO/03/076008</doc-number>
<date>20030900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00595">
<document-id>
<country>WO</country>
<doc-number>WO/03/082403</doc-number>
<date>20031000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00596">
<document-id>
<country>WO</country>
<doc-number>WO/2003/082080</doc-number>
<date>20031000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00597">
<document-id>
<country>WO</country>
<doc-number>WO/2004/026370</doc-number>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00598">
<document-id>
<country>WO</country>
<doc-number>WO/2004/026371</doc-number>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00599">
<document-id>
<country>WO</country>
<doc-number>WO/2004/026374</doc-number>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00600">
<document-id>
<country>WO</country>
<doc-number>WO/2004/030718</doc-number>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00601">
<document-id>
<country>WO</country>
<doc-number>WO/2004/032791</doc-number>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00602">
<document-id>
<country>WO</country>
<doc-number>WO/2004/107965</doc-number>
<date>20041200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00603">
<document-id>
<country>WO</country>
<doc-number>WO/2005/014100</doc-number>
<date>20050200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00604">
<document-id>
<country>WO</country>
<doc-number>WO/2005/016165</doc-number>
<date>20050200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00605">
<document-id>
<country>WO</country>
<doc-number>WO/2005/032646</doc-number>
<date>20050400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00606">
<document-id>
<country>WO</country>
<doc-number>WO-2005/041748</doc-number>
<kind>A2</kind>
<date>20050500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00607">
<document-id>
<country>WO</country>
<doc-number>WO/2005/065284</doc-number>
<date>20050700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00608">
<document-id>
<country>WO</country>
<doc-number>WO/2005/084389</doc-number>
<date>20050900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00609">
<document-id>
<country>WO</country>
<doc-number>WO/2005/097256</doc-number>
<date>20051000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00610">
<document-id>
<country>WO</country>
<doc-number>WO/2005/110528</doc-number>
<date>20051100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00611">
<document-id>
<country>WO</country>
<doc-number>WO-2005110528</doc-number>
<kind>A1</kind>
<date>20051100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00612">
<document-id>
<country>WO</country>
<doc-number>WO/2005/123183</doc-number>
<date>20051200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00613">
<document-id>
<country>WO</country>
<doc-number>WO/2006/007048</doc-number>
<date>20060100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00614">
<document-id>
<country>WO</country>
<doc-number>WO/2006/018528</doc-number>
<date>20060200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00615">
<document-id>
<country>WO</country>
<doc-number>WO/2006/031899</doc-number>
<date>20060300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00616">
<document-id>
<country>WO</country>
<doc-number>WO-2006022790</doc-number>
<kind>A1</kind>
<date>20060300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00617">
<document-id>
<country>WO</country>
<doc-number>WO-2006041847</doc-number>
<date>20060400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00618">
<document-id>
<country>WO</country>
<doc-number>WO-2006041881</doc-number>
<date>20060400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00619">
<document-id>
<country>WO</country>
<doc-number>WO-2006041881</doc-number>
<kind>A2</kind>
<date>20060400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00620">
<document-id>
<country>WO</country>
<doc-number>WO-2007008954</doc-number>
<kind>A2</kind>
<date>20070100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00621">
<document-id>
<country>WO</country>
<doc-number>WO-2007035537</doc-number>
<date>20070300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00622">
<document-id>
<country>WO</country>
<doc-number>WO-2007078997</doc-number>
<kind>A2</kind>
<date>20070700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00623">
<document-id>
<country>WO</country>
<doc-number>WO-2007086965</doc-number>
<date>20070800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00624">
<document-id>
<country>WO</country>
<doc-number>WO-2007103879</doc-number>
<date>20070900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00625">
<document-id>
<country>WO</country>
<doc-number>WO-2007103881</doc-number>
<date>20070900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00626">
<document-id>
<country>WO</country>
<doc-number>WO-2007121309</doc-number>
<date>20071000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00627">
<document-id>
<country>WO</country>
<doc-number>WO-2007146834</doc-number>
<date>20071200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00628">
<document-id>
<country>WO</country>
<doc-number>WO-2008003058</doc-number>
<date>20080100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00629">
<document-id>
<country>WO</country>
<doc-number>WO-2008061150</doc-number>
<date>20080500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00630">
<document-id>
<country>WO</country>
<doc-number>WO-2008061152</doc-number>
<date>20080500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00631">
<document-id>
<country>WO</country>
<doc-number>WO-2008070413</doc-number>
<date>20080600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00632">
<document-id>
<country>WO</country>
<doc-number>WO-2010078175</doc-number>
<kind>A1</kind>
<date>20100700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00633">
<othercit>U.S. Appl. No. 12/910,631, filed Oct. 22, 2010, Wu et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00634">
<othercit>U.S. Appl. No. 12/940,922, filed Nov. 5, 2010, Gelfand et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00635">
<othercit>U.S. Appl. No. 12/790,639, filed May 28, 2010, Wu et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00636">
<othercit>U.S. Appl. No. 12/871,457, filed Aug. 30, 2010, Wu et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00637">
<othercit>U.S. Appl. No. 13/007,370, filed Jan. 18, 2011, Gelfand et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00638">
<othercit>U.S. Appl. No. 12/996,897, filed Dec. 13, 2010, Demarais.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00639">
<othercit>U.S. Appl. No. 13/009,748, filed Jan. 19, 2011, Beetel et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00640">
<othercit>U.S. Appl. No. 13/047,094, filed Mar. 14, 2011, Demarais et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00641">
<othercit>International Search Report, PCT/US04/38498, Mailed Feb. 18, 2005, Applicant: G &#x26; L Consulting, LLC, 4 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00642">
<othercit>International Search Report and Written Opinion, PCT/US05/35693, Mailed on Mar. 8, 2006, Applicant: Ardian, Inc., 29 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00643">
<othercit>International Search Report and Written Opinion, PCT/US05/35757, Mailed on Dec. 27, 2006, Applicant: Ardian, Inc., 8 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00644">
<othercit>International Search Report and Written Opinion, PCT/US06/36120, Mailed on Jun. 25, 2008, Applicant: Ardian, Inc., 10 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00645">
<othercit>International Search Report and Written Opinion, PCT/US06/41889, Mailed on Oct. 20, 2008, Applicant: Ardian, Inc., 7 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00646">
<othercit>International Search Report and Written Opinion, PCT/US06148822, Mailed on Aug. 15, 2008, Applicant: Ardian, Inc., 12 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00647">
<othercit>International Search Report and Written Opinion, PCT/US07/63322, Mailed on Mar. 3, 2008, Applicant: Ardian, Inc., 13 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00648">
<othercit>International Search Report and Written Opinion, PCT/US07/63324. Mailed on Oct. 10, 2008, Applicant: Ardian, Inc., 13 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00649">
<othercit>International Search Report and Written Opinion, PCT/US07/66539, Mailed on Jan. 28, 2008, Applicant: Ardian, Inc., 8 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00650">
<othercit>International Search Report and Written Opinion, PCT/US07/70799, Mailed on Jul. 2, 2008, Applicant: Ardian, Inc., 7 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00651">
<othercit>International Search Report and Written Opinion, PCT/US07/72396, Mailed on Aug. 27, 2008, Applicant: Ardian, Inc., 9 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00652">
<othercit>International Search Report and Written Opinion, PCT/US07/84701, Mailed on Aug. 21, 2008, Applicant: Ardian, Inc., 11 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00653">
<othercit>International Search Report and Written Opinion, PCT/US07184705, Mailed on Jul. 28, 2008, Applicant: Ardian, Inc., 12 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00654">
<othercit>International Search Report and Written Opinion, PCT/US07184708, Mailed on Aug. 11, 2008, Applicant: Ardian, Inc., 9 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00655">
<othercit>International Search Report and Written Opinion for PCT/US2009/069334; Applicant: Ardian, Inc.; Mailing Date: Mar. 1, 2010, 10 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00656">
<othercit>European Search Report; European Patent Application No. 05806045.0; Applicant: Ardian, Inc.; Date of Mailing: Sep. 22, 2009, 8 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00657">
<othercit>European Search Report; European Patent Application No. 05811851.4; Applicant: Ardian, Inc.; Date of Mailing: Oct. 1, 2009, 7 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00658">
<othercit>European Search Report; European Patent Application No. 06847926.0; Applicant: Ardian, Inc.; Date of Mailing: Feb. 10, 2010, 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00659">
<othercit>European Search Report; European Patent Application No. 0775925.8; Applicant: Ardian, Inc.; Date of Mailing: Apr. 29, 2010, 9 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00660">
<othercit>European Search Report; European Patent Application No. 07799148.7; Applicant: Ardian, Inc.; Date of Mailing: Jul. 23, 2009, 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00661">
<othercit>European Search Report; European Patent Application No. 09156661.2; Applicant: Ardian, Inc.; Date of Mailing: Jul. 23, 2009, 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00662">
<othercit>European Search Report; European Patent Application No. 09167937.3; Applicant: Ardian, Inc.; Date of Mailing: Nov. 11, 2009, 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00663">
<othercit>European Search Report; European Patent Application No. 09168202.1; Applicant: Ardian, Inc.; Date of Mailing: Nov. 11, 2009, 5 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00664">
<othercit>European Search Report; European Patent Application No. 09168204.7; Applicant: Ardian, Inc.; Date of Mailing: Nov. 19, 2009, 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00665">
<othercit>European Search Report; European Patent Application No. 07868755.5; Applicant: Ardian, Inc.; Date of Mailing: Jul. 28, 2010, 7 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00666">
<othercit>U.S. Appl. No. 60/813,589, filed Dec. 29, 2005, Demarais et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00667">
<othercit>2003 European Society of Hypertension&#x2014;European Society of Cardiology guidelines for the management of arterial hypertension, Guidelines Committee, Journal of Hypertension 2003, vol. 21, No. 6, pp. 1011-1053.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00668">
<othercit>Aars, H. and S. Akre, Reflex Changes in Sympathetic Activity and Arterial Blood Pressure Evoked by Afferent Stimulation of the Renal Nerve, Feb. 26, 1999, Acta physiol. Scand., vol. 78, 1970, pp. 184-188.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00669">
<othercit>Abramov, G.S. et al., Alteration in sensory nerve function following electrical shock, Burns vol. 22, No. 8, 1996 Elsevier Science Ltd., pp. 602-606.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00670">
<othercit>Achar, Suraj, M.D., and Suriti Kundu, M.D., Principles of Office Anesthesia: Part I. Infiltrative Anesthesia, Office Procedures, American Family Physician, Jul. 1, 2002, vol. 66, No. 1, pp. 91-94.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00671">
<othercit>Advanced Neuromodulation Systems' Comparison Chart, 1 page, Dec. 16, 2008.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00672">
<othercit>Advances in the role of the sympathetic nervous system in cardiovascular medicine, 2001 SNS Report, No. 3, Springer, Published with an educational grant from Servier, pp. 1-8.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00673">
<othercit>Aggarwal, A. et al., Regional sympathetic effects of low-dose clonidine in heart failure. Hypertension. 2003;41:553-7.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00674">
<othercit>Agnew, William F. et al., Evolution and Resolution of Stimulation-Induced Axonal Injury in Peripheral Nerve, May 21, 1999, Muscle &#x26; Nerve, vol. 22, Oct. 1999, John Wiley &#x26; Sons, Inc. 1999, pp. 1393-1402.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00675">
<othercit>Ahadian, Farshad M., M.D., Pulsed Radiofrequency Neurotomy: Advances in Pain Medicine, Current Pain and Headache Reports 2004, vol. 8, 2004 Current Science Inc., pp. 34-40.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00676">
<othercit>Alexander, B.T. et al., Renal denervation abolishes hypertension in low-birth-weight offspring from pregnant rats with reduced uterine perfusion, Hypertension, 2005; 45 (part 2): 754-758.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00677">
<othercit>Alford, J. Winslow, M.D. And Paul D. Fadale, M.D., Evaluation of Postoperative Bupivacaine Infusion for Pain Management After Anterior Cruciate Ligament Reconstruction, The Journal of Arthroscopic and Related Surgery, vol. 19, No. 8, Oct. 2003 Arthroscopy Association of North America, pp. 855-861.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00678">
<othercit>Allen, E.V., Sympathectomy for essential hypertension, Circulation, 1952, 6:131-140.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00679">
<othercit>Amersham Health. Hypaque-Cysto 6 pgs. 2003.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00680">
<othercit>Andrews, B.T. et al., The use of surgical sympathectomy in the treatment of chronic renal pain. Br J Urol. 1997;80:6-10.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00681">
<othercit>Antman, Elliott M. And Eugene Braunwald, Chapter 37&#x2014;Acute Myocardial Infarction, Heart Disease&#x2014;A Textbook of Cardiovascular Medicine, 5th Edition, vol. 2, 1997, Edited by Eugene Braunwald, pp. 1184-1288.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00682">
<othercit>Archer, Steffen et al., Cell Reactions to Dielectrophoretic Manipulation, Mar. 1, 1999, Biochemical and Biophysical Research Communications, 1999 Academic Press, pp. 687-698.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00683">
<othercit>Arentz, T. et al., Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. European Heart Journal. 2003. 24; pp. 963-969.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00684">
<othercit>Arias, M.D., Manuel J., Percutaneous Radio-Frequency Thermocoagulation with Low Temperature in the Treatment of Essential Glossopharyngeal Neuralgia, Surg. Neurol. 1986, vol. 25, 1986 Elsevier Science Publishing Co., Inc., pp. 94-96.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00685">
<othercit>Aronofsky, David H., D.D.S., Reduction of dental postsurgical symptoms using nonthermal pulsed high-peak-power electromagnetic energy, Oral Surg., Nov. 1971, vol. 32, No. 5, pp. 688-696.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00686">
<othercit>Aspelin, Peter, M.D., Ph.D. et al., Nephrotoxic Effects in High-Risk Patients Undergoing Angiography, Feb. 6, 2003, New England Journal of Medicine 2003, vol. 348, No. 6, 2003 Massachusetts Medical Society, pp. 491-499.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00687">
<othercit>Atrial Fibrillation Heart and Vascular Health on Yahoo! Health. 2 pgs. &#x3c;URL: http://health.yahoo.com/topic/heart/overview/article/healthwise/hw160872;<sub>&#x2014;</sub>ylt=AiBT43Ey74HQ7ft3jAb4C.s Pu7cF&#x3e; Feb. 21, 2006.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00688">
<othercit>Augustyniak, Robert A. et al., Sympathetic Overactivity as a Cause of Hypertension in Chronic Renal Failure, Aug. 14, 2001, Journal of Hypertension 2002, vol. 20, 2002 Lippincott Williams &#x26; Wilkins, pp. 3-9.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00689">
<othercit>Awwad, Ziad M., FRCS and Bashir A. Atiyat, GBA, JBA, Pain relief using continuous bupivacaine infusion in the paravertebral space after loin incision, May 15, 2004, Saudi Med J 2004, vol. 25 (10), pp. 1369-1373.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00690">
<othercit>Badyal, D. K., H. Lata and A.P. Dadhich, Animal Models of Hypertension and Effect of Drugs, Aug. 19, 2003, Indian Journal of Pharmacology 2003, vol. 35, pp. 349-362.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00691">
<othercit>Baker, Carol E. et al., Effect of pH of Bupivacaine on Duration of Repeated Sciatic Nerve Blocks in the Albino Rat, Anesth Analg, 1991, vol. 72, The International Anesthesia Research Society 1991, pp. 773-778.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00692">
<othercit>Balazs, Tibor, Development of Tissue Resistance to Toxic Effects of Chemicals, Jan. 26, 1974, Toxicology, 2 (1974), Elsevier/North-Holland, Amsterdam, pp. 247-255.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00693">
<othercit>Barajas, L. Innervation of the renal cortex. Fex Proc. 1978;37:1192-201.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00694">
<othercit>Barrett, Carolyn J. et al., Long-term control of renal blood flow: what is the role of the renal nerves?, Jan. 4, 2001, Am J Physiol Regulatory Integrative Comp Physiol 280, 2001, the American Physiological Society 2001, pp. R1534-R1545.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00695">
<othercit>Barrett, Carolyn J. et al., What Sets the Long-Term Level of Renal Sympathetic Nerve Activity, May 12, 2003, Integrative Physiology, Circ Res. 2003, vol. 92, 2003 American Heart Association, pp. 1330-1336.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00696">
<othercit>Bassett, C. Andrew L. et al., Augmentation of Bone Repair by Inductively Coupled Electromagnetic Fields, May 3, 1974, Science, vol. 184, pp. 575-577.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00697">
<othercit>Bassett, C. Andrew L., Fundamental and Practical Aspects of Therapeutic Uses of Pulsed Electromagnetic Fields (PEMFs), Critical Reviews in Biomedical Engineering, vol. 17, Issue 5, 1989, pp. 451-514.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00698">
<othercit>Beebe, Stephen J. et al., Nanosecond pulsed electric fields modulate cell function through intracellular signal transduction mechanisms, Apr. 8, 2004, Physiol. Meas. 25, 2004, IOP Publishing Ltd. 2004, pp. 1077-1093.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00699">
<othercit>Beebe, Stephen J., et al., Nanosecond Pulsed Electric Field (nsPEF) Effects on Cells and Tissues: Apoptosis Induction and Tumor Growth Inhibition, Oct. 11, 2001, IEEE Transactions on Plasma Science, vol. 30, No. 1, Feb. 2002, IEEE 2002, pp. 286-292.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00700">
<othercit>Bello-Reuss, E. et al., Acute unilateral renal denervation in rats with extracellular volume expansion, Departments of Medicine and Physiology, University of North Carolina School of Medicine. F26-F32 Jul. 1975.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00701">
<othercit>Bello-Reuss, E. et al., Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption, J Clin Invest, 1976;57:1104-1107.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00702">
<othercit>Bello-Reuss, E. et al., Effects of Acute Unilateral Renal Denervation in the Rat, J Clin Invest, 1975;56:208-217.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00703">
<othercit>Berde, C. et al., Local Anesthetics, Anesthesia, Chapter 13, 5th addition, Churchill-Livingston, Philadelphia 2000, pp. 491-521.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00704">
<othercit>Bhadra, Niloy and Kevin L. Kilgore, Direct Current Electrical Conduction Block of Peripheral Nerve, Feb. 25, 2004, IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 12, No. 3, Sep. 2004, pp. 313-324.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00705">
<othercit>Bhandari, A. and Ellias, M., Loin pain hematuria syndrome: Pain control with RFA to the Splanchanic plexus, The Pain Clinic, 2000, vol. 12, No. 4, pp. 323-327.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00706">
<othercit>Bhatt, Deepak L. et al., Rhabdomyolysis Due to Pulsed Electric Fields, May 11, 1989, Plastic and Reconstructive Surgery Jul. 1990, pp. 1-11.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00707">
<othercit>Bichet, D., et al., Renal intracortical blood flow and renin secretion after denervation by 6-hydroxydopamine. Can J Physiol Pharmacol. 1982;60:184-92.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00708">
<othercit>Bigler, D. et al., Tachyphylaxis during postoperative epidural analgesia&#x2014;new insights, Apr. 15, 1987, Letter to the Editor, Acta Anaesthesiol Scand. 1987, vol. 31, pp. 664-665.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00709">
<othercit>Binder, Allan et al., Pulsed Electromagnetic Field Therapy of Persistent Rotator Cuff Tendinitis, The Lancet, Saturday Mar. 31, 1984, The Lancet Ltd., pp. 695-698.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00710">
<othercit>Black, M.D., Henry R., Resistant Hypertension 2004, presentation at Rush University Medical Center, Jul. 15, 2004, 40 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00711">
<othercit>Blad, B., et al., An Electrical Impedance index to Assess Electroporation in Tissue, Tissue and Organ (Therapy), 2001, Oslo, pp. 31-34, www.bl.uk &#x3c;http://www.bl.uk&#x3e; British Library, 2001, Oslo.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00712">
<othercit>Blair, M. L. et al, Sympathetic activation cannot fully account for increased plasma renin levels during water deprivation, Sep. 23, 1996, Am. J. Physiol., vol. 272, 1997, the American Physiological Society 1997, pp. R1197-R1203.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00713">
<othercit>Blomberg, S.G., M.D., PhD, Long-Term Home Self-Treatment with High Thoracic Epidural Anesthesia in Patients with Severe Coronary Artery Disease, Mar. 29, 1994, Anesth Analg 1994, vol. 79, 1994 International Anesthesia Research Society, pp. 413-421.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00714">
<othercit>Boehmer, J.P., Resynchronization Therapy for Chronic CHF: Indications, Devices and Outcomes. Penn State College of Medicine: Penn State Heart and Vascular Institute. Transcatheter Cardiovascular Therapeutics 2005. 31 slides.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00715">
<othercit>Bourge, R.C., Heart Failure Monitoring Devices: Rationale and Status 28 pages, Feb. 2001.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00716">
<othercit>Braunwald, E., Heart Disease, A Textbook of Cardiovascular Medicine, 5th Ed., vol. 2, 1997, pp. 480-481, 824-825, 1184-1288 and 1923-1925, W.B. Saunders Company.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00717">
<othercit>Bravo, E.L., et al., Renal denervation for resistant hypertension, American Journal of Kidney Diseases, 2009, 3 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00718">
<othercit>Bunch, Jared T. et al. Mechanisms of Phrenic Nerve Injury During Radiofrequency Ablation at the Pulmonary Vein Orifice. Journal of Cardiovascular Electrophysiclody. vol. 16, No. 12. pp. 1318-1325. Dec. 2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00719">
<othercit>Burkhoff, D., Interventional Device-Based Therapy for CHF Will Redefine Current Treatment Paradigms. Columbia University. 2004. 32 slides.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00720">
<othercit>Burns, J. et al., Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension. Circulation. 2007;115:1999-2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00721">
<othercit>Cahana, A. et al., Acute Differential Modulation of Synaptic Transmission and Cell Survival During Exposure to Pulsed and Continuous Radiofrequency Energy, May 2003, The Journal of Pain, vol. 4, No. 4, &#xa9; 2003 by the American Pain Society, pp. 197-202.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00722">
<othercit>Cahana, Alex, M.D., Pulsed Radiofrequency: A Neurobiologic and Clinical Reality, May 17, 2005, Anesthesiology 2005, vol. 103, No. 6, Dec. 2005, 2005 American Society of Anesthesiologists, Inc. Lippincott Williams &#x26; Wilkins, Inc., p. 1311.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00723">
<othercit>Calaresu, F.R. et al., Haemodynamic Responses and Renin Release During Stimulation of Afferent Renal Nerves in the Cat, Aug. 12, 1975, J. Physiol. 1976, vol. 255, pp. 687-700.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00724">
<othercit>Cameron, Tracy. Micromodular Implants to Provide Electrical Stimulation of Paralyzed Muscles and Limbs. IEEE Transactions on Biomedical Engineering, vol. 44, No. 9, Sep. 1997. pp. 781-790.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00725">
<othercit>Campese, V.M. et al., Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25:878-82.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00726">
<othercit>Campese, V.M. et al., Renal Afferent Denervation Prevents the Progression of Renal Disease in the Renal Ablation Model of Chronic Renal Failure in the Rat, Am J Kidney Dis. 1995;26:861-5.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00727">
<othercit>Campese, V.M., A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications, Clin Exp Nephrol (2003) 7: 167-171, Japanese Society of Nephrology 2003.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00728">
<othercit>Campese, V.M., Neurogenic factors and hypertension in chronic renal failure, Journal of Nephrology, vol. 10, No. 4, 1997, Societa Italiana di Nefrologia, pp. 184-187.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00729">
<othercit>Campese, V.M., Neurogenic factors and hypertension in renal disease. Kidney Int. 2000;57 Suppl 75:S2-3.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00730">
<othercit>Canbaz, S. et al., Electrophysiological evaluation of phrenic nerve injury during cardiac surgery&#x2014;a prospective, controlled clinical study. BioMed Central. 5 pgs. 2004.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00731">
<othercit>Cardiac Glycosides, Heart Disease&#x2014;Textbook of Cardiovascular Medicine vol. 2, Edited by Eugene Braunwald, 5th Edition, WB Saunders Company, pp. 480-481, 1997.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00732">
<othercit>Chen, S.A. et al., Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablataion, Circulation, 1999, 100:1879-1886.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00733">
<othercit>CODMAN 3000, Implantable Constant&#x2014;Flow Infusion Pump Pamphlet, for Continuous Intrathecal Drug Delivery, 2 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00734">
<othercit>Daniel, Alan and Honig, Carl R. Does Histamine Influence Vasodilation Caused by Prolonged Arterial Occlusion or Heavy Exercise? The Journal of Pharmacology and Experimental Therapeutics. vol. 215 No. 2. Aug. 21, 1980. pp. 533-538.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00735">
<othercit>Dibona, Gerald F., L.L. Sawin, Effect of renal nerve stimulation on NaCl and H2O transport in Henle's loop of the rat,: 1982, American Physiological Society, F576-F580, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00736">
<othercit>Dibona, Gerald, LL Sawin, Effect of renal denervation on dynamic autoregulation of renal blood flow, Feb. 12, 2004, AmJ Physiol Renal Physiol 286, pp. F1209-1218.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00737">
<othercit><i>ECM 830 Specifications Sheet</i>. tech@genetronics.com, 20-001796-01 Rev D. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00738">
<othercit><i>Electropermeabilization (Electroporation), Cyto Pulse Sciences, Inc.</i>, http://www.cytopulse.com/electroporation.html (last accessed Mar. 3, 2005), 3 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00739">
<othercit><i>Electroporation based Technologies and Treatments, ESPE Newsletter </i>No. 6, QLK 02002-2003, Jan. 2005, www.cliniporator.com, 4 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00740">
<othercit>Esler, M. et al., Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol. 1986;8:S39-43.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00741">
<othercit>Esler, M. et al., Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens. 1989; 2:140S-146S.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00742">
<othercit>Esler, M. et al., Sympathetic nerve biology in essential hypertension, Clin and Exp Pharmacology and Physiology, 2001, 28:986-989.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00743">
<othercit>Evelyn, K.A. et al., Effect of thoracolumbar sympathectomy on the clinical course of primary (essential) hypertension, Am J Med, 1960;28:188-221.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00744">
<othercit>Fajardo, J. et al., Effect of chemical sympathectomy on renal hydroelectrolytic handling in dogs with chronic caval constriction. Clin Physiol Biochem. 1986;4:252-6.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00745">
<othercit>Fava, M. et al., Initial Human Experience with CryoPlasty&#x2122; in the Treatment of Infrainguinal Arterial Disease, Abstract. 1 page.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00746">
<othercit>Fava, M., Clinical Testing Establishing Safety &#x26; Efficacy, PowerPoint Presentation. Cryovascular Systems, Inc. 14 slides.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00747">
<othercit>Ferguson, D.R. et al., Responses of the pig isolated renal artery to transmural electrical stimulation and drugs, Dec. 7, 1984, Br. J. Pharmac. 1985, vol. 84, The Macmillan Press Ltd. 1985, pp. 879-882.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00748">
<othercit>Fernandez-Ortiz, Antonio, et al., A New Approach for Local Intravascular Drug Delivery&#x2014;Iontophoretic Balloon, Intravascular Iontophoretic Local Delivery, Circulation, vol. 89, No. 4, Apr. 1994, pp. 1518-1522.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00749">
<othercit>Fields, Larry E. et al., The Burden of Adult Hypertension in the United States 1999 to 2000&#x2014;A Rising Tide, May 18, 2004, American Heart Association 2004, Hypertension Oct. 2004, pp. 1-7.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00750">
<othercit>Final Office Action; U.S. Appl. No. 11/233,814; Mailed on Jan. 29, 2009, 11 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00751">
<othercit>Final Office Action; U.S. Appl. No. 11/266,993; Mailed on Jan. 8, 2010, 7 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00752">
<othercit>Final Office Action; U.S. Appl. No. 11/363,867; Mailed on May 1, 2009, 8 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00753">
<othercit>Final Office Action; U.S. Appl. No. 11/451,728; Mailed on Jan. 13, 2009, 7 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00754">
<othercit>Final Office Action; U.S. Appl. No. 11/599,649; Mailed on Jan. 15, 2009, 10 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00755">
<othercit>Final Office Action; U.S. Appl. No. 11/599,723; Mailed on Apr. 5, 2010, 17 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00756">
<othercit>Final Office Action; U.S. Appl. No. 11/599,890; Mailed on Apr. 29, 2009, 9 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00757">
<othercit>Fischell, Tim A. et al., Ultrasonic Energy: Effects on Vascular Function and Integrity, Circulation: Journal of the American Heart Association. 1991. 84;pp. 1783-1795.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00758">
<othercit>Freeman, Scott A. et al., Theory of Electroporation of Planar Bilayer Membranes: Predictions of the Aqueous Area, Change in Capacitance, and Pore-Pore Separation, Feb. 23, 1994, Biophysical Journal, Jul. 1994, vol. 67, 1994 by the Biophysical Society, pp. 42-56.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00759">
<othercit>Fukuoka, Yuko et al., Imaging of neural conduction block by neuromagnetic recording, Oct. 16, 2002, Clinical Neurophysiology, vol. 113, 2002, Elsevier Science Ireland Ltd. 2002, pp. 1985-1992.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00760">
<othercit>Fuster, Valentin et al. ACC/AHA/ESC Practice Guidelines: ACA/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation. JACC vol. 48, No. 4, Aug. 15, 2006.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00761">
<othercit>Gami, Apoor S., M.D. and Vesna D. Garovic, M.D., Contrast Nephropathy After Coronary Angiography, Mayo Clin Proc. 2004, vol. 79, 2004 Mayo Foundation for Medical Education and Research, pp. 211-219.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00762">
<othercit>Gattone II, Vincent H. et al., Contribution of Renal Innervation to Hypertension in Polycystic Kidney Disease in the Rat, University of Chicago Section of Urology, 16 pages, Mar. 17, 2008.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00763">
<othercit>Gaylor, D.C. et al., Significance of Cell Size and Tissue Structure in Electrical Trauma, Jan. 26, 1988, J. theor. Biol. 1988, vol. 133, 1988 Academic Press Limited, pp. 223-237.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00764">
<othercit>Gazdar, A.F. and G.J. Dammin, Neural degeneration and regeneration in human renal transplants, NEJM, Jul. 30, 1970, 283:222-244.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00765">
<othercit>Gehl, Julie et al., In Vivo Electroporation of Skeletal Muscle: Threshold, Efficacy and Relation to Electric Field Distribution, Biochimica et Biophysica Acta, 1428, 1999, Elsevier Science B.V. 1999, pp. 233-240, www.elsevier.com/locate/bba &#x3c;http:www.elsevier.com/locate/bba&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00766">
<othercit>Getts, R.T. et al., Regression of left ventricular hypertrophy after bilateral nephrectomy, Nephrol Dial Transplant, 2006, vol. 21, pp. 1089-1091.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00767">
<othercit>Ghoname, El-sayed A. et al., Percutaneous electrical nerve stimulation: an alternative to TENS in the management of sciatica, Apr. 26, 1999, Pain 1999, vol. 83, 1999 International Association for the Study of Pain / Published by Elsevier Science B.V., pp. 193-199.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00768">
<othercit>Gimple, M.D., Lawrence et al., Effect of Chronic Subcutaneous or Intramural Administration of Heparin on Femoral Artery Restenosis After Balloon Angioplasty in Hypercholesterolemic Rabbits, Laboratory Investigation, Circulation, vol. 86, No. 5, Nov. 1992, pp. 1536-1546.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00769">
<othercit>Goldberger, Jeffrey J. et al., New technique for vagal nerve stimulation, Jun. 2, 1999, Journal of Neuroscience Methods 91, 1999, Elsevier Science B.V. 1999, pp. 109-114.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00770">
<othercit>Gorbunov, F.E. et al., The Use of Pulsed and Continuous Short Wave Diathermy (Electric Field) in Medical Rehabilitation of the Patients with Guillan-Barre Syndrome and Other Peripheral Myelinopathies, May 6, 1994, 5 pages (most of article in Russian language).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00771">
<othercit>Gottschalk, C.W., Renal nerves and sodium excretion, Ann. Rev. Physiol., 1979, 41:229-240.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00772">
<othercit>Greenwell, T.J. et al., The outcome of renal denervation for managing loin pain haematuria syndrome. BJU International, 2004; 4 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00773">
<othercit>Gruberg, Luis, M.D. et al., The Prognostic Implications of Further Renal Function Deterioration Within 48 h of Interventional Coronary Procedures in Patients with Pre-existent Chronic Renal Insufficiency, Jun. 19, 2000, Journal of the American College of Cardiology 2000, vol. 36, No. 5, 2000 by the American College of Cardiology, pp. 1542-1548.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00774">
<othercit>Guimaraes, Sarfim. Vascular Adrenoceptors: An Update. pp. 319-356, Jun. 1, 2001.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00775">
<othercit>Haissaguerre, M. et al., Spontaneous initiation of atrial fibrillation by ectopic beats orginating in the pulmonary veins, New England Journal of Medicine, 1998, 339: 659-666.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00776">
<othercit>Hajjar, Ihab, M.D., M.S. and Theodore A. Kotchen, M.D., Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000, JAMA, Jul. 9, 2003, vol. 290, No. 2, pp. 199-206.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00777">
<othercit>Hammer, Leah W. Differential Inhibition of Functional Dilation of Small Arterioles by Indomethacin and Glibenclamide. Hypertension. Feb. 2001 Part II. pp. 599-603.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00778">
<othercit>Hampers, C.L. et al., A hemodynamic evaluation of bilateral nephrectomy and hemodialysis in hypertensive man, Circulation. 1967;35:272-288.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00779">
<othercit>Hamza, M.D., Mohamed A. et al., Effect of the Duration of Electrical Stimulation on the Analgesic Response in Patients with Low Back Pain, Anesthesiology, vol. 91, No. 6, Dec. 1999, American Society of Anesthesiologists, Inc. 1999, pp. 1622-1627.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00780">
<othercit>Han, Hyo-Kyung and Gordon L. Amidon, Targeted Prodrug Design to Optimize Drug Delivery, Mar. 21, 2000, AAPS Pharmsci 2000, 2 (1) article 6, pp. 1-11.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00781">
<othercit>Hansen, J.M. et al., The transplanted human kidney does not achieve functional reinnervation, Clin Science, 1994, vol. 87, pp. 13-20.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00782">
<othercit>Hasking, G.J. et al., Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-21.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00783">
<othercit>Hausberg, M. et al., Sympathetic nerve activity in end-stage renal disease, Circulation, 2002, 106: 1974-1979.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00784">
<othercit>Heart Arrhythmia Heart and Vascular Health on Yahoo! Health. 13 pgs. &#x3c;URL: http://health.yahoo.com/topic/heart/overview/article/mayoclinic/21BBE2B0-128D-4AA2-A5CE215065586678;<sub>&#x2014;</sub>ylt=Aqd9M5rNyHD0sbPOmHXFhLcPu7cF&#x3e; Feb. 16, 2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00785">
<othercit>Heart Disease and Stroke Statistics&#x2014;2004 Update, American Heart Association, American Stroke Association, Dallas, Texas, 2003 American Heart Association, 52 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00786">
<othercit>Heida, Tjitske, et al., Investigating Membrane Breakdown of Neuronal Cells Exposed to Nonuniform Electric Fields by Finite-Element Modeling and Experiments, May 9, 2002, IEEE Transactions on Biomedical Engineering, vol. 49, No. 10, Oct. 2002, IEEE 2002, pp. 1195-1203.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00787">
<othercit>Heuer, G.J., The surgical treatment of essential hypertension, Annals of Surgery, 1936; 104 (4): 771-786.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00788">
<othercit>Higuchi, Yoshinori, M.D., Ph.D. et al, Exposure of the Dorsal Root Ganglion in Rats to Pulsed Radiofrequency Currents Activates Dorsal Horn Lamina I and II Neurons, Dec. 4, 2001, Experimental Studies, Neurosurgery, vol. 50, No. 4, Apr. 2002, pp. 850-856.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00789">
<othercit>Hildebrand, Keith R., D.V.M., Ph.D. et al., Stability, Compatibility, and Safety of Intrathecal Bupivacaine Administered Chronically via an Implantable Delivery System, May 18, 2001, The Clinical Journal of Pain, vol. 17, No. 3, 2001 Lippincott Williams &#x26; Wilkins, Inc., pp. 239-244.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00790">
<othercit>Hing, Esther, M.P.H. and Kimberly Middleton, B.S.N., M.P.H., National Hospital Ambulatory Medical Care Survey: 2001 Outpatient Department Summary, Aug. 5, 2003, Advance Data from Vital and Health Statistics, No. 338, CDC, 32 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00791">
<othercit>Hodgkin, Douglas D. et al., Electrophysiologic Characteristics of a Pulsed Iontophoretic Drug-Delivery System in Coronary Arteries, Journal of Cardiovascular Pharmacology. 29(1):pp. 39-44, Jan. 1997. Abstract. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00792">
<othercit>Hopp, F.A. et al., Respiratory Responses to Selective Blockade of Carotid Sinus Baroreceptors in the Dog, Jun. 22, 2005, Am J Physiol Regul Integr Comp Physiol 1998, vol. 275, 2005 American Physiological Society, pp. R10-R18.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00793">
<othercit>Hortobagyi, Gabriel N., Randomized Trial of High-Dose Chemotherapy and Blood Cell Autographs for High-Risk Primary Breast Carcinoma, Journal of the National Cancer Institute, vol. 92, No. 3, Feb. 2, 2000, pp. 225-233.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00794">
<othercit>Horwich, Tamara, M.D., New Advances in the Diagnosis and Management of Acute Decompensated Heart Failure, the heart.org satellite program, Rapid Review, CME Symposium presented on Nov. 8, 2004 at the Sheraton New Orleans Hotel, 4 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00795">
<othercit>Huang, Wann-Chu et al. Renal Denervation Prevents and Reverses Hyperinsulinemia-Induced Hypertension in Rats, Mar. 25, 1998, Hypertension 1998, vol. 32, 1998 American Heart Association, pp. 249-254.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00796">
<othercit>Huang, Yifei et al., Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural and cellular responses, Jan. 8, 2004, Am J Physiol. Heart Circ. Physiol. 2004, vol. 286, 2004 the American Physiological Society, pp. H2141-H2150.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00797">
<othercit><i>Hypertension and Renal Disease: Mechanisms</i>. Slide Show by www.hypertensiononline.org, 22 pages Mar. 30, 2001.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00798">
<othercit>Infumedics Inc., Background and products paper and comparison of Medtronic SynchroMed II and Infumedics Prometra pumps, 3 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00799">
<othercit>Janda, J., Impact of the electrical stimulation apparatus rebox on the course of ischemic renal damage in rats, British Library-The world's knowledge pp. 252-254 (translated and untranslated versions) 1996.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00800">
<othercit>Jia, Jianping et al., Cold injury to nerves is not due to ischaemia alone, Brain. 121;pp. 989-1001. 1998.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00801">
<othercit>Kirchheim, H. et al., Sympathetic modulation of renal hemodynamics, renin release and sodium excretion, Klin Wochenschr, 1989, 67:858-864.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00802">
<othercit>Klein, K. et al., Impaired autofeedback regulation of hypothalamic norepinephrine release in experimental uremia. J Am Soc Nephrol. 2005;16:2081-7.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00803">
<othercit>Knot, H. J. et al., Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. The Journal of Physiology. 1998. 508; pp. 199-209.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00804">
<othercit>Kok, Lai Chow et al. Effect of Heating on Pulmonary Veins: How to Avoid Pulmonary Vein Stenosis. Journal of Cardiovascular Electrophysiology. vol. 14, No. 3, Mar. 2003. pp. 250-254.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00805">
<othercit>Kok, R. J. et al., Specific Delivery of Captopril to the Kidney with the Prodrug Captopril-Lysozyme, Aug. 16, 1998, Journal of Pharmacology and Experimental Therapeutics, vol. 288, No. 1, 1999 by The American Society for Pharmacology and Experimental Therapeutics, pp. 281-285.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00806">
<othercit>Kon, V. Neural Control of Renal Circulation, Miner Electrolyte Metab. 1989;15:33-43.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00807">
<othercit>Koomans, H.A., et al., Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol. 2004;15:524-37.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00808">
<othercit>Kopp, U. et al., Dietary sodium loading increases arterial pressure in afferent renal-denervated rats, Hypertension, 2003, 42:968-973.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00809">
<othercit>Kopp, U.C. et al., Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of alphal- and alpha2-adrenoceptors on renal sensory nerve fibers. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1561-72.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00810">
<othercit>Koyama, Shozo et al., Relative Contribution of Renal Nerve and Adrenal Gland to Renal Vascular Tone During Prolonged Canine Hemorrhagic Hypotension, Sep. 24, 1992, Circulatory Shock 1993, vol. 39, Wiley-Liss, Inc. 1993, pp. 269-274.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00811">
<othercit>Kozak, Lola Jean, Ph.D et al., National Hospital Discharge Survey: 2001 Annual Summary with Detailed Diagnosis and Procedure Data, Vital and Health Statistics, Serices 13 No. 156, Jun. 2004, CDC, 206 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00812">
<othercit>Kumagai, K. et al. New Approach to Pulmonary Vein Isolation for Atrial Fibrillation Using a Multielectrode Basket Catheter. Circulation Journal. 2006;70:88-93.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00813">
<othercit>Lafayette, Richard A., M.D., How Does Knocking Out Angiotensin II Activity Reduce Renal Injury in Mice?, Jun. 14, 1999, Journal Club, American Journal of Kidney Diseases, vol. 35, No. 1, Jan. 2000, National Kidney Foundation, Inc. 2000, pp. 166-172.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00814">
<othercit>Lavie, Peretz, Ph.D. and Victor Hoffstein, M.D., Sleep Apnea Syndrome: A Possible Contributing Factor to Resistant Hypertension, Jun. 2001, Sleep 2001, vol. 24, No. 6, pp. 721-725.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00815">
<othercit>Le Noble, J.L. et al., Pharmacological evidence for rapid destruction of efferent renal nerves in rats by intrarenal infusion of 6-hydroxydopamine. J Hypertens Suppl. 1985;3:5137-40.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00816">
<othercit>Lee, Michael A. (editor). SPORTSMed. Connecticut State Medical Society Committee on the Medical Aspects of Sports. Fall/Winter 2005. 10 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00817">
<othercit>Lee, Raphael C. et al., Biophysical Injury Mechanisms in Electronic Shock Trauma, Annu. Rev. Biomed. Eng., 2000, vol. 2, Copyright &#xa9; 2000 by Annual Reviews, pp. 477-509.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00818">
<othercit>Lee, Raphael C. et al., Clinical Sequelae Manifested in Electrical Shock Survivors, Presentation by the Electrical Trauma Research Program, The University of Chicago, 37 pages Dec. 24, 2004.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00819">
<othercit>Lenoble, L.M. et al., Selective efferent chemical sympathectomy of rat kidneys. Am J Physiol. 1985;249:R496-501.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00820">
<othercit>Lohmeier, Thomas E., Interactions Between Angiotensin II and Baroreflexes in Long-Term Regulation of Renal Sympathetic Nerve Activity, Circulation Research, Jun. 27, 2003, American Heart Association, Inc.2003, pp. 1282-1284.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00821">
<othercit>Luippold, G. et al., Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats, Nephrol Dial Transplant (2004) 19:342-347.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00822">
<othercit>Macarthur, Dr. Alison, Spinal Anesthesia and Sever Gestational Hypertension, presentation at Mount Sinai Hospital, 25 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00823">
<othercit>Maeder, Micha, M.D. et al., Contrast Nephropathy: Review Focusing on Prevention, Jun. 22, 2004, Journal of the American College of Cardiology Nov. 2, 2004, vol. 44, No. 9, 2004 by the American College of Cardiology Foundation, pp. 1763-1771.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00824">
<othercit>Malpas, Simon C., What sets the long-term level of sympathetic nerve activity: is there a role for arterial baroreceptors?, Invited Review, Am J Physiol Regul Integr Comp Physiol 2004, vol. 286, 2004 the American Physiological Society, pp. R1-R12.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00825">
<othercit>Mancia, G., Grassi, G., Giannattasio, C., Seravalle, G., Sympathetic actrivation of pathogenesis of hypertension and progression of organ damage, Hypertension 1999, 34 (4 Pt 2): 724-728.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00826">
<othercit>Marenzi, Giancarlo, M.D. et al., The Prevention of Radiocontrast-Agent-Induced Nephropathy by Hemofiltration, New England Journal of Medicine, Oct. 2, 2003, vol. 349 (14), 2003 Massachusetts Medical Society, pp. 1333-1340.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00827">
<othercit>Market for infusion pumps grows with an aging population, NWL 97-01, The BBI Newsletter, vol. 20, No. 2, Feb. 1, 1997, American Health Consultants, Inc., 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00828">
<othercit>Martin, Jason B. et al., Gene Transfer to Intact Mesenteric Arteries by Electroporation, Mar. 27, 2000, Journal of Vascular Research 2000, vol. 37, 2000 S. Karger AG, Basel, pp. 372-380.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00829">
<othercit>Mathur, Vandana S., Intra-Renal Drug Delivery for Fluid Overload, FlowMedica. Transcatheter Cardiovascular Therapeutics 2005. 31 slides.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00830">
<othercit>McCreery, Douglas B. et al., Charge Density and Charge Per Phase as Cofactors in Neural Injury Induced by Electrical Stimulation, IEEE Transactions on Biomedical Engineering, vol. 17, No. 10, Oct. 1990, pp. 996-1000.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00831">
<othercit>McCullough, Peter A., M.D., MPH et al., Acute Renal Failure after Coronary Intervention: Incidence, Risk Factors and Relationship to Mortality, Apr. 14, 1997, Am J Med. 1997, vol. 103, 1997 Excerpta Medica, Inc., pp. 368-375.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00832">
<othercit>Mcmurray, John J.V., M.D. and Eileen O'Meara, M.D., Treatment of Heart Failure with Spironolactone&#x2014;Trial and Tribulations, Aug. 5, 2004, New England Journal of Medicine, vol. 351, No. 6, 2004 Massachusetts Medical Society, pp. 526-528.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00833">
<othercit>Mcrobbie, D. and M.A. Foster, Thresholds for biological effects of time-varying magnetic fields, Dec. 16, 1983, Clin. Phys. Physiol. Meas. 1984, vol. 5, No. 2, 1984 The Institute of Physics, pp. 67-78.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00834">
<othercit>Medtronic Inc., MiniMed 2007, Implantable Insulin Pump System (Shoreview, MN) 4 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00835">
<othercit>Medtronic Neurostimulation Systems, Expanding the Array of Pain Control Solutions, informational pamphlet, 1999 Medtronic, Inc., 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00836">
<othercit>Medtronic, Spinal Cord Stimulation, Patient Management Guidelines for Clinicians, Medtronic, Inc. 1999, 115 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00837">
<othercit>Medtronic, SynchroMed Infusion System&#x2014;Clinical Reference Guide for Pain Therapy, Medtronic, Inc. 1998, 198 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00838">
<othercit>Mehran, Roxana, Renal insufficiency and contrast nephropathy: The most common, least understood risk factor, Cardiovascular Research Foundation. Columbia University Medical Center. 2005. 86 slides.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00839">
<othercit>Mess, Sarah A., M.D. et al., Implantable Baclofen Pump as an Adjuvant in Treatment of Pressure Sores, Mar. 1, 2003, Annals of Plastic Surgery, vol. 51, No. 5, Nov. 2003, Lippincott Williams &#x26; Wilkins 2003, pp. 465-467.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00840">
<othercit>Micro ETS Hyperhidrosis USA Hyperhidrosis USA. 2 pgs. &#x3c;URL: http://www.hyperhidrosis-usa.com/Index.html&#x3e;. Nov. 6, 2006.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00841">
<othercit>Mihran, Richard T. et al., Temporally-Specific Modification of Myelinated Axon Excitability in Vitro Following a Single Ultrasound Pulse, Sep. 25, 1989, Ultrasound in Med. &#x26; Biol. 1990, vol. 16, No. 3, pp. 297-309.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00842">
<othercit>Miklav{hacek over (c)}i{hacek over (c)}, D. et al, A Validated Model of in Vivo Electric Field Distribution in Tissues for Electrochemotherapy and for DNA Electrotransfer for Gene Therapy, Biochimica et Biophysica Acta, 1523, 2000, pp. 73-83, &#x3c;http:www.elsevier.com/locate/bba&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00843">
<othercit>Mitchell, G. A. G., The Nerve Supply of the Kidneys, Aug. 20, 1949, Acta Anatomica, vol. X, Fasc. &#xbd;, 1950, pp. 1-37.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00844">
<othercit>Morrisey, D.M. et al., Sympathectomy in the treatment of hypertension: Review of 122 cases, Lancet. 1953;1:403-408.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00845">
<othercit>Moss, Nicholas G., Renal function and renal afferent and efferent nerve activity, Am. J. Physiol. 1982, vol. 243, 1982 the American Physiological Society, pp. F425-F433.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00846">
<othercit>Munglani, Rajesh, The longer term effect of pulsed radiofrequency for neuropathic pain, Jun. 8, 1998, Pain 80, 1999, International Association for the Study of Pain 1999, Published by Elsevier Science B.V., pp. 437-439.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00847">
<othercit>Naropin (ropivacaine HCI) Injection, RX only Description, AstraZeneca 2001, 3 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00848">
<othercit>National High Blood Pressure Education Program, 1995 Update of the Working Group Reports on Chronic Renal Failure and Renovascular Hypertension, presentation, 13 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00849">
<othercit>National Kidney Foundation, Are You At Increased Risk for Chronic Kidney Disease?, 2002 National Kidney Foundation, Inc., 14 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00850">
<othercit>Nelson, L. et al., Neurogenic Control of Renal Function in Response to Graded Nonhypotensive Hemorrahage in Conscious Dogs, Sep. 13, 1992, Am J. Physiol. 264, 1993, American Physiological Society 1993, pp. R661-R667.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00851">
<othercit>Nikolsky, Eugenia, M.D. et al., Radiocontrast Nephropathy: Identifying the High-Risk Patient and the Implications of Exacerbating Renal Function, Rev Cardiovasc Med. 2003, vol. 4, Supp. 1, 2003 MedReviews, LLC, pp. S7-S14.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00852">
<othercit>Non-Final Office Action; U.S. Appl. No. 10/408,665; Mailed on Mar. 21, 2006, 14 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00853">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/129,765; Mailed on May 18, 2007, 10 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00854">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/129,765; Mailed on Sep. 10, 2007, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00855">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/129,765; Mailed on Oct. 6, 2006, 30 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00856">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/133,925; Mailed on Oct. 8, 2008, 41 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00857">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/144,173; Mailed on Apr. 5, 2007, 33 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00858">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/144,173; Mailed on Sep. 10, 2007, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00859">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/144,298; Mailed Oct. 29, 2009, 8 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00860">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/144,298; Mailed on Apr. 5, 2007, 33 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00861">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/144,298; Mailed on Sep. 10, 2007, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00862">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/144,298; Mailed on Dec. 29, 2008, 7 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00863">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/145,122; Mailed on Apr. 11, 2007, 33 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00864">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/145,122; Mailed on Sep. 10, 2007, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00865">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/189,563; Mailed on May 28, 2009, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00866">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/233,814; Mailed on Jun. 17, 2008, 12 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00867">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/252,462; Mailed on Feb. 22, 2010, 6 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00868">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/266,993; Mailed on Jul. 8, 2009, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00869">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/266,993; Mailed on Dec. 30, 2008, 7 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00870">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/363,867; Mailed on Sep. 25, 2008, 10 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00871">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/368,553; Mailed on May 18, 2010, 4 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00872">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/368,553; Mailed on Oct. 7, 2009, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00873">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/368,809; Mailed on Dec. 3, 2009, 4 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00874">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/368,949; Mailed on Jun. 11, 2010, 6 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00875">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/368,971; Mailed on Aug. 24, 2010, 9 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00876">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/451,728; Mailed on Jun. 12, 2008, 41 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00877">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/451,728; Mailed on Jul. 2, 2009, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00878">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/451,728; Mailed on Dec. 28, 2009, 7 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00879">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/504,117; Mailed on Mar. 31, 2009, 10 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00880">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/599,649; Mailed on Mar. 30, 2009, 10 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00881">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/599,649; Mailed on Jun. 23, 2008, 9 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00882">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/599,723; Mailed on Jun. 26, 2009, 17 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00883">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/599,723; Mailed on Oct. 15, 2010, 16 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00884">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/599,882; Mailed on Jul. 6, 2009, 13 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00885">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/688,178; Mailed on Jun. 28, 2010, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00886">
<othercit>Non-Final Office Action; U.S. Appl. No. 11/840,142; Mailed on Apr. 3, 2009, 13 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00887">
<othercit>Non-Final Office Action; U.S. Appl. No. 12/567,521; Mailed on Sep. 3, 2010, 9 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00888">
<othercit>Non-Final Office Action; U.S. Appl. No. 12/616,708; Mailed Sep. 16, 2010, 10 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00889">
<othercit>Non-Final Office Action; U.S. Appl. No. 12/725,375; Mailed on Oct. 12, 2010, 14 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00890">
<othercit>Nozawa, T.et al., Effects of Long Term Renal Sympathetic Denervation on Heart Failure After Myocardial Infarction in Rats, Sep. 22, 2001, Heart Vessels, 2002, 16, Springer-Verlag 2002, pp. 51-56.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00891">
<othercit>O'Hagan, K.P. et al., Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension, Am J Hypertens., 1990, 3:62-64.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00892">
<othercit>Onesti, G. et al., Blood pressure regulation in end-stage renal disease and anephric man, Circ Res Suppl., 1975, 36 &#x26; 37: 145-152.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00893">
<othercit>Osborn, et al., Effect of renal nerve stimulation on renal blood flow autoregulation and antinatriuresis during reductions in renal perfusion pressure, in Proceedings of the Society for Experimental Biology and Medicine, vol. 168, 77-81, 1981. (Abstract).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00894">
<othercit>Packer, Douglas L. et al., Clinical Presentation, Investigation, and Management of Pulmonary Vein Stenosis Complication Ablation for Atrial Fibrillation, Circulation: Journal of the American Heart Association. Feb. 8, 2005. pp. 546-554.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00895">
<othercit>Page, I.H. et al., The Effect of Renal Denervation on the Level of Arterial Blood Pressure and Renal Function in Essential Hypertension. J Clin Invest. 1935;14:27-30.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00896">
<othercit>Page, I.H., et al., The Effect of Renal Efficiencyof Lowering Arterial Blood Pressure in Cases of Essential Nephritis, Hospital of the Rockefeller Institue, Jul. 12, 1934, 7 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00897">
<othercit>Palmer, Biff, F., M.D., Managing Hyperkalemia Caused by Inhibitors of the Renin-Angiotensin-Aldosterone System, Aug. 5, 2004, The New England Journal of Medicine 2004, vol. 351;6, 2004 Massachusetts Medical Society, pp. 585-592.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00898">
<othercit>Pappone, Carlo et al., [2005][P2-70] Safety Report of Circumferential Pulmonary Vein Ablation. A 9-Year Single-Center Experience on 6,442 Patients with Atrial Fibrillation, Abstract only. 1 page, May 2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00899">
<othercit>Pappone, Carlo et al., [2004][759] Pulmonary Vein Denervation Benefits Paroxysmal Atrial Fibrillation Patients after Circumferential Ablation, Abstract only. 1 page, Jan. 5, 2004.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00900">
<othercit>Pappone, Carol and Santinelli, Vincenzo. Multielectrode basket catheter: A new tool for curing atrial fibrillation? Heart Rhythm, vol. 3, Issue 4, pp. 385-386. Apr. 2006.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00901">
<othercit>Peacock, J.M. and R. Orchardson, Action potential conduction block of nerves in vitro by potassium citrate, potassium tartrate and potassium oxalate, May 6, 1998, Journal of Clinical Periodontology, Munksgaard 1999, vol. 26, pp. 33-37.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00902">
<othercit>Petersson, M. et al., Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J. 2005;26:906-13.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00903">
<othercit>Pettersson, A. et al., Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure, Nov. 25, 1988, Acta Physiol Scand 1989, 135, pp. 487-492.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00904">
<othercit><i>PHCL 762 Pharmacology of the Autonornic Nervous System, Chapter 2 and 6.8 in Mosby</i>, http://www.kumc.edu/research/medicine/pharmacology/CAI/phcl762.html, last accessed Aug. 24, 2004, 14 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00905">
<othercit>Pitt, B. et al., Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy: The 4E-Left Ventricular Hypertrophy Study, Circulation, 2003, vol. 108, pp. 1831-1838.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00906">
<othercit>Pliquett, U., Joule heating during solid tissue electroporation, Oct. 22, 2002, Med. Biol. Eng. Comput., 2003, vol. 41, pp. 215-219.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00907">
<othercit>Podhajsky R.J. et al, The Histologic Effects of Pulsed and Continuous Radiofrequency Lesions at 42 C to Rat Dorsal Root Ganglion and Sciatic Nerve, SPINE, vol. 30, No. 9, pp. 1008-1013, 2005, Lippincott Williams &#x26; Wilkins Inc.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00908">
<othercit>Pope, Jill. Fixing a Hole: Treating Injury by Repairing Cells. The New York Academy of Sciences. Jul. 6, 2006. 6 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00909">
<othercit>Popovic, Jennifer R. and Margaret J. Hall, 1999 National Hospital Discharge Survey, Apr. 24, 2001, Advance Data, No. 319, CDC, pp. 1-17 &#x26; 20.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00910">
<othercit>Practice Guidelines Writing Committee and ESH/ESC Hypertension Guidelines Committee, Practice Guidelines for Primary Care Physicians: 2003 ESH/ESC Hypertension Guidelines, Published in Journal of Hypertension 2003, vol. 21, No. 10: 1011-1053, European Society of Hypertension 2003, pp. 1779-1786.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00911">
<othercit>Programmable Infusion System, Pumps and Pump Selection, Medtronic Pain Therapies, Medtronic, Inc. Sep. 5, 2001, 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00912">
<othercit>Pucihar, Gorazd et al., The influence of medium conductivity on electropermeabilization and survival of cells in vitro, May 31, 2001, Bioelectrochemistry, vol. 54, 2001, Elsevier Science B.V. 2001, pp. 107-115.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00913">
<othercit>Pulmonary Concepts in Critical Care Breath Sounds, http://rnbob.tripod.com/breath.htm, last accessed Aug. 23, 2004, 5 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00914">
<othercit>Pulmonary Function Testing http://jan.ucc.nau.edu/&#x2dc;daa/lecture/pft.htm last accessed Aug. 23, 2004 8 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00915">
<othercit>Purerfellner, Helmut and Martinek, Martin. Pulmonary vein stenosis following catheter ablation of atrial fibrillation. Current Opinion in Cardiology. 20; pp. 484-490. 2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00916">
<othercit>Purerfellner, Helmut et al., Pulmonary Vein Stenosis by Ostial Irrigated-Tip Ablation: Incidence, Time Course, and Prediction, Journal of Cardiovascular Electrophysiology. vol. 14, No. 2, Feb. 2003. pp. 158-164.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00917">
<othercit>Raji, A. R. M. And R. E. M. Bowden, Effects of High-Peak Pulsed Electromagnetic Field on the Degeneration and Regeneration of the Common Peroneal Nerve in Rats, The Journal of Bone and Joint Surgery Aug. 1983, vol. 65-B, No. 4, 1983 British Editorial Society of Bone and Joint Surgery, pp. 478-492.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00918">
<othercit>Ram, C. Venkata S., M.D., Understanding refractory hypertension, May 15, 2004, Patient Care May 2004, vol. 38, pp. 12-16, 7 pages from http://www.patientcareonline.com/patcare/content/printContentPopup.jsp?id=108324.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00919">
<othercit>Ravalia, A. et al., Tachyphylaxis and epidural anaesthesia, Edgware General Hospital, Correspondence, p. 529, Jun. 1989.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00920">
<othercit>Renal Parenchymal Disease, Ch. 26, 5th Edition Heart Disease, A Textbook of Cardiovascular Medicine vol. 2, Edited by Eugene Braunwald, WB Saunders Company, pp. 824-825 1997.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00921">
<othercit>Ribstein, Jean and Michael H. Humphreys, Renal nerves and cation excretion after acute reduction in functioning renal mass in the rat, Sep. 22, 1983, Am. J. Physiol., vol. 246, 1984 the American Physiological Society, pp. F260-F265.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00922">
<othercit>Richebe, Philippe, M.D. et al., Immediate Early Genes after Pulsed Radiofrequency Treatment: Neurobiology in Need of Clinical Trials, Oct. 13, 2004, Anesthesiology Jan. 2005, vol. 102, No. 1, 2004 American Society of Anesthesiologists, Inc. Lippincott Williams &#x26; Wilkins, Inc., pp. 1-3.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00923">
<othercit>Rihal, Charanjit S. et al., Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention, Mar. 6, 2002, Circulation May 14, 2002, vol. 10, 2002 American Heart Association, Inc., pp. 2259-2264.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00924">
<othercit>Rosen, S.M. et al., Relationship of Vascular Reactivity to Plasma Renin Concentration in Patients with Terminal Renal Failure, Proc. Dialysis Transplant Forum 1974, pp. 45-47.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00925">
<othercit>Roth, Bradley J. and Peter J. Basser, A Model of the Stimulation of a Nerve Fiber by Electromagnetic Induction, IEEE Transactions on Biomedical Engineering, vol. 37, No. 6, Jun. 1990, pp. 588-597.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00926">
<othercit>Rudin, Asa, M.D. et al., Postoperative Epidural or Intravenous Analgesia after Major Abdominal or Thoraco-Abdominal Surgery, The Journal of the American Society of Anesthesiologists, Inc., Anesthesiology 2001, vol. 95, A-970, 1 page.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00927">
<othercit>Rudnick, Michael R. et al., Contrast-induced nephropathy: How it develops, how to prevent it, Cleveland Clinic Journal of Medicine Jan. 2006, vol. 73, No. 1, pp. 75-87.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00928">
<othercit>Rump, L.C., The Role of Sympathetic Nervous Activity in Chronic Renal Failure, J Clinical Basic Cardiology 2001, vol. 4, pp. 179-182.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00929">
<othercit>Ruohonen, Jarmo et al., Modeling Peripheral Nerve Stimulation Using Magnetic Fields, Journal of the Peripheral Nervous System, vol. 2, No. 1, 1997, Woodland Publications 1997, pp. 17-29.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00930">
<othercit>Saad, Eduardo B. et al., Pulmonary Vein Stenosis After Radiofrequency Ablation of Atrial Fibrillation: Functional Characterization, Evolution, and Influence of the Ablation Strategy, Circulation. 108; pp. 3102-3107. 2003.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00931">
<othercit>Schauerte, P et al., Focal atrial fibrillation: experimental evidence for a pathophysiologic role of the autonomic nervous system, Journal of Cardiovascular Electrophysiology. 12(5). May 2001. Abstract only. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00932">
<othercit>Schauerte, P et al., Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation, Circulation. 102(22). Nov. 28, 2000. Abstract only. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00933">
<othercit>Schauerte, P et al., Transvenous parasympathetic nerve stimulation in the inferior vena cava and atrioventricular conduction, Journal of Cardiovascular Electrophysiology. 11(1). Jan. 2000. Abstract only. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00934">
<othercit>Schlaich, M.P. et al., Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108:560-5.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00935">
<othercit>Schlaich, M.P. et al., Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation, Hypertension, 2004, 43:169-175.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00936">
<othercit>Serrador, Jorge M., Autonomic Regulation of the Cardiovascular System, MIT Lecture. 8 pages, 48 slides.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00937">
<othercit>Shlipak, M.G. et al., The clinical challenge of cardiorenal syndrome. Circulation. 2004;110:1514-7.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00938">
<othercit>Siegel, Rj et al., Clinical demonstration that catheter-delivered ultrasound energy reverses arterial vasoconstriction, Journal of the American College of Cardiology. 1992. 20; 732-735. Summary only. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00939">
<othercit>Simpson, B. et al., Implantable spinal infusion devices for chronic pain and spasticity: an accelerated systematic review, ASERNIP-S Report No. 42, Adelaide, South Australia, ASERNIP-S, May 2003, 56 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00940">
<othercit>Sisken, B.F. et al., 229.17 Influence of Non-Thermal Pulsed Radiofrequency Fields (PRF) on Neurite Outgrowth, Society for Neuroscience, vol. 21, 1995, 2 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00941">
<othercit>Skeie, B. et al., Effect of chronic bupivacaine infusion on seizure threshold to bupivacaine, Dec. 28, 1986, Acta Anaesthesiol Scand 1987, vol. 31, pp. 423-425.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00942">
<othercit>Skopec, M., A Primer on Medical Device Interactions with Magnetic Resonance Imaging Systems. Feb. 4, 1997, CDRH Magnetic Resonance Working Group, U.S. Department of Health and Human Services. Food and Drug Administration, Center for Devices and Radiological Health, Updated May 23, 1997, 17 pages, http://www.fda.gov/cdrh/ode/primerf6.html, (last accessed Jan. 23, 2006.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00943">
<othercit>Slappendel, Robert et al., The efficacy of radiofrequency lesioning of the cervical spinal dorsal root ganglion in a double blinded randomized study, Jun. 26, 1997, Pain 73, 1997 International Association for the Study of Pain, Elsevier Science B.V., pp. 159-163.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00944">
<othercit>Sluijter, M.D., Ph.D., Pulsed Radiofrequency, May 17, 2005, Anesthesiology Dec. 2005, vol. 103, No. 6, 2005 American Society of Anesthesiologists, Inc. Lippincott Williams &#x26; Wilkins, Inc., pp. 1313-1314.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00945">
<othercit>Sluijter, M.D., Ph.D., Radiofrequency Part 1: The Lumbosacral Region, Chapter 1 Mechanisms of Chronic Pain and part of Chapter 2 Spinal Pain, 2001 FlivoPress SA, Meggen (LU), Switzerland, pp. 1-26.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00946">
<othercit>Sluijter, M.D., Ph.D., Radiofrequency Part 2: Thoracic and Cervical Region, Headache and Facial Pain, various pages from, FlivoPress SA, Meggen (LU), Switzerland, 13 pages 2002.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00947">
<othercit>Sluijter, M.D., Ph.D., The Role of Radiofrequency in Failed Back Surgery Patients, Current Review of Pain 2000, vol. 4, 2000 by Current Science Inc., pp. 49-53.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00948">
<othercit>Smithwick, R.H. et al., Hypertension and associated cardiovascular disease: comparison of male and female mortality rates and their influence on selection of therapy, JAMA, 1956, 160:1023-1033.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00949">
<othercit>Smithwick, R.H. et al., Splanchnicectomy for essential hypertension, Journal Am Med Assn, 1953;152:1501-1504.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00950">
<othercit>Smithwick, R.H., Surgical treatment of hypertension, Am J Med 1948, 4:744-759.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00951">
<othercit>Sobotka, Paul A., Treatment Strategies for Fluid Overload, CHF Patients, Chf Solutions. Transcatheter Cardiovascular Therapeutics 2005. 20 slides.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00952">
<othercit>Solis-Herruzo, J.A. et al., Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome, Journal of Hepatology, 1987; 5: 167-173.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00953">
<othercit>Souza, D.R.B. et al., Chronic experimental myocardial infarction produces antinatriuresis by a renal nerve-dependent mechanism, Oct. 14, 2003, Brazilian Journal of Medical and Biological Research 2004, vol. 37, pp. 285-293.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00954">
<othercit>Standl, Thomas, M.D., et al., Patient-controlled epidural analgesia reduces analgesic requirements compared to continuous epidural infusion after major abdominal surgery, Aug. 29, 2002, Canada Journal of Anesthesia 2003, vol. 50 (3), pp. 258-264.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00955">
<othercit>Steffen, W. et al., Catheter-delivered high intensity, low frequency ultrasound induces vasodilation in vivo, European Heart Journal. 1994. 15;pp. 369-376.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00956">
<othercit>Steg, PG. et al., Pulsed ultraviolet laser irradiation produces endothelium-independent relaxation of vascular smooth muscle, Circulation: Journal of the American Heart Association. 1989. pp. 189-197.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00957">
<othercit>Stone, Gregg W., M.D. et al., Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy, JAMA Nov. 5, 2003, vol. 290, No. 17, 2003 American Medical Association, pp. 2284-2291.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00958">
<othercit>Strojek, K. et al., Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy? J Am Soc Nephrol. 2001;12:602-5.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00959">
<othercit>Summary, Critical Reviews in Biomedical Engineering, vol. 17, Issue 5, 1989, pp. 515-529.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00960">
<othercit>Sung, Duk Hyun, M.D. et al., Phenol Block of Peripheral Nerve Conduction: Titrating for Optimum Effect, Jun. 27, 2000, Arch. Phys. Med. Rehabil. vol. 82, May 2001, pp. 671-676.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00961">
<othercit>Taka, Tomomi et al., Impaired Flow-Mediated Vasodilation in vivo and Reduced Shear-Induced Platelet Reactivity in vitro in Response to Nitric Oxide in Prothrombotic, Stroke-Prone Spontaneously Hypertensive Rats, Pathophysiology of Haemostasis and Thrombosis. Dec. 23, 2002. pp. 184-189.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00962">
<othercit>Taler, Sandra J. et al., Resistant Hypertension, Comparing Hemodynamic Management to Specialist Care, Mar. 12, 2002, Hypertension 2002, vol. 39, 2002 American Heart Association, Inc., pp. 982-988.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00963">
<othercit>Tamborero, David et al., Incidence of Pulmonary Vein Stenosis in Patients Submitted to Atrial Fibrillation Ablation: a Comparison of the Selective Segmental Ostial Ablation vs. The Circumferential Pulmonary Veins Ablation, Journal of Intervocational Cardiac Electrophysiology. 14; pp. 41-25. 2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00964">
<othercit>Tay, Victoria KM, et al., Computed tomography fluoroscopy-guided chemical lumbar sympathectomy: Simple, safe and effective, Oct. 31, 2001, Diagnostic Radiology, Australasian Radiology 2002, vol. 46, pp. 163-166.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00965">
<othercit>Terashima, Mitsuyasu et al. Feasibility and Safety of a Novel CryoPlastyTM System. Poster. 1 page, Mar. 15, 2002.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00966">
<othercit>Thatipelli et al., CT Angiography of Renal Artery Anatomy for Evaluating Embolic Protection Devices, Journal of Vascular and Interventional Radiology, Jul. 2007, pp. 842-846.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00967">
<othercit>The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, ALLHAT Research Group, JAMA, 2002, vol. 288, pp. 2981-2997.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00968">
<othercit>Thomas, John R. and Oakley, E. Howard N. Chapter 15: Nonfreezing Cold Injury Medical Aspects of Harsh Environments, vol. 1. pp. 467-490, 2001.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00969">
<othercit>Thompson, Gregory W., et al., Bradycardia Induced by Intravascular Versus Direct Stimulation of the Vagus Nerve, Aug. 24, 1997, The Society of Thoracic Surgeons 1998, pp. 637-642.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00970">
<othercit>Thrasher, Terry N., Unloading arterial baroreceptors causes neurogenic hypertension, Dec. 4, 2001, Am J. Physiol Regulatory Integrative Comp Physiol, vol. 282, 2002 the American Physiological Society, pp. R1044-R1053.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00971">
<othercit>Tokuno, Hajime A. et al., Local anesthetic effects of cocaethylene and isopropylcocaine on rat peripheral nerves, Oct. 7, 2003, Brain Research 996, 2004, Elsevier B.V. 2003, pp. 159-167.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00972">
<othercit>Trapani, Angelo J. et al., Neurohumoral interactions in conscious dehydrated rabbit, Am. J. Physiol. 254, 1988, the American Physiological Society 1988, pp. R338-R347.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00973">
<othercit>Vince, D. Geoffrey. Virtual Histology: A new technique for the assessment of plaque composition. The Cleveland Clinic Foundation. 28 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00974">
<othercit>Vonend, O. et al., Moxonidine treatment of hypertensive patients with advanced renal failure. J Hypertens. 2003;21:1709-17.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00975">
<othercit>Wagner, C.D. et al., Very low frequency oscillations in arterial blood pressure after autonomic blockade in conscious dogs, Feb. 5, 1997, Am J Physiol Regul Integr Comp Physiol 1997, vol. 272, 1997 the American Physiological Society, pp. 2034-2039.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00976">
<othercit>Wald, Jan D., Ph.D, et al., Cardiology Update: 2003, Sep. 11, 2003, AG Edwards 2003, 120 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00977">
<othercit>Wang, Xi et al., Alterations of adenylyl cyclase and G proteins in aortocaval shunt-induced heart failure, Jul. 2004, AM J Physiol Heart Circ Physiol vol. 287, 2004 the American Physiological Society, pp. H118-H125.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00978">
<othercit>Weaver, James C., Chapter 1 Electroporation Theory, Concepts and Mechanisms, Methods in Molecular Biology, vol. 55, Plant Cell Electroporation and Electrofusion Protocols, Edited by J.A. Nickoloff, Humana Press Inc., pp. 3-28, 1995.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00979">
<othercit>Weaver, James C., Electroporation: A General Phenomenon for Manipulating Cells and Tissues, Oct. 22, 1992, Journal of Cellular Biochemistry, vol. 51, 1993 Wiley-Liss, Inc., pp. 426-435.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00980">
<othercit>Weiner, Richard L., M.D., Peripheral nerve neurostimulation, Neurosurg. Clin. N. Am. vol. 14, 2003, Elsevier, Inc. 2003, pp. 401-408.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00981">
<othercit>Weisbord, Steven D., M.D. and Paul M. Palevsky, M.D., Radiocontrast-Induced Acute Renal Failure, Jul. 10, 2004, Journal of Intensive Care Medicine 2005, vol. 20 (2), 2005 Sage Publications, pp. 63-75.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00982">
<othercit>Whitelaw, G.P., Kinsey, D., Smithwick, R.H., Factors influencing the choice of treatment in essential hypertension: surgical, medical, or a combination of both, Am J Surg, 1964, 107:220-231.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00983">
<othercit>Wilson, D.H. et al., The Effects of Pulsed Electromagnetic Energy on Peripheral Nerve Regeneration, Annals New York Academy of Sciences, pp. 575-585, Oct. 1974.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00984">
<othercit>Wolinsky, Harvey, M.D. PhD and Swan N. Thung, M.D., Use of a Perforated Balloon Catheter to Deliver Concentrated Heparin Into the Wall of the Normal Canine Artery, Aug. 30, 1989, JACC 1990, vol. 15, 1990 by the American College of Cardiology, pp. 475-481.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00985">
<othercit>Wyss, J. Michael et al., Neuronal control of the kidney: Contribution to hypertension, Apr. 8, 1991, Can. J. Physiol. Pharmacol. 1992;70: 759-770.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00986">
<othercit>Yamaguchi, Jun-ichi, M.D. et al., Prognostic Significance of Serum Creatinine Concentration for In-Hospital Mortality in Patients with Acute Myocardial Infarction Who Underwent Successful Primary Percutaneous Coronary Intervention (from the Heart Institute of Japan Acute Myocardial Infarction [Hijami] Registry), Feb. 24, 2004, The American Journal of Cardiology vol. 93, Jun. 15, 2004, by Excerpta Medica, Inc., pp. 1526-1528.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00987">
<othercit>Ye, Richard D., M.D., Ph.D., Pharmacology of the Peripheral Nervous System, E-425 MSB, 6 pages, Jan. 2000.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00988">
<othercit>Ye, S. et al., A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens. 1998;11:723-8.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00989">
<othercit>Ye, Shaohua et al., Renal Injury Caused by Intrarenal Injection of Pheno Increases Afferent and Efferent Renal Sympathetic Nerve Activity, Mar. 12, 2002, American Journal of Hypertension, Aug. 2002, vol. 15, No. 8, 2002 the American Journal of Hypertension, Ltd. Published by Elsevier Science Inc., pp. 717-724.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00990">
<othercit>Yong-Quan, Dong et al., The therapeutic effect of pulsed electric field on experimental spinal cord injury, Beijing Army General Hospital of People's Liberation Army, Beijing, 5 pages (full article in Chinese; abstract on last page) Mar. 30, 1992.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00991">
<othercit>Young, James B., M.D., FACC, Management of Chronic Heart Failure: What Do Recent Clinical Trials Teach Us?, Reviews in Cardiovascular Medicine, vol. 5, Suppl. 1, 2004, MedReviews, LLC 2004, pp. S3-S9.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00992">
<othercit>Yu, Wen-Chung et al. Acquired Pulmonary Vein Stenosis after Radiofrequency Catheter Ablation of Paroxysmal Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. vol. 12, No. 8. Aug. 2001. pp. 887-892.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00993">
<othercit>Zanchetti, A. et al., Neural Control of the Kidney&#x2014;Are There Reno-Renal Reflexes?, Clin. and Exper. Hyper. Theory and Practice, A6 (1&#x26;2), 1984, Marcel Dekker, Inc. 1984, pp. 275-286.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00994">
<othercit>Zanchetti, A. et al., Practice Guidelines for Primary Care Physicians: 2003 ESH/ESC Hypertension Guidelines, Journal of Hypertension, vol. 21, No. 10, 2003, pp. 1779-1786.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00995">
<othercit>Zanchetti, A.S., Neural regulation of renin release: Experimental evidence and clinical implications in arterial hypertension, Circulation, 1977, 56(5) 691-698.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00996">
<othercit>Zimmermann, Ulrich, Electrical Breakdown, Electropermeabilization and Electrofusion, Rev. Physiol. Biochem. Pharmacol., vol. 105, Springer-Verlag 1986, pp. 175-256.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00997">
<othercit>Zoccali, C. et al., Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002;105:1354-9.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00998">
<othercit>Zucker, Irving H. et al., The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide, Progress in Biophysics &#x26; Molecular Biology, vol. 84, 2004, Elsevier Ltd. 2003, pp. 217-232.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00999">
<othercit>Zundert, Jan Van, M.D. Fipp and Alex Cahana, M.D. Daapm, Pulsed Radiofrequency in Chronic Pain Management: Looking for the Best Use of Electrical Current, Pain Practice 2005, vol. 5, Issue 2, 2005 World Institute of Pain, pp. 74-76.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01000">
<othercit>Avitall et al., &#x201c;The Creation of Linear Contiguous Lesions in the Atria with an Expandable Loop Catheter&#x201d;; Journal of the American College of Cardiology, 1999; vol. 33, No. 4; pp. 972-984, located online at: http://content/onlinejacc.org/cgi/content/full/33/4/972.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01001">
<othercit>Excerpt of Operator's Manual, 110V; Boston Scientific's EPT-1000 XP Cardiac Ablation Controller &#x26; Accessories, Version of Apr. 2003, (6 pages).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01002">
<othercit>Excerpt of Operator's Manual, 150; Boston Scientific, &#x201c;Maestro 3000 Cardiac Ablation System&#x201d;, Version of Oct. 17, 2005, Ref. Catalog No. 21020, (4 pages).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01003">
<othercit>Opposition to European Patent No. EP2092957, Granted Jan. 5, 2011, Date of Opposition Oct. 5, 2011 (26 pages).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01004">
<othercit>Opposition to European Patent No. EP2037840, Granted Dec. 7, 2011, Date of Opposition Sep. 7, 2012 (25 pages).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01005">
<othercit>Opposition to European Patent No. EP1802370, Granted Jan. 5, 2011, Date of Opposition Oct. 5, 2011 (20 pages).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01006">
<othercit>Wittkampf et al., &#x201c;Control of Radiofrequency Lesion Size by Power Regulation&#x201d;; Circulation: Journal of the American Heart Association; 1989, vol. 80: pp. 962-968, located online at: http://circ.ahajournals.org/content/80/4/962.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01007">
<othercit>Zheng et al., &#x201c;Comparison of the temperature profile and pathological effect at unipolar, bipolar and phased radiofrequency current configurations,&#x201d; Journal of Interventional Cardian Electrophysiology, 2001, pp. 401-410.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01008">
<othercit>U.S. Appl. No. 95/002,110, filed Aug. 29, 2012, Demarais et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01009">
<othercit>U.S. Appl. No. 95/002,209, filed Sep. 13, 2012, Levin et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01010">
<othercit>U.S. Appl. No. 95/002,233, filed Sep. 13, 2012, Levin et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01011">
<othercit>U.S. Appl. No. 95/002,243, filed Sep. 13, 2012, Levin et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01012">
<othercit>U.S. Appl. No. 95/002,253, filed Sep. 13, 2012, Demarais et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01013">
<othercit>U.S. Appl. No. 95/002,255, filed Sep. 13, 2012, Demarais et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01014">
<othercit>U.S. Appl. No. 95/002,292, filed Sep. 14, 2012, Demarais et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01015">
<othercit>U.S. Appl. No. 95/002,327, filed Sep. 14, 2012, Demarais et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01016">
<othercit>U.S. Appl. No. 95/002,335, filed Sep. 14, 2012, Demarais et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01017">
<othercit>U.S. Appl. No. 95/002,336, filed Sep. 14, 2012, Levin et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01018">
<othercit>U.S. Appl. No. 95/002,356, filed Sep. 14, 2012, Demarais et al.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01019">
<othercit>Benito, F., et al. &#x201c;Radiofrequency cateheter ablation of accessory pathways in infants.&#x201d; Heart, 78:160-162 (1997).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01020">
<othercit>Curtis, J.J., et al., &#x201c;Surgical therapy for presistent hypertension after renal transplantation.&#x201d; Trasnplantation, 31: 125-128.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01021">
<othercit>Dibona, G.F. &#x201c;Sympathetic nervous system and kidney in hypertension.&#x201d; Nephrol and Hypertension, 11: 197-200 (2002).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01022">
<othercit>Dibona, G.F., et al. &#x201c;Neural control of renal function.&#x201d; Physiol Rev, 77:75-197 (1997).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01023">
<othercit>Dubuc, M., et al., &#x201c;Feasibility of cardiac cryoablation using a transvenous steerable electrode catheter.&#x201d; J Interv Cardiac Electrophysiol, 2:285-292 (1998).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01024">
<othercit>Gelfand, M., et al., &#x201c;Treatment of renal failure and hypertension.&#x201d; U.S. Appl. No. 60/442,970.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01025">
<othercit>Han, Y.-M, et al., &#x201c;Renal artery ebolization with diluted hot contrast medium: An experimental study.&#x201d; J Vasc Intery Radiol, 12: 862-868 (2001).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01026">
<othercit>Huang et al., &#x201c;Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats.&#x201d; Hypertension 32 (1998) pp. 249-54.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01027">
<othercit>Kompanowska, E., et al., &#x201c;Early Effects of renal denervation in the anaesthetised rat: Natriuresis and increased cortical blood flow.&#x201d; J Physiol, 531. 2:527-534 (2001).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01028">
<othercit>Lee, S.J., et al. &#x201c;Ultrasonic energy in endoscopic surgery.&#x201d; Yonsei Med J, 40:545-549 (1999).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01029">
<othercit>Lustrgarten, D.L.,et al., &#x201c;Cryothermal ablation: Mechanism of tissue injury and current experience in the treatment of tachyarrhythmias.&#x201d; Progr Cardiovasc Dis, 41:481-498 (1999).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01030">
<othercit>Oliverira, V., et al., &#x201c;Renal denervation normalizes pressure and baroreceptor reflex in high renin hypertension in conscious rats.&#x201d; Hypertension, 19:II-17-II-21 (1992).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01031">
<othercit>Peet, M., &#x201c;Hypertension and its Surgical Treatment by bilateral supradiaphragmatic splanchnicectomy&#x201d; Am J Surgery (1948) pp. 48-68.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01032">
<othercit>Schauerte, P., et al. &#x201c;Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation.&#x201d; Circulation, 102:2774-2780 (2000).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01033">
<othercit>Smithwick et al., &#x201c;Splanchnicectomy for essential hypertension.&#x201d; J. Am. Med. Assn. 152:16 (1953), pp. 1501-1504.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01034">
<othercit>Solis-Herruzo et al., &#x201c;Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome,&#x201d; J. Hepatol. 5 (1987), pp. 167-173.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01035">
<othercit>Stella, A., et al., &#x201c;Effects of reversible renal deneravation on haemodynamic and excretory functions on the ipsilateral and contralateral kidney in the cat.&#x201d; Hypertension, 4:181-188 (1986).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01036">
<othercit>Swartz, J.F., et al., &#x201c;Radiofrequency endocardial cateheter ablation of accessory atrioventricular pathway atrial insertion sites.&#x201d; Circulation, 87: 487-499 (1993).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01037">
<othercit>Uchida, F., et al., &#x201c;Effect of radiofrequency catheter ablation on parasympathetic denervation: A comparison of three different ablation sites.&#x201d; PACE, 21:2517-2521 (1998).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01038">
<othercit>Valente, J.F. &#x201c;Laparoscopic renal denervation for intractable ADPKD-related pain.&#x201d; Nephrol Dial Transplant, 16: 160 (2001).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01039">
<othercit>Weinstock, M., et al., &#x201c;Renal denervation prevents sodium rentention and hypertension in salt sensitive rabbits with genetic baroreflex impairment.&#x201d; Clinical Science, 90:287-293 (1996).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01040">
<othercit>Krum, Henry et al., &#x201c;Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: A Mulitcentre Safety and Proof-of Principle Cohort Study,&#x201d; Lancet 2009; 373:1275-81.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01041">
<othercit>Krum, et al., &#x201c;Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension.&#x201d; New England Journal of Med, 361;9.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01042">
<othercit>Mahfoud et al. &#x201c;Treatment strategies for resistant arterial hypertension&#x201d; Dtsch Arztebl Int. 2011;108:725-731.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01043">
<othercit>Page, I.H. et al., &#x201c;The Effect of Renal Denervation on Patients Suffering From Nephritis,&#x201d; Feb. 27, 1935;443-458.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01044">
<othercit>Page, I.H. et al., &#x201c;The Effect of Renal Denervation on the Level of Arterial Blood Pressure and Renal Function in Essential Hypertension,&#x201d; J. Clin Invest. 1934;14:27-30.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01045">
<othercit>Rocha-Singh, &#x201c;Catheter-Based Sympathetic Renal Denervation,&#x201d; Endovascular Today, Aug. 2009.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01046">
<othercit>Schlaich, M.P. et al., &#x201c;Renal Denervation as a Therapeutic Approach for Hypertension: Novel Implications for an Old Concept,&#x201d; Hypertension, 2009; 54:1195-1201.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01047">
<othercit>Schlaich, M.P. et al., &#x201c;Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension,&#x201d; N Engl J Med 2009; 361(9): 932-934.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01048">
<othercit>Symplicity HTN-1 Investigators; Krum H, Barman N, Schlaich M, et al. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57(5):911-917.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01049">
<othercit>Symplicity HTN-2 Investigators, &#x201c;Renal Sympathetic Denervation in Patients with Treatment-Resistant Hypertension (The Symplicity HTN-2 Trial): A Randomised Controlled Trial&#x201d;; Lancet, Dec. 4, 2010, vol. 376, pp. 1903-1909.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01050">
<othercit>USRDS United States Renal Data System 2003 Annual Data Report.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01051">
<othercit>Hall, W. H., et al. &#x201c;Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor.&#x201d; Am. J. Roentgenol,174: 1592-1594 (2000).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01052">
<othercit>Hanson, J. M., et al. &#x201c;The transplanted human kidney does not achieve functional reinnervation.&#x201d; <i>Clin. Sci</i>, 87: 13-19 (1994).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01053">
<othercit>Hendee, W. R. et al. &#x201c;Use of Animals in Biomedical Research: The Challenge and Response.&#x201d; <i>American Medical Association White Paper </i>(1988).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01054">
<othercit>Medical-Dictionary.com, Definition of &#x201c;Animal Model,&#x201d; http://medical-dictionary.com (search &#x201c;Animal Model&#x201d;), 2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01055">
<othercit>Medtronic, Inc., Annual Report (Form 10-K) (Jun. 28, 2011).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01056">
<othercit>Ong, K. L., et al. &#x201c;Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999-2004.&#x201d; Hypertension, 49: 69-75 (2007) (originally published online Dec. 11, 2006).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01057">
<othercit>Renal Denervation (RDN), Symplicity Rdn System Common Q&#x26;A (2011), http://www.medtronic.com/rdn/mediakit/RDN%20FAQ.pdf.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01058">
<othercit>Ahmed, Humera et al., Renal Sympathetic Denervation Using an Irrigated Radiofrequency Ablation Catheter for the Management of Drug-Resistant Hypertension, JACC Cardiovascular Interventions, vol. 5, No. 7, 2012, pp. 758-765.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01059">
<othercit>Blessing, Erwin et al., Cardiac Ablation and Renal Denervation Systems Have Distinct Purposes and Different Technical Requirements, JACC Cardiovascular Interventions, vol. 6, No. 3, 2013.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01060">
<othercit>Mount Sinai School of Medicine clinical trial for Impact of Renal Sympathetic Denervation of Chronic Hypertenion, Mar. 2013, http://clinicaltrials.gov/ct2/show/NCT01628198.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01061">
<othercit>Prochnau, Dirk et al., Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter; EuroIntervention 2012, vol. 7, pp. 1077-1080.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01062">
<othercit>Schneider, Peter A.., &#x201c;Endovascular Skills&#x2014;Guidewires, Catheters, Arteriography, Balloon Angioplasty, Stents&#x201d;, pp. 70-71, 101 and 188-190 (1998).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01063">
<othercit>Kandarpa, Krishna et al., &#x201c;Handbook of Interventional Radiologic Procedures&#x201d;, Third Edition, pp. 194-210 (2002).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01064">
<othercit>ThermoCool Irrigated Catheter and Integrated Ablation System, Biosense Webster (2006).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01065">
<othercit>ClinicalTrials.gov, Renal Denervation in Patients with uncontrolled Hypertension in Chinese (2011), www.clinicaltrials.gov/ct2/show/NCT01390831.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01066">
<othercit>Joles, J.A. et al., Causes and Consequences of Increased Sympathetic Activity in Renal Disease. Hypertension. 2004;43:699-706.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01067">
<othercit>Josh, R. P. and K. H. Schoenbach, Mechanism for membrane electroporation irreversibility under high-intensity, ultrashort electrical pulse conditions, Nov. 11, 2002, Physical Review E 66, 2002, The American Physical Society 2002, pp. 052901-1-052901-4.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01068">
<othercit>Josh, R. P. et al., Improved energy model for membrane electroporation in biological cells subjected to electrical pulses, Apr. 9, 2002, Physical Review E, vol. 65, 041920-1, 2002 The American Physical Society, 8 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01069">
<othercit>Josh, R. P. et al., Self-consistent simulations of electroporation dynamics in biological cells subjected to ultrashort electrical pulses, Jun. 21, 2001, Physical Review E, vol. 64, 011913, 2001 The American Physcial Society, pp. 1-10.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01070">
<othercit>Joye, James D.et al., In Vitro Studies of Arterial Freezing Injury, 4 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01071">
<othercit>Katholi, R.E. et al., Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension, Hypertension, 1982, 4 (suppl II): II-166-II-174.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01072">
<othercit>Katholi, R.E., Renal nerves and hypertension: an update, Fed Proc., 1985, 44:2846-2850.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01073">
<othercit>Cardiac Glycosides, Heart Disease&#x2014;A Textbook of Cardiovascular Medicine vol. 2, Edited by Eugene Braunwald, 5th Edition, WB Saunders Company, pp. 480-481, 1997.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01074">
<othercit>Carls, G. et al., Electrical and magnetic stimulation of the intercostal nerves: a comparative study, Electromyogr, clin. Neurophysiol. 1997, vol. 37, pp. 509-512.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01075">
<othercit>Carlson, Scott H. And J. Michael Wyss, e-Hypertension&#x2014;Opening New Vistas, Introductory Commentary, Hypertension 2000, vol. 35, American Heart Association, Inc. 2000, p. 538.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01076">
<othercit>Carson, P., Device-based Treatment for Chronic Heart Failure: Electrical Modulation of Myocardial Contractility. Transcatheter Cardiovascular Therapeutics 2005. 21 slides.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01077">
<othercit>Chang, Donald C., Cell poration and cell fusion using an oscillating electric field, Biophysical Journal, vol. 56, Oct. 1989, Biophysical Society, pp. 641-652.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01078">
<othercit>Chen, S.A. et al., Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablataion, Circulation, 1999, 100: 1879-1886.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01079">
<othercit>Chin, J.L. et al., Renal autotransplantation for the loin pain-hematuria syndrome: long term follow up of 26 cases, J Urol, 1998, vol. 160, pp. 1232-1236.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01080">
<othercit>Chiou, C.W. et al., Efferent Vagal Innervation of the Canine Atria and Sinus and Atrioventricular Nodes. Circulation. Jun. 1997. 95(11):2573-2584. Abstract only. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01081">
<othercit>Chobanian, Aram V. et al., Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Nov. 6, 2003, Hypertension 2003, vol. 42, 2003 American Heart Association, Inc., pp. 1206-1252.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01082">
<othercit>Clinical Trials in Hypertension and Renal Diseases, Slide Source, www.hypertensiononline.org, 33 pages Aug. 13, 2001.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01083">
<othercit>Codman 3000, Implantable Constant-Flow Infusion Pump Pamphlet, for Continuous Intrathecal Drug Delivery, 2 pages, Nov. 17, 2013.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01084">
<othercit>Conradi, E. and Ines Helen Pages, Effects of Continous and Pulsed Microwave Irradiation on Distribution of Heat in the Gluteal Region of Minipigs, Scand J Rehab Med, vol. 21, 1989, pp. 59-62.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01085">
<othercit>Converse, R.L., Jr. et al., Sympathetic Overactivity in Patients with Chronic Renal Failure, N Engl J Med. Dec. 31, 1992, vol. 327 (27), pp. 1912-1918.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01086">
<othercit>Cosman, E.R., Jr. et al., Electric and Thermal Field Effects in Tissue Around Radiofrequency Electrodes, Pain Medicine, vol. 6, No. 6, 2005, American Academy of Pain Medicine, pp. 405-424.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01087">
<othercit>Cosman, E.R., Ph.D., A Comment on the History of the Pulsed Radiofrequency Technique for Pain Therapy, Anesthesiology Dec. 2005, vol. 103, No. 6, 2005 American Society of Anesthesiologists, Inc. Lippincott Williams &#x26; Wilkins, Inc., p. 1312.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01088">
<othercit>Crawford, William H. et al., Pulsed Radio Frequency Therapy of Experimentally Induced Arthritis in Ponies, Dec. 18, 1989, Can. J. Vet. Res. 1991, vol. 55, pp. 76-85.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01089">
<othercit>Cryovascular Systems, Inc. Pre-Clinical Testing Establishing Parameters. PowerPoint Presentation. 18 slides.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01090">
<othercit>Curtis, J.J. et al., Surgical theray for persistent hypertension after renal transplantation, Transplantation, 1981, 31(2):125-128.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01091">
<othercit>Dahm, Peter et al., Efficacy and Technical Complications of Long-Term Continuous Intraspinal Infusions of Opioid and/or Bupivacaine in Refractory Nonmalignant Pain . . . , Oct. 6, 1997, The Clinical Journal of Pain, vol. 14, No. 1, 1998, Lippincott-Raven Publishers 1998, pp. 4-16.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01092">
<othercit>Dahm, Peter O. et al., Long-Term Intrathecal Infusion of Opioid and/or Bupivacaine in the Prophylaxis and Treatment of Phantom Limb Pain, Neuromodulation, vol. 1, No. 3, 1998, International Neuromodulation Society 1998, pp. 111-128.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01093">
<othercit>Dang, Nicholas C. et al., A Novel Approach to Increase Total Urine Output in Heart Failure: Renal Nerve Blockade, ACC 2005 poster; 1 page.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01094">
<othercit>Daniel, Alan and Honig, Carl R. Does Histamine Influence Vasodilation Caused by Prolonged Arterial Occlusion or Heavy Exercise? The Journal of Pharmacology and Experimental Therapeutics. vol. 215 No. 2. Aug. 21, 1980. pp. 533-538, Nov. 17, 2013.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01095">
<othercit>Davalos, R. et al., Electrical Impedance Tomography for Imaging Tissue Electroporation, Jul. 25, 2003, IEEE Transactions on Biomedical Engineering, vol. 51, No. 5, May 2004, IEEE 2004, pp. 761-767.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01096">
<othercit>Davalos, R.V. et al., Tissue Ablation with Irreversible Electroporation, Sep. 7, 2004, Annals of Biomedical Engineering, Feb. 2005, vol. 33, No. 2, 2005 Biomedical Engineering Society, pp. 223-231.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01097">
<othercit>De Leeuw, Peter W. et al., Renal Vascular Tachyphylaxis to Angiotensin II: Specificity of the Response for Angiotensin, Dec. 28, 1981, Life Sciences, vol. 30, 1982 Pergamon Press Ltd., pp. 813-819.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01098">
<othercit>Deng, Jingdong et al., The Effects of Intense Submicrosecond Electrical Pulses on Cells, Nov. 26, 2002, Biophysical Journal, vol. 84, Apr. 2003, Biophysical Society 2003, pp. 2709-2714.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01099">
<othercit>Denton, Kate M. et al., Differential Neural Control of Glomerular Ultrafiltration, Jan. 30, 2004, Proceedings of the Australian Physiological and Pharmacological Society Symposium: Hormonal, Metabolic and Neural Control of the Kidney, Clinical and Experimental Pharmacology and Physiology (2004) 31, pp. 380-386.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01100">
<othercit>Dev, Nagendu B., Ph.D. et al., Intravascular Electroporation Markedly Attenuates Neointima Formation After Balloon Injury of the Carotid Artery in the Rat, Journal of Interventional Cardiology, vol. 13, No. 5, 2000, pp. 331-338.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01101">
<othercit>Dev, Nagendu B., Ph.D. et al., Sustained Local Delivery of Heparin to the Rabbit Arterial Wall with an Electroporation Catheter, May 5, 1998, Catheterization and Cardiovascular Diagnosis, vol. 45, 1998, Wiley-Liss, Inc. 1998, pp. 337-345.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01102">
<othercit>Devereaux, R.B. et al., Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial, Circulation, 2004, vol. 110, pp. 1456-1462.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01103">
<othercit>Dibona, Gerald F. and Linda L. Sawin, Role of renal nerves in sodium retention of cirrhosis and congestive heart failure, Sep. 27, 1990, Am. J. Physiol. 1991, vol. 260, 1991 the American Physiological Society, pp. R298-R305.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01104">
<othercit>Dibona, Gerald F. and Susan Y. Jones, Dynamic Analysis of Renal Nerve Activity Responses to Baroreceptor Denervation in Hypertensive Rats, Sep. 19, 2000, Hypertension Apr. 2001, American Heart Association, Inc. 2001, pp. 1153-1163.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01105">
<othercit>Dibona, Gerald F. and Ulla C. Kopp, Neural Control of Renal Function, Physiological Reviews, vol. 77, No. 1, Jan. 1997, the American Physiological Society 1997, pp. 75-197.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01106">
<othercit>Dibona, Gerald F. and Ulla C. Kopp, Role of the Renal Sympathetic Nerves in Pathophysiological States, Neural Control of Renal Function, vol. 77, pp. 142-197 Jan. 1997.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01107">
<othercit>Dibona, Gerald F., Functionally Specific Renal Sympathetic Nerve Fibers: Role in Cardiovascular Regulation, Mar. 6, 2001, American Journal of Hypertension, 2001, vol. 14, 2001 American Journal of Hypertension, Ltd. Published by Elsevier Science Inc., pp. 163S-170S.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01108">
<othercit>Dibona, Gerald F., L.L. Sawin, Effect of renal nerve stimulation on NaCI and H2O transport in Henle's loop of the rat,: 1982, American Physiological Society, F576-F580, 5 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01109">
<othercit>Dibona, Gerald F., Nervous Kidney&#x2014;Interaction Between Renal Sympathetic Nerves and the Renin-Angiotensin System in the Control of Renal Function, Jun. 21, 2000, Hypertension 2000, vol. 36, 2000 American Heart Association, Inc., pp. 1083-1088.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01110">
<othercit>Dibona, Gerald F., Neural Control of the Kidney&#x2014;Past, Present and Future, Nov. 4, 2002, Novartis Lecture, Hypertension 2003, 41 part 2, 2002 American Heart Association, Inc., pp. 621-624.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01111">
<othercit>Dibona, Gerald F., Neural Control of the Kidney: Functionally Specific Renal Sympathetic Nerve Fibers, Starling Lecture, Am J Physiol Regulatory Integrative Comp Physiol, 2000, 279, 2000 The American Physiological Society, pp. R1517-R1524.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01112">
<othercit>Dibona, Gerald F., Peripheral and Central Interactions between the Renin-Angiotensin System and the Renal Sympathetic Nerves in Control of Renal Function, Annals New York Academy of Sciences, pp. 395-406 Jan. 25, 2006.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01113">
<othercit>Dibona, Gerald F., Renal Innervation and Denervation: Lessons from Renal Transplantation Reconsidered, Artificial Organs, vol. 11, No. 6, Raven Press, Ltd., 1987 International Society for Artificial Organs, pp. 457-462.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01114">
<othercit>Dibona, Gerald F., Sympathetic Nervous System and the Kidney in Hypertension, Current Opinion in Nephrology and Hypertension 2002, vol. 11, 2002 Lippincott Williams &#x26; Wilkins, pp. 197-200.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01115">
<othercit>Dibona, Gerald F., The Sympathetic Nervous System and Hypertension, Dec. 4, 2003, Hypertension Highlights, Hypertension Feb. 2004, vol. 43, 2004 American Heart Association, Inc., pp. 147-150.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01116">
<othercit>Dibona, Gerald, LL Sawin, Effect of renal denervation on dynamic autoregulation of renal blood flow, Feb. 12, 2004, AmJ Physiol Renal Physiol 286, pp. F1209-F1218.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01117">
<othercit>Dong, Jun et al. Incidence and Predictors of Pulmonary Vein Stenosis Following Catheter Ablation of Atrial Fibrillation Using the Anatomic Pulmonary Vein Ablation Approach: Results from Paired Magnetic Resonance Imaging. Journal of Cardiovascular Electrophysiology. vol. 16, No. 8, Aug. 2005. PP. 845-852.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01118">
<othercit>Dorros, Gerald, M.D., Renal Artery Stenting State of the Art, presentation, TCT, Washington D.C., Sep. 2003, 27 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01119">
<othercit>Dueck, Ron, M.D., Noninvasive Cardiac Output Monitoring, The Cardiopulmonary and Critical Care Journal, Chest, vol. 120, sec. 2, Aug. 2001, American College of Chest Physicians 2005, pp. 339-341, 5 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01120">
<othercit>Dunn, Matthew D. et al., Laparoscopic Nephrectomy in Patients With End-Stage Renal Disease and Autosomal Dominant Polycystic Kidney Disease,Oct. 25, 1999, American Journal of Kidney Diseases, vol. 35, No. 4 Apr. 2000, National Kidney Foundation, Inc. 2000, pp. 720-725.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01121">
<othercit>Durand, D.M., Electric Field Effects in Hyperexcitable Neural Tissue: A Review, Radiation Protection Dosimetry, vol. 106, No. 4, 2003 Nuclear Technology Publishing, pp. 325-331.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01122">
<othercit>ECM 830 Specifications Sheet. tech@genetronics.com, 20-001796-01 Rev. D, 2 pgs., Nov. 17, 2013.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01123">
<othercit>Effects of Renal Failure on the Cardiovascular System, 5th Edition Heart Disease, A Textbook of Cardiovascular Medicine, vol. 2, Edited by Eugene Braunwald, W.B. Saunders Company, pp. 1923-1925 1997.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01124">
<othercit>Electrical Stimulation for the Treatment of Chronic Wounds, Radiation Protection Standard, Maximum Exposure Levels to Radiofrequency Fields&#x2014;3 KHz to 300 GHz, Radiation Protection Series No. 3, Australian Radiation Protection and Nuclear Safety Agency, Apr. 1996, 322 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01125">
<othercit>Electropermeaubilization (Electroporation), Cyto Pulse Sciences, Inc., http://www.cytopulse.com/electrporation.html (last accessed Mar. 3, 2005), 3 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01126">
<othercit>Electroporation based Technologies and Treatments ESPE Newsletter No. 6, QLK 02002-2003 Jan. 2005, www.cliniporator.com, 4 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01127">
<othercit>End-stage renal disease payment policies in traditional Medicare, Chapter 8, Report to the Congress: Medicare Payment Policy, Mar. 2001, Medpac, pp. 123-138.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01128">
<othercit>Epidemiology of Renal Disease in Hypertension, slide presentation by hypertensiononline.org, 21 pages Mar. 30, 2001.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01129">
<othercit>Erdine, Serap and Alev Arat-Ozkan, Resistant Hypertension, European Society of Hypertension Scientific Newsletter: Update on Hypertension Management 2003, vol. 4, No. 15, 2 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01130">
<othercit>Esler, M. et al., Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol. 1986; 8: 539-43.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01131">
<othercit>Esler, M. et al., Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens. 1989; 2: 140S-146S.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01132">
<othercit>Esler, M. et al., Sympathetic nerve biology in essential hypertension, Clin and Exp Pharmacology and Physiology, 2001, 28: 986-989.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01133">
<othercit>European Examination Report; European Patent Application No. 07799148.7; Applicant: Ardian, Inc.; Date of Mailing: Jan. 19, 2010, 4 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01134">
<othercit>European Examination Report; European Patent Application No. 09156661.2; Applicant: Ardian, Inc.; Date of Mailing: Jan. 19, 2010, 6 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01135">
<othercit>European Search Report; European Patent Application No. 07798341.9; Applicant: Ardian, Inc.; Date of Mailing Aug. 4, 2011; 6 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01136">
<othercit>Evelyn, K.A. et al., Effect of thoracolumbar sympathectomy on the clinical course of primary (essential) hypertension, Am J Med, 1960; 28: 188-221.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01137">
<othercit>Ex parte Quayle Office Action; U.S. Appl. No. 11/144,173; Mailed on May 28, 2009, 4 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01138">
<othercit>Fact Book Fiscal Year 2003, National Institutes of Health National Heart, Lung, and Blood Institute, Feb. 2004, 197 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01139">
<othercit>Fajardo, J. et al., Effect of chemical sympathectomy on renal hydroelectrolytic handling in dogs with chronic caval constriction. Clin Physiol Biochem. 1986; 4: 252-6.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01140">
<othercit>Fareed, Jawed, Ph.D. et al., Some Objective Considerations for the Use of Heparins and Recombinant Hirudin in Percutaneous Transluminal Coronary Angoplasty, Seminars in Thrombosis and Hemostasis 1991, vol. 17, No. 4, 1991 by Thieme Medical Publishers, Inc., pp. 455-470.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01141">
<othercit>Fava, M. et al., Initial Human Experience with CryoPlasty&#x2122; in the Treatment of Infrainguinal Arterial Disease, Abstract. 1 page, Nov. 17, 2013.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01142">
<othercit>Hughes, Gordon B., M.D. et al., A Comparative Study of Neuropathologic Changes Following Pulsed and Direct Current Stimulation of the Mouse Sciatic Nerve, Jun. 27, 1980, American Journal of Otolaryngology, Nov. 1980, vol. 1, No. 5, pp. 378-384.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01143">
<othercit>Hypertension and Renal Disease: Mechanisms. Slide Show by www.hypertensiononline.org, 22 pages, Mar. 30, 2001.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01144">
<othercit>Hypertension Incidence and Prevalence, Age-Specific Rates, by Gender, B.C., 2001/2002, Graph, Chronic Disease Management, May 2003, British Columbia Ministry of Health Services, 1 page.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01145">
<othercit>Implantable Neurostimulation Systems, Medtronic Neurological, http://medtronic.com/neuro/paintherapies/pain<sub>&#x2014;</sub>treatment<sub>&#x2014;</sub>ladder/pdf/implantable<sub>&#x2014;</sub>brochure.pdf.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01146">
<othercit>Implantable Pump&#x2014;The Medtronic MiniMed 2007 Implantable Insulin Pump System, Medtronic MiniMed 2004, 4 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01147">
<othercit>Infumedics Inc., Background and products paper and comparison of Medtronic SynchroMed II and Infumedics Prometra pumps, 3 pgs., Nov. 17, 2013.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01148">
<othercit>International Search Report, PCT/US02/0039, Mailed Sep. 11, 2002, Applicant: Advanced Neuromodulation Systems, Inc.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01149">
<othercit>International Search Report, PCT/US02/25712, Mailed on Apr. 23, 2003, Applicant: Cyberonics, Inc.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01150">
<othercit>International Search Report, PCT/US03/08014, Mailed on Sep. 23, 2003, Applicant: The General Hospital Corporation.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01151">
<othercit>International Search Report, PCT/US03/09764, Mailed on Oct. 28, 2003, Applicant: CVRX, Inc.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01152">
<othercit>Introduction to Autonomic Pharmacology, Chapter 3, Part 2 Autonomic Pharmacology, pp. 18-26, May 24, 2002.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01153">
<othercit>Isovue: Data Sheet. Regional Health Limited. 8 pgs. Mar. 11, 2003.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01154">
<othercit>Israili, Z.H., Clinical pharmacokinetics of angiotensin II (AT) receptor blockers in hypertension, Journal of Human Hypertension, 2000, Macmillan Publishers Ltd., vol. 14, pp. S73-S86.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01155">
<othercit>Janda, J., Impact of the electrical stimulation apparatus rebox on the course of ischemic renal damage in rats, British Library&#x2014;The world's knowledge pp. 252-254 (translated and untranslated versions) 1996.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01156">
<othercit>Janssen, Ben J.A. et al., Effects of complete renal denervation and selective afferent renal denervation on the hypertension induced by intrarenal norepinephrine infusion in conscious rats, Jan. 4, 1989, Journal of Hypertension 1989, vol. 7, No. 6, Current Science Ltd, pp. 447-455.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01157">
<othercit>Jia, Jianping et al., Cold injury to nerves is not due to ischaemia alone, Brain. 121; pp. 989-1001. 1998.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01158">
<othercit>Jia, Jianping et al.., the pathogenesis of non-freezing cold nerve injury: Observations in the rat, Brain. 120; pp. 631-646. 1997.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01159">
<othercit>Jin, Yuanzhe et al., Pulmonary Vein Stenosis and Remodeling After Electrical Isolation for Treatment of Atrial Fibrillation: Short- and Medium-Term Follow-Up, PACE, vol. 27. pp. 1362-1370. Oct. 2004.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01160">
<othercit>Johansson, Bjorn, Electrical Membrane Breakdown, A Possible Mediator of the Actions of Electroconvulsive Therapy, Medical Hypotheses 1987, vol. 24, Longman Group UK Ltd 1987, pp. 313-324.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01161">
<othercit>Joles, J.A. et al., Causes and Consequences of Increased Sympathetic Activity in Renal Disease. Hypertension. 2004; 43: 699-706.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01162">
<othercit>Jorgensen, William A. et al., Electrochemical Therapy of Pelvic Pain: Effects of Pulsed Electromagnetic Fields (PEMF) on Tissue Trauma, Eur J Surg 1994, Suppl 574, vol. 160, 1994 Scandinavian University Press, pp. 83-86.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01163">
<othercit>Joshi, R. P. and K. H. Schoenbach, Mechanism for membrane electroporation irreversibility under high-intensity, ultrashort electrical pulse conditions, Nov. 11, 2002, Physical Review E 66, 2002, The American Physical Society 2002, pp. 052901-1-052901-4.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01164">
<othercit>Joshi, R. P. et al., Improved energy model for membrane electroporation in biological cells subjected to electrical pulses, Apr. 9, 2002, Physical Review E, vol. 65, 041920-1, 2002 The American Physical Society, 8 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01165">
<othercit>Joshi, R. P. et al., Self-consistent simulations of electroporation dynamics in biological cells subjected to ultrashort electrical pulses, Jun. 21, 2001, Physical Review E, vol. 64, 011913, 2001 The American Physcial Society, pp. 1-10.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01166">
<othercit>Joye, James D. et al., In Vitro Studies of Arterial Freezing Injury, 4 pgs., Nov. 17, 2013.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01167">
<othercit>Joye, James D.et al., In Vivo Study of Endovascular Cryotherapy for the Prevention of Restenosis, 4 pages, 2003.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01168">
<othercit>Kanduser, Masa et al., Effect of surfactant polyoxyethylene glycol (C12E8) on electroporation of cell line DC3F, Aug. 20, 2002, Colloids and Surfaces A: Physicochem. Eng. Aspects 214, 2003, Elsevier Science B.V. 2002, pp. 205-217.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01169">
<othercit>Kassab, S. et al., Renal denervation attenuates the sodium retention and hypertension associated with obesity, Hypertension, 1995, 25:893-897.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01170">
<othercit>Katholi, R.E. et al., Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension, Hypertension, 1982, 4 (suppl II): II-166-11-174.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01171">
<othercit>Katholi, R.E. et al., Role of the renal nerves in the pathogenesis of one-kidney renal hypertension in the rat, Hypertension, 1981, 3(4) 404-409.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01172">
<othercit>Katholi, R.E., Renal nerves and hypertension: an update, Fed Proc., 1985, 44: 2846-2850.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01173">
<othercit>Katholi, Richard E., Renal nerves in the pathogenesis of hypertension in experimental animals and humans, Am. J. Physiol. vol. 245, 1983, the American Physiological Society 1983, pp. F1-F14.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01174">
<othercit>Kaye, D.M. et al., Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans, Circulation, 1993, vol. 88, pp. 1101-1109.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01175">
<othercit>Kelleher, Catherine L. et al., Characteristics of Hypertension in Young Adults with Autosomal Dominant Polycystic Kidney Disease Compared with the General U.S. Population, Jun. 9, 2004, American Journal of Hypertension 2004, pp. 1029-1034.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01176">
<othercit>King, Ronald W. P., Nerves in a Human Body Exposed to Low-Frequency Electromagnetic Fields, Jun. 7, 1999, IEEE Transactions on Biomedical Engineering, vol. 46, No. 12, Dec. 1999, IEEE 1999, pp. 1426-1431.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01177">
<othercit>Kinney, Brian M., M.D., High-Tech Healing&#x2014;The evolution of therapeutic electromagnetic fields in plastic surgery, Plastic Surgery Products, Jun. 2004, pp. 32-36, 3 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01178">
<othercit>Lee, Raphael C. et al., Membrane Biology and Biophysics, Chapter 25, Surgical Research, 2001 Academic Press, pp. 297-305.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01179">
<othercit>Lee, Raphael C., M.D., Sc.D. and Michael S. Kolodney, S.B., Electrical Injury Mechanisms: Electrical Breakdown of Cell Membranes, Oct. 1, 1986, Plastic and Reconstructive Surgery, Nov. 1987, vol. 80, No. 5, pp. 672-679.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01180">
<othercit>Lenoble, L.M. et al., Selective efferent chemical sympathectomy of rat kidneys. Am J Physiol. 1985; 249: R496-501.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01181">
<othercit>Ligtenberg, Gerry M.D. et al., Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure, Apr. 29, 1999, New England Journal of Medicine 1999, vol. 340, No. 17, 1999 Massachusetts Medical Society, pp. 1321-1328.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01182">
<othercit>Lin, Vernon W. H. et al., High intensity magnetic stimulation over the lumbosacral spine evokes antinociception in rats, Apr. 16, 2002, Clinical Neurophysiology, vol. 113, 2002 Elsevier Science Ireland Ltd., pp. 1006-1012.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01183">
<othercit>Lipfert, Peter, M.D. et al., Tachyphylaxis to Local Anesthetics Does Not Result form Reduced Drug Effectiveness at the Nerve Itself, Aug. 3, 1988, Anesthesiology 1989, vol. 70, pp. 71-75.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01184">
<othercit>Lohmeier, Thomas E. and Drew A. Hildebrandt, Renal Nerves Promote Sodium Excretion in Angiotensin-Induced Hypertension, Oct. 20, 1997, Hypertension 1998, vol. 31, part 2, 1998 American Heart Association, Inc., pp. 429-434.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01185">
<othercit>Lohmeier, Thomas E. et al., Prolonged Activation of the Baroreflex Produces Sustained Hypotension, Harry Goldblatt Award, Nov. 26, 2003, Hypertension 2004, vol. 43, Part 2, 2004 American Heart Association, Inc., pp. 306-311.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01186">
<othercit>Lohmeier, Thomas E. et al., Renal Nerves Promote Sodium Excretion During Long-Term Increases in Salt Intake, Oct. 23, 1998, Hypertension 1999, vol. 33, part II, 1999 American Heart Association, Inc., pp. 487-492.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01187">
<othercit>Lohmeier, Thomas E. et al., Sustained influence of the renal nerves to attenuate sodium retention in angiotensin hypertension, Apr. 13, 2001, Am J Physiol Regulatory Integrative Comp Physiol, vol. 281, 2001 the American Physiological Society, pp. R434-R443.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01188">
<othercit>Lohmeier, Thomas E., et al., Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension, American Journal Physiol Regulatory Integrative Comp Physiol, vol. 279, 2000 the American Physiological Society, pp. R1437-R1448.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01189">
<othercit>Lohmeier, Thomas E., Interactions Between Angiotensin II and Baroreflexes in Long-Term Regulation of Renal Sympathetic Nerve Activity, Circulation Research, Jun. 27, 2003, American Heart Association, Inc. 2003, pp. 1282-1284.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01190">
<othercit>Luff, S.E. et al., Two types of sympathetic axon innervating the juxtaglomerular arterioles of the rabbit and rat kidney differ structurally from those supplying other arteries, May 1, 1991, Journal of Neurocytology 1991, vol. 20, 1991 Chapman and Hall Ltd., pp. 781-795.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01191">
<othercit>Luippold, G. et al., Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats, Nephrol Dial Transplant (2004) 19: 342-347.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01192">
<othercit>Lundborg, C. et al., Clinical experience using intrathecal (IT) bupivacaine infusion in three patients with complex regional pain syndrome type I (CRPS-I), Acta Anaesthesiol Scand 1999, vol. 43, pp. 667-678.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01193">
<othercit>MacArthur, Dr. Alison, Spinal Anesthesia and Sever Gestational Hypertension, presentation at Mount Sinai Hospital, 25 pages, Nov. 17, 2013</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01194">
<othercit>Sabbah, Hani N., Animal Models for Heart Failure and Device Development, Henry Ford Health System. 24 slides, Oct. 17, 2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01195">
<othercit>Schauerte, P. et al., Focal atrial fibrillation: experimental evidence for a pathophysiologic role of the autonomic nervous system, Journal of Cardiovascular Electrophysiology. 12(5). May 2001. Abstract only. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01196">
<othercit>Schauerte, P. et al., Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation, Circulation. 102(22). Nov. 28, 2000. Abstract only. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01197">
<othercit>Schauerte, P. et al., Transvenous parasympathetic nerve stimulation in the inferior vena cava and atrioventricular conduction, Journal of Cardiovascular Electrophysiology. 11(1). Jan. 2000. Abstract only. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01198">
<othercit>Scheiner, Avram, Ph.D., The design, development and implementation of electrodes used for functional electrial stimulation, Thesis paper, Case Western Reserve University, May 1992, 220 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01199">
<othercit>Scherlag, BJ and Po, S., the intrinsic cardiac nervous system and atrial fibrillation, Current Opinion in Cardiology. 21(1):51-54, Jan. 2006. Abstract only. 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01200">
<othercit>Schlaich, M.P. et al., Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003; 108: 560-5.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01201">
<othercit>Schlaich, M.P. et al., Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation, Hypertension, 2004, 43: 169-175.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01202">
<othercit>Schmitt, Joseph et al., Intravascular Optical Coherence Tomography&#x2014;Opening a Window into Coronary Artery Disease, LightLab Imaging, Inc. Business Briefing: European Cardiology 2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01203">
<othercit>Schoenbach, Karl H. et al, Intracellular Effect of Ultrashort Electrical Pulses, Dec. 26, 2000, Bioelectromagnetics, vol. 22, 2001, Wiley-Liss, Inc. 2001, pp. 440-448.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01204">
<othercit>Schrier, Robert et al., Cardiac and Renal Effects of Standard Versus Rigorous Blood Pressure Control in Autosomal-Dominant Polycistic Kidney Disease, Mar. 23, 2002, Journal of the American Society of Nephrology, American Society of Nephrology 2002, pp. 1733-1739.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01205">
<othercit>Scremin, Oscar U., M.D., Ph.D. and Daniel P. Holschneider, M.D., 31 &#x26; 32.. An Implantable Bolus Infusion Pump for the Neurosciences, FRP, 04-05, 3 pages, Apr. 2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01206">
<othercit>Sensorcaine&#x2014;MPF Spinal Injection, informational document, AstraZeneca 2001, 2 pgs.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01207">
<othercit>Serrador, Jorge M., Autonomic Regulation of the Cardiovascular System, MIT Lecture. 8 pages, 48 slides, Nov. 17, 2013.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01208">
<othercit>Shah, D.C., Haissaguerre, M., Jais, P., Catheter ablation of pulmonary vein foci for atrial fibrillation: pulmonary vein foci ablation for atrial firbrillation, Thorac Cardiovasc Surg, 1999, 47 (suppl. 3): 352-356.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01209">
<othercit>Shannon, J.L. et al., Studies on the innervation of human renal allografts, J Pathol. 1998, vol. 186, pp. 109-115.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01210">
<othercit>Shlipak, M.G. et al., The clinical challenge of cardiorenal syndrome. Circulation. 2004; 110: 1514-7.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01211">
<othercit>Shupak, Naomi M., Therapeutic Uses of Pulsed Magnetic-Field Exposure: A Review, Radio Science Bulletin Dec. 2003, No. 307, pp. 9-32.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01212">
<othercit>Shu-Qing, Liu et al., Old spinal cord injury treated by pulsed electric stimulation, General Hospital of Beijing Command, Beijing, 5 pages (full article in Chinese; abstract on last page) Dec. 6, 1990.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01213">
<othercit>Trock, David H. et al., The Effect of Pulsed Electromagnetic Fields in the Treatment of Osteoarthritis of the Knee and Cervical Spine. Report of Randomized, Double Blind, Placebo Controlled Trials, Mar. 22, 1994, The Journal of Rheumatology 1994, vol. 21, pp. 1903-1911.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01214">
<othercit>Troiano, Gregory C. et al., The Reduction in Electroporation Voltages by the Addition of a Surfactant to Planar Lipid Bilayers, May 12, 1998, Biophysical Journal, vol. 75, Aug. 1998, The Biophysical Society 1998, pp. 880-888.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01215">
<othercit>Trumble, Dennis R. and James A. MaGovern, Comparison of Dog and Pig Models for Testing Substernal Cardiac Compression Devices, Nov. 2003, ASAIO Journal 2004, pp. 188-192.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01216">
<othercit>Tsai, E., Intrathecal drug delivery for pain indications, technique, results, Pain Lecture presentation, Jun. 8, 2001, 31 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01217">
<othercit>Uematsu, Toshihiko, M.D., Ph.D., F.I.C.A. et al., Extrinsic Innervation of the Canine Superior Vena Cava, Pulmonary, Portal and Renal Veins, Angiology&#x2014;Journal of Vascular Diseases, Aug. 1984, pp. 486-493.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01218">
<othercit>United States Renal Data System, USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003, 593 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01219">
<othercit>Upadhyay, Pramod, Electroporation of the skin to deliver antigen by using a piezo ceramic gas igniter, Jan. 27, 2001, International Journal of Pharmaceutics, vol. 217, 2001 Elsevier Science B.V., pp. 249-253.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01220">
<othercit>Valente, John F. et al., Laparoscopic renal denervation for intractable ADPKD-related pain, Aug. 24, 2000, Nephrol Dial Transplant 2001, vol. 16, European Renal Association-European Dialysis and Transplant Association, p. 160.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01221">
<othercit>Van Antwerp, Bill and Poonam Gulati, Protein Delivery from Mechanical Devices Challenges and Opportunities, Medtronic presentation, 19 pages, Jul. 2003.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01222">
<othercit>Velazquez, Eric J., An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: The VALIANT registry, Aug. 5, 2004, European Heart Journal vol. 25, 2004 Elsevier, pp. 1911-1919.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01223">
<othercit>Velez-Roa, Sonia, M.D. et al., Peripheral Sympathetic Control During Dobutamine Infusion: Effects of Aging and Heart Failure, Jul. 7, 2003, Journal of the American College of Cardiology, vol. 42, No. 9, 2003, American College of Cardiology Foundation 2003, pp. 1605-1610.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01224">
<othercit>Vigilance, Deon W. et al., A Novel Approach to Increase Total Urine Output in Acute Heart Failure: Unilateral Renal Nerve Blockade, RNB Abstract AHA, 2 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01225">
<othercit>Villarreal, Daniel et al., Effects of renal denervation on postprandial sodium excretion in experimental heart failure, Oct. 29, 1993, Am J Physiol 266, 1994, pp. R1599-R1604.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01226">
<othercit>Villarreal, Daniel et al., Neurohumoral modulators and sodium balance in experimental heart failure, Nov. 6, 1992, Am. J. Physiol, vol. 264, 1993, pp. H1187-H1193.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01227">
<othercit>Vince, D. Geoffrey. Virtual Histology: A new technique for the assessment of plaque composition. The Cleveland Clinic Foundation. 28 pgs., Nov. 17, 2013.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01228">
<othercit>Vonend, O. et al., Moxonidine treatment of hypertensive patients with advanced renal failure. J Hypertens. 2003; 21: 1709-17.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01229">
<othercit>Final Office Action; U.S. Appl. No. 12/827,700; Mailed on Feb. 5, 2013, 61 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01230">
<othercit>Golwyn, D. H., Jr., et al. &#x201c;Percutaneous Transcatheter Renal Ablation with Absolute Ethanol for Uncontrolled Hypertension or Nephrotic Syndrome: Results in 11 Patients with End-Stage Renal Disease.&#x201d; JVIR, 8: 527-533 (1997).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01231">
<othercit>Holmes et al., Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation: Clinical Spectrum and Interventional Considerations, JACC: Cardiovascular Interventions, 2: 4, 2009, 10 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01232">
<othercit>Millard, F. C., et al, &#x201c;Renal Embolization for ablation of function in renal failure and hypertension.&#x201d; Postgraduate Medical Journal, 65, 729-734, (1989).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01233">
<othercit>Oz, Mehmet, Pressure Relief, TIME, Jan. 9, 2012, 2 pages. &#x3c;www.time.come/time/printout/0,8816,2103278,00.html&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01234">
<othercit>Papademetriou, Vasilios, Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension, Int. Journal of Hypertension, 2011, 8 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01235">
<othercit>Purerfellner, Helmut et al., Incidence, Management, and Outcome in Significant Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation, Am. J. Cardiol , 93, Jun. 1, 2004, 4 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01236">
<othercit>Purerfellner, Helmut et al., Pulmonary Vein Stenosis Following Catheter Ablation of Atrial Fibrillation, Curr. Opin. Cardio. 20: 484-490, 2005.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01237">
<othercit>Schneider, Peter A., &#x201c;Endovascular Skills&#x2014;Guidewire and Catheter Skills for Endovascular Surgery,&#x201d; Second Edition Revised and Expanded, 10 pages, (2003).</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01238">
<othercit>Tsao, Hsuan-Ming, Evaluation of Pulmonary Vein Stenosis after Catheter Ablation of Atrial Fibrillation, Cardiac Electrophysiology Review, 6, 2002, 4 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01239">
<othercit>Wilcox, Josiah N., Scientific Basis Behind Renal Denervation for the Control of Hypertension, ICI 2012, Dec. 5-6, 2012.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01240">
<othercit>&#x201c;2011 Edison Award Winners.&#x201d; Edison Awards: Honoring Innovations &#x26; Innovators, 2011, 6 pages, &#x3c;http://www.edisonawards.com/BestNewProduct<sub>&#x2014;</sub>2011.php&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01241">
<othercit>&#x201c;2012 top 10 advances in heart disease and stroke research: American Heart Association/America Stroke Association Top 10 Research Report.&#x201d; American Heart Association, Dec. 17, 2012, 5 pages, &#x3c;http://newsroom.heart.org/news/2012-top-10-advances-in-heart-241901&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01242">
<othercit>&#x201c;Ardian(R) Receives 2010 EuroPCR Innovation Award and Demonstrates Further Durability of Renal Denervation Treatment for Hypertension.&#x201d; PR Newswire, Jun. 3, 2010, 2 pages, &#x3c;http://www.prnewswire.com/news-releases/ardianr-receives-2010-europer-innovation-award-and-demonstrates-further-durability-of-renal-denervation-treatment-for-hypertension-95545014.html&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01243">
<othercit>&#x201c;Boston Scientific to Acquire Vessix Vascular, Inc.: Company to Strengthen Hypertension Program with Acquisition of Renal Denervation Technology.&#x201d; Boston Scientific: Advancing science for life- Investor Relations, Nov. 8, 2012, 2 pages, &#x3c;http://phx.corporate-ir.net/phoenix.zhtml?c=62272&#x26;p=irol-newsArticle&#x26;id=1756108&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01244">
<othercit>&#x201c;Cleveland Clinic Unveils Top 10 Medical Innovations for 2012: Experts Predict Ten Emerging Technologies that will Shape Health Care Next Year.&#x201d; Cleveland Clinic, Oct. 6, 2011, 2 pages. &#x3c;http://my.clevelandclinic.org/media<sub>&#x2014;</sub>relations/library/2011/2011-10-6-cleveland-clinic-unveils-top-10-medical-innovations-for-2012.aspx&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01245">
<othercit>&#x201c;Does renal denervation represent a new treatment option for resistant hypertension?&#x201d; Interventional News, Aug. 3, 2010, 2 pages. &#x3c;http://www.cxvascularcom/in-latest-news/interventional-news---latest-news/does-renal-denervation-represent-a-new-treatment-option-for-resistant-hypertension&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01246">
<othercit>&#x201c;Iberis&#x2014;Renal Sympathetic Denervation System: Turning innovation into quality care.&#x201d; [Brochure], Terumo Europe N.V., 2013, Europe, 3 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01247">
<othercit>&#x201c;Neurotech Reports Announces Winners of Gold Electrode Awards.&#x201d; Neurotech business report, 2009. 1 page. &#x3c;http://www.neurotechreports.com/pages/goldelectrodes09.html&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01248">
<othercit>&#x201c;Quick. Consistent. Controlled. OneShot renal Denervation System&#x201d; [Brochure], Covidien: positive results for life, 2013, (n.l.), 4 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01249">
<othercit>&#x201c;Renal Denervation Technology of Vessix Vascular, Inc. been acquired by Boston Scientific Corporation (BSX) to pay up to $425 Million.&#x201d; Vessix Vascular Pharmaceutical Intelligence: A blog specializing in Pharmaceutical Intelligence and Analytics, Nov. 8, 2012, 21 pages, &#x3c;http://pharmaceuticalintelligence.com/tag/vessix-vascular/&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01250">
<othercit>&#x201c;The Edison AwardsTM&#x201d; Edison Awards: Honoring Innovations &#x26; Innovators, 2013, 2 pages, &#x3c;http://www.edisonawards.com/Awards.php&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01251">
<othercit>&#x201c;The Future of Renal denervation for the Treatment of Resistant Hypertension.&#x201d; St. Jude Medical, Inc., 2012, 12 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01252">
<othercit>&#x201c;Vessix Renal Denervation System: So Advanced It's Simple.&#x201d; [Brochure], Boston Scientific: Advancing science for life, 2013, 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01253">
<othercit>Asbell, Penny, &#x201c;Conductive Keratoplasty For The Correction of Hyperopia.&#x201d; Tr Am Ophth Soc, 2001, vol. 99, 10 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01254">
<othercit>Badoer, Emilio, &#x201c;Cardiac afferents play the dominant role in renal nerve inhibition elicited by vol. expansion in the rabbit.&#x201d; Am J Physiol Regul Integr Comp Physiol, vol. 274, 1998, 7 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01255">
<othercit>Bengel, Frank, &#x201c;Serial Assessment of Sympathetic Reinnervation After Orthotopic Heart Transplantation: A longitudinal Study Using PET and C-11 Hydroxyephedrine.&#x201d; Circulation, vol. 99, 1999, 7 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01256">
<othercit>Bettmann, Michael, Carotid Stenting and Angioplasty: A Statement for Healthcare Professionals From the Councils on Cardiovascular Radiology, Stroke, Cardio-Thoracic and Vascular Surgery, Epidemiology and Prevention, and Clinical Cardiology, American Heart Association, Circulation, vol. 97, 1998, 4 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01257">
<othercit>Bohm, Michael et al., &#x201c;Rationale and design of a large registry on renal denervation: the Global Symplicity registry.&#x201d; Eurolntervention, vol. 9, 2013, 9 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01258">
<othercit>Davis, Mark et al., &#x201c;Effectiveness of Renal Denervation Therapy for Resistant Hypertension.&#x201d; Journal of the American College of Cardiology, vol. 62, No. 3, 2013, 11 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01259">
<othercit>Geisler, Benjamin et al., &#x201c;Cost-Effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension.&#x201d; Journal of the American College of Cardiology, Col. 60, No. 14, 2012, 7 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01260">
<othercit>Gertner, Jon, &#x201c;Meet the Tech Duo That's Revitalizing the Medical Device Industry.&#x201d; Fast Company, Apr. 15, 2013, 6:00 AM, 17 pages, &#x3c;http://www.fastcompany.com/3007845/meet-tech-duo-thats-revitalizin-medical-device-industry&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01261">
<othercit>Hering, Dagmara et al., &#x201c;Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.&#x201d; Eurolntervention, vol. 9, 2013, 9 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01262">
<othercit>Imimdtanz, &#x201c;Medtronic awarded industry's highest honour for renal denervation system.&#x201d; The official blog of Medtronic Australasia, Nov. 12, 2012, 2 pages, &#x3c;http://97waterlooroad.wordpress.com/2012/11/12/medtronic-awarded-industrys-highest-honour-for-renal-denervation-system/&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01263">
<othercit>Kaiser, Chris, AHA Lists Year's Big Advances in CV Research, medpage Today, Dec. 18, 2012, 4 pages, &#x3c;http://www.medpagetoday.com/Cardiology/PCI/36509&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01264">
<othercit>Linz, Dominik et al., &#x201c;Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs.&#x201d; Heart Rhythm, vol. 0, No. 0, 2013, 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01265">
<othercit>Mabin, Tom et al., &#x201c;First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension.&#x201d; EuroIntervention, vol. 8, 2012, 5 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01266">
<othercit>Mahfoud, Felix et al., &#x201c;Ambulatory Blood Pressure Changes after Renal Sympathetic Denervation in Patients with Resistant Hypertension.&#x201d; Circulation, 2013, 25 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01267">
<othercit>Mahfoud, Felix et al., &#x201c;Expert consensus document from the European Society of Cardiology on catheter-based renal denervation.&#x201d; European Heart Journal, 2013, 9 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01268">
<othercit>Mahfoud, Felix et al., &#x201c;Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension.&#x201d; Hypertension, 2012, 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01269">
<othercit>Ormiston, John et al., &#x201c;First-in-human use of the OneShot&#x2122; renal denervation system from Covidien.&#x201d; EuroIntervention, vol. 8, 2013, 4 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01270">
<othercit>Ormiston, John et al., &#x201c;Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial.&#x201d; EuroIntervention, vol. 9, 2013, 5 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01271">
<othercit>Pedersen, Amanda, &#x201c;TCT 2012: Renal denervation device makers play show and tell.&#x201d; Medical Device Daily, Oct. 26, 2012, 2 pages, &#x3c;http://www.medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines article&#x26;forceid=80880&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01272">
<othercit>Schlaich, Markus et al., &#x201c;Renal Denervation in Human Hypertension: Mechanisms, Current Findings, and Future Prospects.&#x201d; Curr Hypertens Rep, vol. 14, 2012, 7 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01273">
<othercit>Schmid, Axel et al., &#x201c;Does Renal Artery Supply Indicate Treatment Success of Renal Denervation.&#x201d; Cardiovasc Intervent Radiol, vol. 36, 2013, 5 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01274">
<othercit>Schmieder, Roland E. et al., &#x201c;Updated ESH position paper on interventional therapy of resistant hypertension.&#x201d; Eurolntervention, vol. 9, 2013, 9 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01275">
<othercit>Sievert, Horst, &#x201c;Novelty Award EuroPCR 2010.&#x201d; Euro PCR, 2010, 15 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01276">
<othercit>Stouffer, G. A. et al., Journal of Molecular and Cellular Cardiology, vol. 62, 2013, 6 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01277">
<othercit>Verloop, W. L. et al., &#x201c;Renal denervation: a new treatment option in resistant arterial hypertension.&#x201d; Neth Heart J., Nov. 30, 2012, 6 pages, &#x3c;http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547427/&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01278">
<othercit>Worthley, Stephen et al., &#x201c;Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.&#x201d; European Heart Journal, vol. 34, 2013, 9 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01279">
<othercit>Worthley, Stephen, &#x201c;The St. Jude Renal Denervation System Technology and Clinical Review.&#x201d; The University of Adelaide Australia, 2012, 24 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01280">
<othercit>Zuern, Christine S., &#x201c;Impaired Cardiac Baroflex Sensitivity Predicts Response to Renal Sympathetic Denervation in Patients with Resistant Hypertension.&#x201d; Journal of the American College of Cardiology, 2013, doi: 10.1016/j.jacc.2013.07.046, 24 pages.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="01281">
<othercit>Brosky, John, &#x201c;EuroPCR 2013: CE-approved devices line up for renal denervation approval.&#x201d; Medical Device Daily, May 28, 2013, 3 pages, &#x3c;http://www.medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines<sub>&#x2014;</sub>article&#x26;forceid=83002&#x3e;.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
</us-references-cited>
<number-of-claims>17</number-of-claims>
<us-exemplary-claim>1</us-exemplary-claim>
<us-field-of-classification-search>
<classification-national>
<country>US</country>
<main-classification>607  1-  3</main-classification>
<additional-info>unstructured</additional-info>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>607 44</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>607 46</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>607 62</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>607 72</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>607 96</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>607117-118</main-classification>
<additional-info>unstructured</additional-info>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>604 20</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>604 21</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>600381</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>600385</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>606 27- 31</main-classification>
<additional-info>unstructured</additional-info>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>606 41- 50</main-classification>
<additional-info>unstructured</additional-info>
</classification-national>
</us-field-of-classification-search>
<figures>
<number-of-drawing-sheets>15</number-of-drawing-sheets>
<number-of-figures>34</number-of-figures>
</figures>
<us-related-documents>
<continuation>
<relation>
<parent-doc>
<document-id>
<country>US</country>
<doc-number>11599723</doc-number>
<date>20061114</date>
</document-id>
<parent-status>ABANDONED</parent-status>
</parent-doc>
<child-doc>
<document-id>
<country>US</country>
<doc-number>13046595</doc-number>
</document-id>
</child-doc>
</relation>
</continuation>
<continuation-in-part>
<relation>
<parent-doc>
<document-id>
<country>US</country>
<doc-number>10408665</doc-number>
<date>20030408</date>
</document-id>
<parent-grant-document>
<document-id>
<country>US</country>
<doc-number>7162303</doc-number>
</document-id>
</parent-grant-document>
</parent-doc>
<child-doc>
<document-id>
<country>US</country>
<doc-number>11599723</doc-number>
</document-id>
</child-doc>
</relation>
</continuation-in-part>
<continuation-in-part>
<relation>
<parent-doc>
<document-id>
<country>US</country>
<doc-number>11189563</doc-number>
<date>20050725</date>
</document-id>
<parent-grant-document>
<document-id>
<country>US</country>
<doc-number>8145316</doc-number>
</document-id>
</parent-grant-document>
</parent-doc>
<child-doc>
<document-id>
<country>US</country>
<doc-number>11599723</doc-number>
</document-id>
</child-doc>
</relation>
</continuation-in-part>
<continuation-in-part>
<relation>
<parent-doc>
<document-id>
<country>US</country>
<doc-number>11129765</doc-number>
<date>20050513</date>
</document-id>
<parent-grant-document>
<document-id>
<country>US</country>
<doc-number>7653438</doc-number>
</document-id>
</parent-grant-document>
</parent-doc>
<child-doc>
<document-id>
<country>US</country>
<doc-number>11189563</doc-number>
</document-id>
</child-doc>
</relation>
</continuation-in-part>
<continuation-in-part>
<relation>
<parent-doc>
<document-id>
<country>US</country>
<doc-number>11504117</doc-number>
<date>20060814</date>
</document-id>
<parent-grant-document>
<document-id>
<country>US</country>
<doc-number>7617005</doc-number>
</document-id>
</parent-grant-document>
</parent-doc>
<child-doc>
<document-id>
<country>US</country>
<doc-number>11599723</doc-number>
</document-id>
</child-doc>
</relation>
</continuation-in-part>
<us-provisional-application>
<document-id>
<country>US</country>
<doc-number>60816999</doc-number>
<date>20060628</date>
</document-id>
</us-provisional-application>
<us-provisional-application>
<document-id>
<country>US</country>
<doc-number>60370190</doc-number>
<date>20020408</date>
</document-id>
</us-provisional-application>
<us-provisional-application>
<document-id>
<country>US</country>
<doc-number>60415575</doc-number>
<date>20021003</date>
</document-id>
</us-provisional-application>
<us-provisional-application>
<document-id>
<country>US</country>
<doc-number>60442970</doc-number>
<date>20030129</date>
</document-id>
</us-provisional-application>
<us-provisional-application>
<document-id>
<country>US</country>
<doc-number>60616254</doc-number>
<date>20041005</date>
</document-id>
</us-provisional-application>
<us-provisional-application>
<document-id>
<country>US</country>
<doc-number>60624793</doc-number>
<date>20041102</date>
</document-id>
</us-provisional-application>
<related-publication>
<document-id>
<country>US</country>
<doc-number>20110208096</doc-number>
<kind>A1</kind>
<date>20110825</date>
</document-id>
</related-publication>
</us-related-documents>
<us-parties>
<us-applicants>
<us-applicant sequence="001" app-type="applicant" designation="us-only">
<addressbook>
<last-name>Demarais</last-name>
<first-name>Denise</first-name>
<address>
<city>Saratoga</city>
<state>CA</state>
<country>US</country>
</address>
</addressbook>
<residence>
<country>US</country>
</residence>
</us-applicant>
<us-applicant sequence="002" app-type="applicant" designation="us-only">
<addressbook>
<last-name>Wu</last-name>
<first-name>Andrew</first-name>
<address>
<city>Foster City</city>
<state>CA</state>
<country>US</country>
</address>
</addressbook>
<residence>
<country>US</country>
</residence>
</us-applicant>
<us-applicant sequence="003" app-type="applicant" designation="us-only">
<addressbook>
<last-name>Gifford, III</last-name>
<first-name>Hanson</first-name>
<address>
<city>Woodside</city>
<state>CA</state>
<country>US</country>
</address>
</addressbook>
<residence>
<country>US</country>
</residence>
</us-applicant>
<us-applicant sequence="004" app-type="applicant" designation="us-only">
<addressbook>
<last-name>Deem</last-name>
<first-name>Mark</first-name>
<address>
<city>Mountain View</city>
<state>CA</state>
<country>US</country>
</address>
</addressbook>
<residence>
<country>US</country>
</residence>
</us-applicant>
<us-applicant sequence="005" app-type="applicant" designation="us-only">
<addressbook>
<last-name>Gelfand</last-name>
<first-name>Mark</first-name>
<address>
<city>New York</city>
<state>NY</state>
<country>US</country>
</address>
</addressbook>
<residence>
<country>US</country>
</residence>
</us-applicant>
<us-applicant sequence="006" app-type="applicant" designation="us-only">
<addressbook>
<last-name>Levin</last-name>
<first-name>Howard R.</first-name>
<address>
<city>Teaneck</city>
<state>NJ</state>
<country>US</country>
</address>
</addressbook>
<residence>
<country>US</country>
</residence>
</us-applicant>
</us-applicants>
<inventors>
<inventor sequence="001" designation="us-only">
<addressbook>
<last-name>Demarais</last-name>
<first-name>Denise</first-name>
<address>
<city>Saratoga</city>
<state>CA</state>
<country>US</country>
</address>
</addressbook>
</inventor>
<inventor sequence="002" designation="us-only">
<addressbook>
<last-name>Wu</last-name>
<first-name>Andrew</first-name>
<address>
<city>Foster City</city>
<state>CA</state>
<country>US</country>
</address>
</addressbook>
</inventor>
<inventor sequence="003" designation="us-only">
<addressbook>
<last-name>Gifford, III</last-name>
<first-name>Hanson</first-name>
<address>
<city>Woodside</city>
<state>CA</state>
<country>US</country>
</address>
</addressbook>
</inventor>
<inventor sequence="004" designation="us-only">
<addressbook>
<last-name>Deem</last-name>
<first-name>Mark</first-name>
<address>
<city>Mountain View</city>
<state>CA</state>
<country>US</country>
</address>
</addressbook>
</inventor>
<inventor sequence="005" designation="us-only">
<addressbook>
<last-name>Gelfand</last-name>
<first-name>Mark</first-name>
<address>
<city>New York</city>
<state>NY</state>
<country>US</country>
</address>
</addressbook>
</inventor>
<inventor sequence="006" designation="us-only">
<addressbook>
<last-name>Levin</last-name>
<first-name>Howard R.</first-name>
<address>
<city>Teaneck</city>
<state>NJ</state>
<country>US</country>
</address>
</addressbook>
</inventor>
</inventors>
</us-parties>
<assignees>
<assignee>
<addressbook>
<orgname>Medtronic Ardian Luxembourg S.a.r.l.</orgname>
<role>03</role>
<address>
<city>Luxembourg</city>
<country>LU</country>
</address>
</addressbook>
</assignee>
</assignees>
<examiners>
<primary-examiner>
<last-name>Stoloksa</last-name>
<first-name>Joseph</first-name>
<department>3762</department>
</primary-examiner>
</examiners>
</us-bibliographic-data-grant>
<abstract id="abstract">
<p id="p-0001" num="0000">Methods and apparatus are provided for thermally-induced renal neuromodulation. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. In some embodiments, parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermally-induced neuromodulation. In some embodiments, protective elements may be provided to reduce a degree of thermal damage induced in the non-target tissues. In some embodiments, thermally-induced renal neuromodulation is achieved via delivery of a pulsed thermal therapy.</p>
</abstract>
<drawings id="DRAWINGS">
<figure id="Fig-EMI-D00000" num="00000">
<img id="EMI-D00000" he="134.62mm" wi="174.75mm" file="US08626300-20140107-D00000.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00001" num="00001">
<img id="EMI-D00001" he="219.71mm" wi="177.21mm" file="US08626300-20140107-D00001.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00002" num="00002">
<img id="EMI-D00002" he="247.14mm" wi="196.93mm" file="US08626300-20140107-D00002.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00003" num="00003">
<img id="EMI-D00003" he="203.45mm" wi="170.60mm" file="US08626300-20140107-D00003.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00004" num="00004">
<img id="EMI-D00004" he="237.91mm" wi="182.88mm" file="US08626300-20140107-D00004.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00005" num="00005">
<img id="EMI-D00005" he="213.61mm" wi="176.87mm" file="US08626300-20140107-D00005.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00006" num="00006">
<img id="EMI-D00006" he="222.93mm" wi="189.74mm" file="US08626300-20140107-D00006.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00007" num="00007">
<img id="EMI-D00007" he="219.46mm" wi="195.41mm" file="US08626300-20140107-D00007.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00008" num="00008">
<img id="EMI-D00008" he="227.33mm" wi="217.51mm" file="US08626300-20140107-D00008.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00009" num="00009">
<img id="EMI-D00009" he="195.41mm" wi="175.26mm" file="US08626300-20140107-D00009.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00010" num="00010">
<img id="EMI-D00010" he="243.50mm" wi="180.26mm" file="US08626300-20140107-D00010.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00011" num="00011">
<img id="EMI-D00011" he="187.96mm" wi="171.20mm" file="US08626300-20140107-D00011.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00012" num="00012">
<img id="EMI-D00012" he="130.39mm" wi="118.62mm" orientation="landscape" file="US08626300-20140107-D00012.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00013" num="00013">
<img id="EMI-D00013" he="177.88mm" wi="127.85mm" orientation="landscape" file="US08626300-20140107-D00013.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00014" num="00014">
<img id="EMI-D00014" he="166.96mm" wi="118.45mm" file="US08626300-20140107-D00014.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00015" num="00015">
<img id="EMI-D00015" he="191.60mm" wi="163.83mm" orientation="landscape" file="US08626300-20140107-D00015.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
</drawings>
<description id="description">
<?RELAPP description="Other Patent Relations" end="lead"?>
<heading id="h-0001" level="1">REFERENCE TO RELATED APPLICATIONS</heading>
<p id="p-0002" num="0001">The present application is a continuation of U.S. patent application Ser. No. 11/599,723, filed Nov. 14, 2006, which claims the benefit of U.S. Provisional Application No. 60/816,999 filed on Jun. 28, 2006. U.S. patent application Ser. No. 11/599,723, filed Nov. 14, 2006, is also a continuation-in-part application of U.S. patent application Ser. No. 10/408,665, filed on Apr. 8, 2003, now U.S. Pat. No. 7,162,303, which claims the benefit of U.S. Provisional Application Nos. (a) 60/370,190, filed on Apr. 8, 2002, (b) 60/415,575, filed on Oct. 3, 2002, and (c) 60/442,970, filed on Jan. 29, 2003. Furthermore, U.S. patent application Ser. No. 11/599,723, filed Nov. 14, 2006, is a continuation-in-part application of co-pending U.S. patent application Ser. No. 11/189,563, filed on Jul. 25, 2005, which is a continuation-in-part application of U.S. patent application Ser. No. 11/129,765, filed on May 13, 2005, now U.S. Pat. No. 7,653,665, and which claims the benefit of U.S. Provisional Application Nos. (a) 60/616,254, filed on Oct. 5, 2004, and (b) 60/624,793, filed on Nov. 2, 2004. Further still, U.S. patent application Ser. No. 11/599,723, filed Nov. 14, 2006, is a continuation-in-part application of U.S. patent application Ser. No. 11/504,117, filed on Aug. 14, 2006, now U.S. Pat. No. 7,617,005.</p>
<p id="p-0003" num="0002">All of these applications are incorporated herein by reference in their entireties.</p>
<?RELAPP description="Other Patent Relations" end="tail"?>
<?BRFSUM description="Brief Summary" end="lead"?>
<heading id="h-0002" level="1">INCORPORATION BY REFERENCE</heading>
<p id="p-0004" num="0003">All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.</p>
<heading id="h-0003" level="1">TECHNICAL FIELD</heading>
<p id="p-0005" num="0004">The present invention relates to methods and apparatus for neuromodulation. More particularly, the present invention relates to methods and apparatus for achieving renal neuromodulation via thermal heating and/or cooling mechanisms.</p>
<heading id="h-0004" level="1">BACKGROUND</heading>
<p id="p-0006" num="0005">Heart Failure or Chronic Heart Failure (&#x201c;CHF&#x201d;) is a condition that occurs when the heart becomes damaged and reduces blood flow to the organs of the body. If blood flow decreases sufficiently, kidney function becomes altered, which results in fluid retention, abnormal hormone secretions and increased constriction of blood vessels. These results increase the workload of the heart and further decrease the capacity of the heart to pump blood through the kidneys and circulatory system.</p>
<p id="p-0007" num="0006">It is believed that progressively decreasing perfusion of the kidneys is a principal non-cardiac cause perpetuating the downward spiral of CHF. Moreover, the fluid overload and associated clinical symptoms resulting from these physiologic changes result in additional hospital admissions, poor quality of life and additional costs to the health care system.</p>
<p id="p-0008" num="0007">In addition to their role in the progression of CHF, the kidneys play a significant role in the progression of Renal Failure or Chronic Renal Failure (&#x201c;CRF&#x201d;), Renal Disease or End-Stage Renal Disease (&#x201c;ESRD&#x201d;), Hypertension (pathologically high blood pressure) and other cardio-renal diseases. The functions of the kidneys can be summarized under three broad categories: filtering blood and excreting waste products generated by the body's metabolism; regulating salt, water, electrolyte and acid-base balance; and secreting hormones to maintain vital organ blood flow. Without properly functioning kidneys, a patient will suffer water retention, reduced urine flow and an accumulation of waste toxins in the blood and body. These conditions result from reduced renal function or renal failure (kidney failure) and are believed to increase the workload of the heart. In a CHF patient, renal failure will cause the heart to further deteriorate as fluids are retained and blood toxins accumulate due to the poorly functioning kidneys.</p>
<p id="p-0009" num="0008">It has been established in animal models that the heart failure condition results in abnormally high sympathetic activation of the kidneys. An increase in renal sympathetic nerve activity leads to decreased removal of water and sodium from the body, as well as increased renin secretion. Increased renin secretion leads to vasoconstriction of blood vessels supplying the kidneys, which causes decreased renal blood flow. Reduction of sympathetic renal nerve activity, e.g., via denervation, may reverse these processes.</p>
<p id="p-0010" num="0009">Applicants have described methods and apparatus for treating renal disorders by applying a pulsed electric field, preferably non-thermal, to neural fibers that contribute to renal function. See, for example, Applicants' co-pending U.S. patent application Ser. Nos. (a) 11/129,765, filed on May 13, 2005, (b) 11/189,563, filed on Jul. 25, 2005, and (c) 11/363,867, filed Feb. 27, 2006, all of which are incorporated herein by reference in their entireties. A pulsed electric field (&#x201c;PEF&#x201d;) may initiate renal denervation or other neuromodulation via irreversible electroporation or other processes. The PEF may be delivered from apparatus positioned intravascularly, extravascularly, intra-to-extravascularly or a combination thereof. Additional methods and apparatus for achieving renal neuromodulation via localized drug delivery (such as by a drug pump or infusion catheter) or use of a stimulation electric field are described in co-owned and co-pending U.S. patent application Ser. No. 10/408,665, filed Apr. 8, 2003, and U.S. Pat. No. 6,978,174, both of which are incorporated herein by reference in their entireties.</p>
<p id="p-0011" num="0010">A potential challenge of using non-thermal PEF systems for treating renal disorders is to selectively electroporate target cells without affecting other cells. For example, it may be desirable to irreversibly electroporate renal nerve cells that travel along or in proximity to renal vasculature, but it may not be desirable to damage the smooth muscle cells of which the vasculature is composed. As a result, an overly aggressive course of non-thermal PEF therapy may persistently injure the renal vasculature, but an overly conservative course of non-thermal PEF therapy may not achieve the desired renal neuromodulation.</p>
<p id="p-0012" num="0011">Applicants have previously described methods and apparatus for monitoring changes in tissue impedance or conductivity in order to determine the effects of pulsed electric field therapy. Such changes in tissue can be used to determine an extent of electroporation and/or its degree of irreversibility in target or non-target tissue. See, for example, Applicant's co-pending U.S. patent application Ser. No. 11/233,814, filed Sep. 23, 2005, which is incorporated herein by reference in its entirety. However, in some patients it may be difficult or impractical to achieve such real-time monitoring when utilizing non-thermal pulsed electric field neuromodulatory mechanisms. In some patients, this may necessitate re-intervention the degree of induced neuromodulation was not sufficient to achieve a desired treatment outcome. Conversely, an overly aggressive course of relatively unmonitored or uncontrolled therapy may induce undesirable and/or persistent damage in non-target tissue. Thus, it would be desirable to achieve renal neuromodulation via more easily monitored and/or controlled neuromodulatory mechanisms.</p>
<?BRFSUM description="Brief Summary" end="tail"?>
<?brief-description-of-drawings description="Brief Description of Drawings" end="lead"?>
<description-of-drawings>
<heading id="h-0005" level="1">BRIEF DESCRIPTION OF THE DRAWINGS</heading>
<p id="p-0013" num="0012">Several embodiments of the present invention will be apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference characters refer to like parts throughout, and in which:</p>
<p id="p-0014" num="0013"><figref idref="DRAWINGS">FIG. 1</figref> is a schematic view illustrating human renal anatomy.</p>
<p id="p-0015" num="0014"><figref idref="DRAWINGS">FIG. 2</figref> is a schematic isometric detail view showing the location of the renal nerves relative to the renal artery.</p>
<p id="p-0016" num="0015"><figref idref="DRAWINGS">FIG. 3</figref> is a schematic side view, partially in section, illustrating an example of an extravascular method and apparatus for thermal renal neuromodulation.</p>
<p id="p-0017" num="0016"><figref idref="DRAWINGS">FIGS. 4A-4C</figref> are schematic side views, partially in section, illustrating examples of intravascular methods and apparatus for thermal renal neuromodulation.</p>
<p id="p-0018" num="0017"><figref idref="DRAWINGS">FIGS. 5A and 5B</figref> are schematic side views, partially in section, illustrating an alternative embodiment of the intravascular methods and apparatus of <figref idref="DRAWINGS">FIG. 4</figref> comprising wall-contact electrodes.</p>
<p id="p-0019" num="0018"><figref idref="DRAWINGS">FIGS. 6A and 6B</figref> are schematic side views, partially in section, illustrating an additional alternative embodiment of the intravascular methods and apparatus of <figref idref="DRAWINGS">FIG. 4</figref> comprising alternative wall-contact electrodes.</p>
<p id="p-0020" num="0019"><figref idref="DRAWINGS">FIGS. 7A and 7B</figref> are schematic side views, partially in section, illustrating other alternative embodiments of the intravascular methods and apparatus of <figref idref="DRAWINGS">FIG. 4</figref> comprising multiple wall-contact electrodes.</p>
<p id="p-0021" num="0020"><figref idref="DRAWINGS">FIGS. 8A-8H</figref> are schematic side views, partially in section, illustrating embodiments of the intravascular methods and apparatus of <figref idref="DRAWINGS">FIG. 4</figref> comprising one or more wall-contact electrodes, as well as optional blood flow occlusion and thermal fluid injection.</p>
<p id="p-0022" num="0021"><figref idref="DRAWINGS">FIG. 9</figref> is a schematic side view, partially in section, illustrating an example of an intra-to-extravascular method and apparatus for thermal renal neuromodulation.</p>
<p id="p-0023" num="0022"><figref idref="DRAWINGS">FIG. 10</figref> is a schematic side view, partially in section, of an alternative embodiment of the method and apparatus of <figref idref="DRAWINGS">FIG. 8</figref> configured for thermal renal neuromodulation via direct application of thermal energy.</p>
<p id="p-0024" num="0023"><figref idref="DRAWINGS">FIG. 11</figref> is a schematic side view, partially in section, illustrating a method and apparatus for thermal renal neuromodulation comprising a thermoelectric element suitable for direct application of thermal energy to target neural fibers.</p>
<p id="p-0025" num="0024"><figref idref="DRAWINGS">FIG. 12</figref> is a schematic side view, partially in section, illustrating another method and apparatus for thermal renal neuromodulation comprising a thermoelectric element.</p>
<p id="p-0026" num="0025"><figref idref="DRAWINGS">FIGS. 13A and 13B</figref> are schematic side views, partially in section, illustrating a method and apparatus for thermal renal neuromodulation via high-intensity focused ultrasound.</p>
<p id="p-0027" num="0026"><figref idref="DRAWINGS">FIG. 14</figref> is a schematic side view, partially in section, illustrating an alternative embodiment of the apparatus and method of <figref idref="DRAWINGS">FIG. 13</figref>.</p>
<p id="p-0028" num="0027"><figref idref="DRAWINGS">FIGS. 15A and 15B</figref> are schematic diagrams for classifying the various types of thermal neuromodulation that may be achieved with the apparatus and methods of the present invention.</p>
<p id="p-0029" num="0028"><figref idref="DRAWINGS">FIG. 16</figref> is a schematic side-view, partially in section, of an intravascular catheter having a plurality of electrodes in accordance with one embodiment of the invention.</p>
<p id="p-0030" num="0029"><figref idref="DRAWINGS">FIG. 17</figref> is a schematic side-view, partially in section, of an intravascular device having a pair of expanding helical electrodes arranged at a desired distance from one another in accordance with another embodiment of the invention.</p>
<p id="p-0031" num="0030"><figref idref="DRAWINGS">FIG. 18</figref> illustrates stimulation of renal nerves across the wall of a renal vein.</p>
<p id="p-0032" num="0031"><figref idref="DRAWINGS">FIGS. 19A and 19B</figref> are side views, partially in section, illustrating an intravascular device having detectors for measuring or monitoring treatment efficacy in accordance with another embodiment of the invention.</p>
</description-of-drawings>
<?brief-description-of-drawings description="Brief Description of Drawings" end="tail"?>
<?DETDESC description="Detailed Description" end="lead"?>
<heading id="h-0006" level="1">DETAILED DESCRIPTION</heading>
<heading id="h-0007" level="1">A. Overview</heading>
<p id="p-0033" num="0032">The following describes several embodiments of methods and apparatus for renal neuromodulation via thermal heating and/or thermal cooling mechanisms. Many embodiments of such methods and apparatus may reduce renal sympathetic nerve activity. Thermally-induced (via heating and/or cooling) neuromodulation may be achieved via apparatus positioned proximate target neural fibers, such as being positioned (a) within renal vasculature (i.e., positioned intravascularly), (b) extravascularly, (c) intra-to-extravascularly, or (d) a combination thereof. Thermal neuromodulation by heating or cooling may be caused by directly effecting or otherwise altering the neural structures that are subject to the thermal stress. Additionally or alternatively, the thermal neuromodulation may at least in part be due to alteration of arteries, arterioles, capillaries, or veins or other vascular structures which perfuse the target neural fibers or surrounding tissue. Further still, the modulation may at least in part be caused by electroporation of the target neural fibers or of surrounding tissue.</p>
<p id="p-0034" num="0033">As used herein, thermal heating mechanisms for neuromodulation include both thermal ablation and non-ablative thermal injury or damage (e.g., via sustained heating or resistive heating). Thermal heating mechanisms may include raising the temperature of target neural fibers above a desired threshold to achieve non-ablative thermal injury, or above a higher temperature) to achieve ablative thermal injury. For example, the target temperature can be above body temperature (e.g., approximately 37&#xb0; C.) but less than about 45&#xb0; C. for non-ablative thermal injury, or the target temperature can be about 45&#xb0; C. for the ablative thermal injury.</p>
<p id="p-0035" num="0034">As used herein, thermal cooling mechanisms for neuromodulation include non-freezing thermal slowing of nerve conduction and/or non-freezing thermal nerve injury, as well as freezing thermal nerve injury. Thermal cooling mechanisms may include reducing the temperature of target neural fibers below a desired threshold, for example, below the body temperature of about 37&#xb0; C. (e.g., below about 20&#xb0; C.) to achieve non-freezing thermal injury. Thermal cooling mechanisms also may include reducing the temperature of the target neural fibers below about 0&#xb0; C., e.g., to achieve freezing thermal injury.</p>
<p id="p-0036" num="0035">In addition to monitoring or controlling the temperature during thermal neuromodulation, the length of exposure to thermal stimuli may be specified to affect an extent or degree of efficacy of the thermal neuromodulation. In many embodiments, the length of exposure to thermal stimuli is longer than instantaneous exposure, such as longer than about 30 seconds, or even longer than 2 minutes. In certain specific embodiments, the length of exposure can be less than 10 minutes, but this should in no way be construed as the upper limit of the exposure period. Exposure times measured in hours, days or longer, may be utilized to achieve desired thermal neuromodulation.</p>
<p id="p-0037" num="0036">When conducting neuromodulation via thermal mechanisms, the temperature threshold discussed previously may be determined as a function of the duration of exposure to thermal stimuli. Additionally or alternatively, the length of exposure may be determined as a function of the desired temperature threshold. These and other parameters may be specified or calculated to achieve and control desired thermal neuromodulation.</p>
<p id="p-0038" num="0037">In some embodiments, thermally-induced renal neuromodulation may be achieved by directly applying thermal cooling or heating energy to the target neural fibers. For example, a chilled or heated fluid can be applied at least proximate to the target neural fiber, or heated or cooled elements (e.g., a thermoelectric element or a resistive heating element) can be placed in the vicinity of the neural fibers. In other embodiments, thermally-induced renal neuromodulation may be achieved via indirect generation and/or application of the thermal energy to the target neural fibers, such as through application of a &#x2018;thermal&#x2019; electric field, high-intensity focused ultrasound, laser irradiation, etc., to the target neural fibers. For example, thermally-induced renal neuromodulation may be achieved via delivery of a pulsed or continuous thermal electric field to the target neural fibers, the electric field being of sufficient magnitude and/or duration to thermally induce the neuromodulation in the target fibers (e.g., to heat or thermally ablate or necrose the fibers). Additional and alternative methods and apparatus may be utilized to achieve thermally-induced renal neuromodulation, as described hereinafter.</p>
<p id="p-0039" num="0038">When utilizing thermal heating mechanisms for thermal neuromodulation, protective cooling elements, such as convective cooling elements, optionally may be utilized to protect smooth muscle cells or other non-target tissue from undesired thermal effects during the thermally-induced renal neuromodulation. Likewise, when utilizing thermal cooling mechanisms, protective heating elements, such as convective heating elements, may be utilized to protect the non-target tissue. Non-target tissue additionally or alternatively may be protected by focusing the thermal heating or cooling energy on the target neural fibers so that the intensity of the thermal energy outside of the target zone is insufficient to induce undesired thermal effects in the non-target tissue. When thermal neuromodulation is achieved via thermal energy delivered intravascularly, the non-target tissue may be protected by utilizing blood flow as a conductive and/or convective heat sink that carries away excess thermal energy (hot or cold). For example, when blood flow is not blocked, the circulating blood may remove excess thermal energy from the non-target tissue during the procedure. The intravascularly-delivered thermal energy may heat or cool target neural fibers located proximate to the vessel to modulate the target neural fibers while blood flow within the vessel protects non-target tissue of the vessel wall from the thermal energy. For example, the thermal energy can target neural fibers within the adventitia to necrose or ablate the target fibers, and the blood flow can protect tissue in the vessel wall.</p>
<p id="p-0040" num="0039">One drawback of using a continuous, intravascularly-delivered thermal energy therapy in the presence of blood flow to achieve desired intravascularly-induced neuromodulation is that the feasible thermal magnitude (e.g., power) and/or duration of the therapy may be limited or insufficient. This can be caused by the limited heat capacity of the blood flowing through the blood vessel to remove excess thermal energy from the vessel wall to mitigate damage or necrosis to the non-target tissue. Pulsed RF electric fields or other type of pulsed thermal energy may facilitate greater thermal magnitude (e.g., higher power), longer total duration and/or better controlled intravascular renal neuromodulation therapy compared to a continuous thermal energy therapy. For example, a pulsed thermal therapy may allow for monitoring of effects of the therapy on target or non-target tissue during the interval between the pulses. This monitoring data optionally may be used in a feedback loop to better control therapy, e.g., to determine whether to continue or stop treatment, and it may facilitate controlled delivery of a higher power or longer duration therapy.</p>
<p id="p-0041" num="0040">Furthermore, the time interval between delivery of thermal energy pulses may facilitate additional convective or other cooling of the non-target tissue of the vessel wall compared to applying an equivalent magnitude or duration of continuous thermal energy. Without being limited to theory, this may occur because blood flow through the blood vessel may convectively cool (heat) the non-target tissue of the vessel wall with which the blood contacts faster than target neural fibers positioned outside of the vessel.</p>
<p id="p-0042" num="0041">When providing a pulsed thermal therapy, this difference in the heat transfer rate between the tissue of the blood vessel wall and the relatively remote target neural fibers may be utilized to ablate, necrose or otherwise modulate the target neural fibers without undesirably affecting the non-target tissue. The pulsed thermal energy therapy may be applied with greater thermal magnitude and/or of longer total duration (i.e., the cumulative duration of all thermal energy pulses within the therapy) than a continuous thermal therapy. Heat transfer from the vessel wall to the blood (or vice versa) during the off-time or low-energy interval between the thermal energy pulses facilitates the greater magnitude/longer duration delivery with moderated damage to the non-target tissue.</p>
<p id="p-0043" num="0042">In addition or as an alternative to utilizing the patient's blood as a heat sink to establish the difference in heat transfer rate, a thermal fluid (hot or cold) may be injected, infused or otherwise delivered into the vessel to remove excess thermal energy and protect the non-target tissues. The thermal fluid may, for example, comprise a saline or other biocompatible fluid that is heated, chilled or at a room temperature. The thermal fluid may, for example, be injected through the device catheter or through a guide catheter at a location upstream from an energy delivery element, or at other locations relative to the tissue for which protection is sought. The thermal fluid may be injected in the presence of blood flow or with the flow temporarily occluded.</p>
<p id="p-0044" num="0043">Occlusion of flow in combination with thermal fluid delivery may facilitate good control over the heat transfer kinetics along the non-target tissues. For example, the normal variability in blood flow rate between patients, which would vary the heat transfer capacity of the blood flow, may be controlled for by transferring thermal energy between the vessel wall and a thermal fluid that is delivered at a controlled rate. Use of injected thermal fluids to remove excess thermal energy from non-target tissues to relatively protect the non-target tissues during therapeutic treatment of target tissues may be utilized in body lumens other than blood vessels.</p>
<p id="p-0045" num="0044">In some embodiments, methods and apparatus for real-time monitoring of an extent or degree of neuromodulation or denervation (e.g., an extent or degree of thermal damage) in tissue innervated by the target neural fibers and/or of thermal damage in the non-target tissue may be provided. Likewise, real-time monitoring of the thermal energy delivery element may be provided. Such methods and apparatus may, for example, comprise a thermocouple or other temperature sensor for measuring the temperature of the monitored tissue or of the thermal energy delivery element. Other parameters that can be measured include the power, total energy delivered, or impedance. Monitoring data may be used for feedback control of the thermal therapy. For example, intravascularly-delivered thermal therapy may be monitored and controlled by acquiring temperature or impedance measurements along the wall of the vessel in the vicinity of the treatment zone, and/or by limiting the power or duration of the therapy.</p>
<p id="p-0046" num="0045">To better understand the structures of several embodiments of devices described below, as well as the methods of using such devices for thermally-induced renal neuromodulation, a description of the renal anatomy in humans is provided.</p>
<heading id="h-0008" level="1">B. Renal Anatomy Summary</heading>
<p id="p-0047" num="0046">With reference to <figref idref="DRAWINGS">FIG. 1</figref>, the human renal anatomy includes the kidneys K, which are supplied with oxygenated blood by the renal arteries RA. The renal arteries are connected to the heart via the abdominal aorta AA. Deoxygenated blood flows from the kidneys to the heart via the renal veins RV and the inferior vena cava IVC.</p>
<p id="p-0048" num="0047"><figref idref="DRAWINGS">FIG. 2</figref> illustrates a portion of the renal anatomy in greater detail. More specifically, the renal anatomy also includes renal nerves RN extending longitudinally along the lengthwise dimension L of renal artery RA, generally within the adventitia of the artery. The renal artery RA has smooth muscle cells SMC that surround the arterial circumference and spiral around the angular axis <b>9</b> of the artery. The smooth muscle cells of the renal artery accordingly have a lengthwise or longer dimension extending transverse (i.e., non-parallel) to the lengthwise dimension of the renal artery. The misalignment of the lengthwise dimensions of the renal nerves and the smooth muscle cells is defined as &#x201c;cellular misalignment.&#x201d;</p>
<heading id="h-0009" level="1">C. Embodiments of Apparatus and Methods for Neuromodulation</heading>
<p id="p-0049" num="0048"><figref idref="DRAWINGS">FIGS. 3-14</figref> illustrate examples of systems and methods for thermally-induced renal neuromodulation. <figref idref="DRAWINGS">FIG. 3</figref> shows one embodiment of an extravascular apparatus <b>200</b> that includes one or more electrodes configured to deliver a thermal electric field to renal neural fibers for renal neuromodulation via heating. The apparatus <b>200</b> of <figref idref="DRAWINGS">FIG. 3</figref> is configured for temporary extravascular placement; however, it should be understood that partially or completely implantable extravascular apparatus additionally or alternatively may be utilized. Applicants have previously described extravascular pulsed electric field systems, for example, in co-pending U.S. patent application Ser. No. 11/189,563, filed Jul. 25, 2005, which has been incorporated herein by reference in its entirety.</p>
<p id="p-0050" num="0049">The specific embodiment of the apparatus <b>200</b> shown in <figref idref="DRAWINGS">FIG. 3</figref> comprises a laparoscopic or percutaneous system having a probe <b>210</b> configured for insertion in proximity to the track of the renal neural supply along the renal artery, vein, hilum and/or within Gerota's fascia under a suitable guidance system. The probe <b>210</b> can have at least one electrode <b>212</b> for delivering a thermal electric field therapy. The electrode(s) <b>212</b>, for example, may be mounted on a catheter and electrically coupled to a thermal electric field generator <b>50</b> via wires <b>211</b>. The electrode <b>212</b> can be passed through the probe <b>210</b>, or in an alternative embodiment electrode <b>212</b> may be mounted to the probe <b>210</b>. The probe <b>210</b> may have an electrical connector to couple the electrode <b>212</b> to the field generator <b>50</b>.</p>
<p id="p-0051" num="0050">The field generator <b>50</b> is located external to the patient. The generator, as well as any of the electrode embodiments described herein, may be utilized with any embodiment of the present invention for delivery of a thermal electric field with desired field parameters, e.g., parameters sufficient to thermally or otherwise induce renal neuromodulation in target neural fibers via heating and/or electroporation. It should be understood that electrodes of embodiments described hereinafter may be electrically connected to the generator even though the generator is not explicitly shown or described with each embodiment. Furthermore, the field generator optionally may be positioned internally within the patient. Further still, the field generator may additionally comprise or may be substituted with an alternative thermal energy generator, such as a thermoelectric generator for heating or cooling (e.g., a Peltier device), or a thermal fluid injection system for heating or cooling, etc.</p>
<p id="p-0052" num="0051">The electrode(s) <b>212</b> can be individual electrodes that are electrically independent of each other, a segmented electrode with commonly connected contacts, or a continuous electrode. A segmented electrode may, for example, be formed by providing a slotted tube fitted onto the electrode, or by electrically connecting a series of individual electrodes. Individual electrodes or groups of electrodes <b>212</b> may be configured to provide a bipolar signal. The electrodes <b>212</b> may be dynamically assignable to facilitate monopolar and/or bipolar energy delivery between any of the electrodes and/or between any of the electrodes and a remote electrode. Such a remote electrode may be attached externally to the patient's skin, e.g., to the patient's leg or flank. In <figref idref="DRAWINGS">FIG. 3</figref>, the electrodes <b>212</b> comprise a bipolar electrode pair. The probe <b>210</b> and the electrodes <b>212</b> may be similar to the standard needle or trocar-type used clinically for RF nerve block. Alternatively, the apparatus <b>200</b> may comprise a flexible and/or custom-designed probe for the renal application described herein.</p>
<p id="p-0053" num="0052">In <figref idref="DRAWINGS">FIG. 3</figref>, the probe <b>210</b> has been advanced through a percutaneous access site P into proximity with a patient's renal artery RA. The probe pierces the patient's Gerota's fascia F, and the electrodes <b>212</b> are advanced into position through the probe and along the annular space between the patient's artery and fascia. Once properly positioned, the target neural fibers may be heated via a pulsed or continuous electric field delivered across the bipolar electrodes <b>212</b>. Such heating may, for example, ablate or cause non-ablative thermal injury to the target neural fibers to at least partially denervate the kidney innervated by the target neural fibers. The electric field also may induce reversible or irreversible electroporation in the target neural fibers, which may compliment the thermal injury induced in the neural fibers. After treatment, the apparatus <b>200</b> may be removed from the patient to conclude the procedure.</p>
<p id="p-0054" num="0053">Referring now to <figref idref="DRAWINGS">FIGS. 4A and 4B</figref>, several embodiments of intravascular systems for thermally-induced renal neuromodulation are described. Applicants have previously described intravascular pulsed electric field systems, for example, in co-pending U.S. patent application Ser. No. 11/129,765, filed May 13, 2005, which has been incorporated herein by reference in its entirety. The embodiments of <figref idref="DRAWINGS">FIGS. 4A and 4B</figref> are apparatus <b>300</b> comprising a catheter <b>302</b> having an optional positioning element <b>304</b>, shaft electrodes <b>306</b><i>a </i>and <b>306</b><i>b </i>disposed along the shaft of the catheter, and optional radiopaque markers <b>308</b> disposed along the shaft of the catheter in the region of the positioning element <b>304</b>. The positioning element <b>304</b> can be a balloon, an expandable wire basket, other mechanical expander that holds the electrodes <b>306</b><i>a</i>-<i>b </i>at a desired location in the vessel. The electrodes <b>306</b><i>a</i>-<i>b </i>can be arranged such that the electrode <b>306</b><i>a </i>is near a proximal end of the positioning element <b>304</b> and the electrode <b>306</b><i>b </i>is near the distal end of the positioning element <b>304</b>. The electrodes <b>306</b> are electrically coupled to the field generator <b>50</b> (see <figref idref="DRAWINGS">FIG. 3</figref>) for delivery of a thermal electric field for heating of target neural fibers. In an alternative embodiment, one or more of the electrodes may comprise Peltier electrodes for cooling the target neural fibers to modulate the fibers.</p>
<p id="p-0055" num="0054">The positioning element <b>304</b> optionally may center or otherwise position the electrodes <b>306</b><i>a </i>and <b>306</b><i>b </i>within a vessel. Additionally, as in <figref idref="DRAWINGS">FIG. 4A</figref>, the positioning element may comprise an impedance-altering element that alters the impedance between electrodes <b>306</b><i>a </i>and <b>306</b><i>b </i>during the therapy to direct the thermal electric field across the vessel wall. This may reduce an energy required to achieve desired renal neuromodulation and may reduce a risk of undesirably affecting non-target tissue. Applicants have previously described use of a suitable impedance-altering element in co-pending U.S. patent application Ser. No. 11/266,993, filed Nov. 4, 2005, which is incorporated herein by reference in its entirety. When the positioning element <b>304</b> comprises an inflatable balloon as in <figref idref="DRAWINGS">FIG. 4A</figref>, the balloon may serve as both a centering element for the electrodes <b>306</b> and as an impedance-altering electrical insulator for directing an electric field delivered across the electrodes, e.g., for directing the electric field into or across the vessel wall for modulation of target neural fibers. Electrical insulation provided by the positioning element <b>304</b> may reduce the magnitude of applied energy or other parameters of the thermal electric field necessary to achieve desired heating at the target fibers.</p>
<p id="p-0056" num="0055">Furthermore, the positioning element <b>304</b> optionally may be utilized as a cooling element and/or a heating element. For example, the positioning element <b>304</b> may be inflated with a chilled fluid that serves as a heat sink for removing heat from tissue that contacts the element. Conversely, the positioning element <b>304</b> optionally may be a heating element by inflating it with a warmed fluid that heats tissue in contact with the element. The thermal fluid optionally may be circulated and/or exchanged within the positioning element <b>304</b> to facilitate more efficient conductive and/or convective heat transfer. Thermal fluids also may be used to achieve thermal neuromodulation via thermal cooling or heating mechanisms, as described in greater detail herein below. The positioning element <b>304</b> (or any other portion of apparatus <b>300</b>) additionally or alternatively may comprise one or more sensors for monitoring the process. In one embodiment, the positioning element <b>304</b> has a wall-contact thermocouple <b>310</b> (<figref idref="DRAWINGS">FIG. 4A</figref>) for monitoring the temperature or other parameters of the target tissue, the non-target tissue, the electrodes, the positioning element and/or any other portion of the apparatus <b>300</b>.</p>
<p id="p-0057" num="0056">The electrodes <b>306</b> can be individual electrodes (i.e., independent contacts), a segmented electrode with commonly connected contacts, or a single continuous electrode. Furthermore, the electrodes <b>306</b> may be configured to provide a bipolar signal, or the electrodes <b>306</b> may be used together or individually in conjunction with a separate patient ground pad for monopolar use. As an alternative or in addition to placement of the electrodes <b>306</b> along the central shaft of the catheter <b>302</b>, as in <figref idref="DRAWINGS">FIGS. 4A and 4B</figref>, the electrodes <b>306</b> may be attached to the positioning element <b>304</b> such that they contact the wall of the renal artery RA. In such a variation, the electrodes may, for example, be affixed to the inside surface, outside surface or at least partially embedded within the wall of the positioning element. <figref idref="DRAWINGS">FIG. 4C</figref>, described hereinafter, illustrates one example of wall-contact electrodes, while <figref idref="DRAWINGS">FIGS. 5-8</figref> illustrate alternative wall-contact electrodes.</p>
<p id="p-0058" num="0057">In use, the catheter <b>302</b> may be delivered to the renal artery RA as shown, or it may be delivered to a renal vein or to any other vessel in proximity to neural tissue contributing to renal function, in a low profile delivery configuration through a guide catheter or other device. Alternatively, catheters may be positioned in multiple vessels for thermal renal neuromodulation, e.g., within both the renal artery and the renal vein. Techniques for pulsed electric field renal neuromodulation in multiple vessels have been described previously, for example, in co-pending U.S. patent application Ser. No. 11/451,728, filed Jul. 12, 2006, which is incorporated herein by reference in its entirety.</p>
<p id="p-0059" num="0058">Once the positioning element <b>304</b> is at a desired location within the renal vasculature, it may be expanded into contact with an interior wall of the vessel. A thermal electric field then may be delivered via the electrodes <b>306</b> across the wall of the artery. The electric field thermally modulates the activity along neural fibers that contribute to renal function via heating. In several embodiments, the thermal modulation at least partially denervates the kidney innervated by the neural fibers via heating. This may be achieved, for example, via thermal ablation or non-ablative damage of the target neural fibers. The electric field also may induce electroporation in the neural fibers.</p>
<p id="p-0060" num="0059">In the embodiment of <figref idref="DRAWINGS">FIG. 4A</figref>, the positioning element <b>304</b> illustratively comprises an inflatable balloon, which may preferentially direct the electric field as discussed. In the embodiment of <figref idref="DRAWINGS">FIG. 4B</figref>, the positioning element comprises an expandable wire basket that substantially centers the electrodes <b>306</b> within the vessel without blocking blood flow through the vessel. During delivery of the thermal electric field (or of other thermal energy), the blood may act as a heat sink for conductive and/or convective heat transfer to remove excess thermal energy from the non-target tissue. This protects the non-target tissue from undesired thermal effects. This effect may be enhanced when blood flow is not blocked during energy delivery, as in the embodiment of <figref idref="DRAWINGS">FIG. 4B</figref>.</p>
<p id="p-0061" num="0060">Using the patient's blood as a heat sink is expected to facilitate delivery of longer or greater magnitude thermal treatments with reduced risk of undesired effects to the non-target tissue, which may enhance the efficacy of the treatment at the target neural fibers. Although the embodiment of <figref idref="DRAWINGS">FIG. 4B</figref> illustratively comprises a positioning element for centering the electrodes without blocking flow, it should be understood that the positioning element may be eliminated and/or that the electrodes may be attached to the positioning element such that they are not centered in the vessel upon expansion of the centering element. In such embodiments, the patient's blood may still mitigate excess thermal heating or cooling to protect non-target tissues.</p>
<p id="p-0062" num="0061">One drawback of using a continuous, intravascularly-delivered thermal energy therapy in the presence of blood flow to achieve desired intravascularly-induced neuromodulation is that the feasible thermal magnitude (e.g., power) and/or duration of the therapy may be limited or insufficient. This can occur because the capacity of the blood to remove heat is limited, and thus the blood flowing through the blood vessel may not remove enough excess thermal energy from the vessel wall to mitigate or avoid undesirable effect in the non-target tissue. Use of a pulsed thermal energy therapy, such as a pulsed thermal RF electric field, may facilitate greater thermal magnitude (e.g., higher power), longer total duration and/or better controlled intravascular renal neuromodulation therapy compared to a continuous thermal energy therapy. For example, the effects of the therapy on target or non-target tissue may be monitored during the intervals between the pulses. This monitoring data optionally may be used in a feedback loop to better control the therapy, e.g., to determine whether to continue or stop treatment, and it may facilitate controlled delivery of a higher power or longer duration therapy.</p>
<p id="p-0063" num="0062">Furthermore, the off-time or low-energy intervals between thermal energy pulses may facilitate additional convective or other cooling of the non-target tissue of the vessel wall compared to use of a continuous thermal therapy of equivalent magnitude or duration. This may occur because blood flow through the blood vessel can convectively cool (heat) the non-target tissue of the vessel wall faster than the target neural fibers positioned outside of the vessel wall.</p>
<p id="p-0064" num="0063">When providing a pulsed thermal therapy, the difference in heat transfer rates between tissue of the blood vessel wall and the relatively remote target neural fibers may be utilized to ablate, necrose or otherwise modulate the target neural fibers without producing undesirable effects in the non-target tissue. As a result, the pulsed thermal energy therapy may be applied with greater thermal magnitude and/or of longer total duration (i.e., the cumulative duration of all thermal energy pulses) compared to a continuous thermal therapy. The higher heat transfer rate at the vessel wall during the intervals between the thermal energy pulses facilitates the greater magnitude/longer duration delivery.</p>
<p id="p-0065" num="0064">In addition or as an alternative to utilizing the patient's blood as a heat sink to create a difference in the heat transfer rate, a thermal fluid (hot or cold) may be injected, infused or otherwise delivered into the vessel to remove excess thermal energy and protect the non-target tissues. The thermal fluid may, for example, comprise saline or another biocompatible fluid that is heated, chilled or at room temperature saline. The thermal fluid may, for example, be injected through the device catheter or through a guide catheter at a location upstream from an energy delivery element, or at other locations relative to the tissue for which protection is sought. The thermal fluid may be injected in the presence of blood flow or with the blood flow temporarily occluded.</p>
<p id="p-0066" num="0065">In several embodiments, the occlusion of the blood flow in combination with thermal fluid delivery may facilitate good control over the heat transfer kinetics along the non-target tissues. For example, the normal variability in blood flow rate between patients, which would vary the heat transfer capacity of the blood flow, may be controlled for by transferring thermal energy between the vessel wall and a thermal fluid that is delivered at a controlled rate. Furthermore, this method of using an injected thermal fluid to remove excess thermal energy from non-target tissues in order to protect the non-target tissues during therapeutic treatment of target tissues may be utilized in body lumens other than blood vessels.</p>
<p id="p-0067" num="0066">One or more sensors, such as the thermocouple <b>310</b> of <figref idref="DRAWINGS">FIG. 4A</figref>, may be used to monitor the temperature(s) or other parameter(s) at the electrodes <b>306</b>, the wall of the vessel and/or at other desired locations along the apparatus or the patient's anatomy. The thermal neuromodulation may be controlled using the measured parameter(s) as feedback. This feedback may be used, for example, to maintain the parameter(s) below a desired threshold. For example, the parameter(s) may be maintained below a threshold that may cause undesired effects in the non-target tissues. With blood flowing through the vessel, more thermal energy may be carried away, which may allow for longer or higher energy treatments than when blood flow is blocked in the vessel.</p>
<p id="p-0068" num="0067">As discussed, when utilizing intravascular apparatus to achieve thermal neuromodulation, in addition or as an alternative to central positioning of the electrode(s) within a blood vessel, the electrode(s) optionally may be configured to contact an internal wall of the blood vessel. Wall-contact electrode(s) may facilitate more efficient transfer of a thermal electric field across the vessel wall to target neural fibers, as compared to centrally-positioned electrode(s). In some embodiments, the wall-contact electrode(s) may be delivered to the vessel treatment site in a reduced profile configuration, then expanded in vivo to a deployed configuration wherein the electrode(s) contact the vessel wall. In some embodiments, expansion of the electrode(s) is at least partially reversible to facilitate retrieval of the electrode(s) from the patient's vessel.</p>
<p id="p-0069" num="0068"><figref idref="DRAWINGS">FIG. 4C</figref> depicts an embodiment of an apparatus <b>400</b> having one or more wall-contact electrodes <b>306</b>. One or more of the struts of the expandable basket positioning element <b>304</b> may comprise a conductive material that is insulated in regions other than along segments that contact the vessel wall and form electrode(s) <b>306</b>. The electrode(s) may be used in either a bipolar or a monopolar configuration. Furthermore, the electrode(s) may comprise sensor(s), e.g., impedance or temperature sensors, for monitoring and/or controlling the effects of the thermal energy delivery. The sensors, for example, can be thermocouples.</p>
<p id="p-0070" num="0069"><figref idref="DRAWINGS">FIGS. 5A and 5B</figref> depict an alternative embodiment of intravascular apparatus <b>500</b> having electrodes configured to contact the interior wall of a vessel. The apparatus <b>500</b> of <figref idref="DRAWINGS">FIGS. 5A and 5B</figref> is an alternative embodiment of the apparatus <b>300</b> of <figref idref="DRAWINGS">FIGS. 4A and 4B</figref> wherein the proximal electrode <b>306</b><i>a </i>of <figref idref="DRAWINGS">FIGS. 4A and 4B</figref> has been replaced with wall-contact electrode <b>306</b><i>a</i>&#x2032;. The wall-contact electrode comprises proximal connector <b>312</b><i>a </i>that connects the electrode to the shaft of the catheter <b>302</b> and is electrically coupled to the pulse generator. The apparatus <b>500</b> also has a plurality of extensions <b>314</b><i>a </i>that extend from the proximal connector <b>312</b><i>a </i>and at least partially extend over a surface of positioning element <b>304</b>. The extensions <b>314</b><i>a </i>optionally may be selectively insulated such that only a selective portion of the extensions, e.g., the distal tips of the extensions, are electrically active. The electrode <b>306</b><i>a</i>&#x2032; optionally may be fabricated from a slotted tube, such as a stainless steel or shape-memory (e.g., NiTi) slotted tube. Furthermore, all or a portion of the electrode may be gold-plated to improve radiopacity and/or conductivity.</p>
<p id="p-0071" num="0070">As seen in <figref idref="DRAWINGS">FIG. 5A</figref>, the catheter <b>302</b> may be delivered over a guidewire G to a treatment site within the patient's vessel with the electrode <b>306</b><i>a</i>&#x2032; positioned in a reduced profile configuration. The catheter <b>302</b> optionally may be delivered through a guide catheter <b>303</b> to facilitate such reduced profile delivery of the wall-contact electrode. When positioned as desired at a treatment site, the electrode <b>306</b><i>a</i>&#x2032; may be expanded into contact with the vessel wall by expanding the positioning element <b>304</b> (shown in <figref idref="DRAWINGS">FIG. 5B</figref>). A thermal monopolar or bipolar electric field then may be delivered across the vessel wall and between the electrodes <b>306</b><i>a</i>&#x2032; and <b>306</b><i>b </i>to induce thermal neuromodulation, as discussed previously. The optional positioning element <b>304</b> may alter impedance within the blood vessel and more efficiently route the electrical energy across the vessel wall to the target neural fibers.</p>
<p id="p-0072" num="0071">After terminating the electric field, the electrode <b>306</b><i>a</i>&#x2032; may be returned to a reduced profile and the apparatus <b>300</b> may be removed from the patient or repositioned in the vessel. For example, the positioning element <b>304</b> may be collapsed (e.g., deflated), and the electrode <b>306</b><i>a</i>&#x2032; may be contracted by withdrawing the catheter <b>302</b> within the guide catheter <b>303</b>. Alternatively, the electrode may be fabricated from a shape-memory material biased to the collapsed configuration, such that the electrode self-collapses upon collapse of the positioning element.</p>
<p id="p-0073" num="0072">Although in <figref idref="DRAWINGS">FIGS. 5A and 5B</figref> the electrode <b>306</b><i>a</i>&#x2032; is expanded into contact with the vessel wall, it should be understood that the electrode alternatively may be fabricated from a self-expanding material biased such that the electrode self-expands into contact with the vessel wall upon positioning of the electrode distal of the guide catheter <b>303</b>. A self-expanding embodiment of the electrode <b>306</b><i>a</i>&#x2032; may obviate a need for the positioning element <b>304</b> and/or may facilitate maintenance of blood flow through the blood vessel during delivery of an electric field via the electrode. After delivery of the electric field, the self-expanding electrode <b>306</b><i>a</i>&#x2032; may be returned to a reduced profile to facilitate removal of the apparatus <b>300</b> from the patient by withdrawing the catheter <b>302</b> within the guide catheter <b>303</b>.</p>
<p id="p-0074" num="0073"><figref idref="DRAWINGS">FIGS. 6A and 6B</figref> depict another embodiment of an apparatus <b>600</b> and methods for delivering a field using a wall-contact electrode. As an alternative to the proximal connector <b>312</b><i>a </i>of the electrode <b>306</b><i>a</i>&#x2032; of <figref idref="DRAWINGS">FIGS. 5A and 5B</figref>, the electrode <b>306</b><i>a</i>&#x2033; of <figref idref="DRAWINGS">FIG. 6</figref> comprises a distal connector <b>316</b><i>a </i>for coupling the electrode to the shaft of catheter <b>302</b> on the distal side of the positioning element <b>304</b>. The distal connector enables the electrode to extend over the entirety of the positioning element <b>304</b> and may facilitate contraction of the electrode <b>306</b><i>a</i>&#x2033; after thermal neuromodulation. For example, the electrode <b>306</b><i>a</i>&#x2033; can be contracted by proximally retracting the proximal connector <b>312</b><i>a </i>relative to the catheter <b>302</b> during or after contraction of the positioning element <b>304</b>. <figref idref="DRAWINGS">FIG. 6A</figref> shows the electrode <b>306</b><i>a</i>&#x2033; in the reduced profile configuration, and <figref idref="DRAWINGS">FIG. 6B</figref> shows the electrode in the expanded in which the conductive portions contact the vessel wall.</p>
<p id="p-0075" num="0074"><figref idref="DRAWINGS">FIGS. 7A and 7B</figref> show additional alternative embodiments of methods and an apparatus <b>700</b>. In <figref idref="DRAWINGS">FIGS. 7A and 7B</figref>, the apparatus <b>700</b> comprises the proximal electrode <b>306</b><i>a</i>&#x2032; of <figref idref="DRAWINGS">FIGS. 5A and 5B</figref>, and a distal wall-contact electrode <b>306</b><i>b</i>&#x2032;. The embodiment of <figref idref="DRAWINGS">FIG. 7A</figref> comprises proximal and distal positioning elements <b>304</b><i>a </i>and <b>304</b><i>b</i>, respectively, for expanding the proximal and distal wall-contact electrodes <b>306</b><i>a</i>&#x2032; and <b>306</b><i>b</i>&#x2032;, respectively, into contact with the vessel wall. The embodiment of <figref idref="DRAWINGS">FIG. 7B</figref> comprises only a single positioning element <b>304</b>, but the distal wall-contact electrode <b>306</b><i>b</i>&#x2032; is proximal facing and positioned over the distal portion of the positioning element <b>304</b> to facilitate expansion of the distal electrode <b>306</b><i>b</i>&#x2032;. In the embodiment of <figref idref="DRAWINGS">FIG. 7B</figref>, the extensions of the proximal and distal electrodes optionally may be connected along non-conductive connectors <b>318</b> to facilitate collapse and retrieval of the electrodes post-treatment.</p>
<p id="p-0076" num="0075">A bipolar electric field may be delivered between the proximal and distal wall-contact electrodes, or a monopolar electric field may be delivered between the proximal and/or distal electrode(s) and an external ground. Having both the proximal and distal electrodes in contact with the wall of the vessel may facilitate more efficient energy transfer across the wall during delivery of a thermal electric field, as compared to having one or both of the proximal and distal electrodes centered within the vessel.</p>
<p id="p-0077" num="0076"><figref idref="DRAWINGS">FIGS. 8A-8H</figref> illustrate additional embodiments of the apparatus and methods that can comprise one or more wall-contact electrodes, blood flow occlusion features, and thermal fluid injection functions. The embodiments of <figref idref="DRAWINGS">FIG. 8</figref> are described as monopolar devices, but it should be understood that any or all of the embodiments may be configured or operated as bipolar devices. Furthermore, although blood flow occlusion and thermal fluid injection are described in combination with wall-contact electrode(s), it should be understood that such occlusion and injection features may be provided in combination with electrode(s) that do not contact the vessel wall.</p>
<p id="p-0078" num="0077">As discussed previously, in addition or as an alternative to utilizing the patient's blood as a heat sink to create different heat transfer rates between target neural fibers and non-target tissue of the wall of the vessel within which thermal energy is delivered, a thermal fluid (hot or cold) may be injected, infused or otherwise delivered into the vessel. The thermal fluid may further remove excess thermal energy and protect the non-target tissues. When delivering thermal RF therapy, the thermal fluid may, for example, comprise chilled or room temperature saline (e.g., saline at a temperature lower than the temperature of the vessel wall during the therapy delivery). The thermal fluid may be injected through the device catheter or through a guide catheter at a location upstream from an energy delivery element, or at other locations relative to the tissue for which protection is sought. The thermal fluid may be injected in the presence of blood flow or with blood flow temporarily occluded. The occlusion of blood flow in combination with thermal fluid delivery may facilitate good control over the heat transfer kinetics along the non-target tissues, as well as injection of fluid from a downstream location.</p>
<p id="p-0079" num="0078"><figref idref="DRAWINGS">FIGS. 8A and 8B</figref> show an embodiment of an apparatus <b>800</b><i>a </i>that comprises the catheter <b>802</b> having an element <b>804</b>, which may be used to position the apparatus within the vessel and/or to occlude blood flow. The element <b>304</b> can be an inflatable balloon. The apparatus <b>800</b> can further have an active monopolar electrode <b>806</b> located proximally from the element <b>304</b> such that inflation of the element <b>304</b> blocks blood flow downstream of the electrode <b>806</b>. The monopolar electrode <b>806</b> illustratively comprises multiple extensions <b>814</b>, and it should be understood that any desired number of extensions may be provided, including a single extension. The monopolar electrode is utilized in combination with a remote electrode, such as a ground pad, positioned external to the patient. The apparatus can also comprise an infusion port <b>805</b> between the element <b>804</b> and the monopolar electrode <b>806</b>.</p>
<p id="p-0080" num="0079">In <figref idref="DRAWINGS">FIG. 8A</figref>, the catheter <b>802</b> may be advanced within the renal artery RA in a reduced profile delivery configuration. In <figref idref="DRAWINGS">FIG. 8B</figref>, once properly positioned, the electrode <b>806</b> may be actively expanded, or it may self-expand by removing a sheath, the guide catheter or another type of restraint from the electrode. The expanded electrode <b>806</b> contacts the vessel wall. The element <b>804</b> may be expanded (before, during or after expansion of the electrode) to properly position the electrode within the vessel and/or to occlude blood flow within the renal artery downstream of the electrode. A monopolar electric field may be delivered between the active electrode <b>806</b> and the external ground. The electric field may, for example, comprise a pulsed or continuous RF electric field that thermally induces neuromodulation (e.g., necrosis or ablation) in the target neural fibers. The thermal therapy may be monitored and controlled, for example, via data collected with thermocouples <b>810</b>, impedance sensors or other sensors.</p>
<p id="p-0081" num="0080">To increase the power that may be delivered or the duration of the thermal treatment without undesirably affecting non-target tissue, a thermal fluid infusate I may be injected through injection port <b>805</b> of the catheter <b>802</b> to cool (heat) the non-target tissue. This is expected to mitigate undesired effects in the non-target tissue. The infusate may, for example, comprise chilled saline that removes excess thermal energy (hot or cold) from the wall of the vessel during thermal RF therapy.</p>
<p id="p-0082" num="0081">Convective or other heat transfer between the non-target vessel wall tissue and the infusate I may facilitate cooling (heating) of the vessel wall at a faster rate than cooling (heating) occurs at the target neural fibers. This difference in the heat transfer rates between the wall of the vessel and the target neural fibers may be utilized to modulate the neural fibers. Furthermore, when utilizing a pulsed thermal therapy, the accelerated heat transfer at the wall relative to the neural fibers may allow for relatively higher power or longer duration therapies (as compared to continuous thermal therapies). Also, the interval between pulses may be used to monitor and/or control effects of the therapy.</p>
<p id="p-0083" num="0082"><figref idref="DRAWINGS">FIG. 8C</figref> shows an embodiment of another apparatus <b>801</b> with wall-contact electrodes, flow occlusion and thermal fluid injection. In <figref idref="DRAWINGS">FIG. 8C</figref>, the occlusion element <b>804</b> is coupled to the guide wire G, which may comprise an inflation lumen, and the infusate I is delivered through a distal outlet of the catheter <b>802</b>. As will be apparent, the occlusion element alternatively may be coupled to a separate catheter or sheath rather than to the guide wire. Also, the infusate may, for example, be delivered through the guide wire lumen or through an additional lumen or annulus of the catheter <b>802</b>. <figref idref="DRAWINGS">FIG. 8D</figref> illustrates another embodiment of an apparatus <b>830</b> wherein the occlusion element <b>804</b> is positioned proximal or upstream of the electrode(s) <b>806</b>, and the infusate I is delivered at a position distal of the occlusion element but proximal of the electrode(s). [Ken: Make numbering changes in text to correspond to figures.]</p>
<p id="p-0084" num="0083"><figref idref="DRAWINGS">FIG. 8E</figref> is an embodiment of apparatus <b>804</b> with occlusion elements <b>804</b> positioned both proximal and distal of the electrode(s) <b>306</b>. In addition to having a first injection port <b>305</b><i>a</i>, the catheter <b>302</b> comprises an aspiration port <b>305</b><i>b</i>. Separate lumens can extend through the catheter for injection and aspiration of the infusate I via the ports <b>305</b>. Providing both injection and aspiration of the infusate facilitates good control over the flow dynamics of the infusate, and thereby the heat transfer kinetics of the infusate. For example, providing aspiration and injection at the same rate may provide consistent heat transfer kinetics between the vessel and the electrode(s).</p>
<p id="p-0085" num="0084"><figref idref="DRAWINGS">FIG. 8F</figref> illustrates another embodiment of an apparatus <b>850</b> having a catheter <b>852</b> comprising a wall-contact electrode <b>856</b> that may be moved into contact with the vessel wall via an elongated member <b>857</b>. In this embodiment, the elongated member <b>857</b> is distally connected to the catheter in the vicinity of the electrode <b>306</b>. The elongated member may be configured for self expansion, or it may extend through port <b>305</b> of the catheter <b>302</b> and through a lumen of the catheter to a proximal location for manipulation by a medical practitioner. The proximal section of the elongated member may be advanced relative to the catheter <b>302</b> by the medical practitioner such that the member assumes the illustrated curved profile.</p>
<p id="p-0086" num="0085">Upon expansion of the elongated member, the catheter <b>302</b> is deflected such that the electrode <b>306</b> coupled to the catheter shaft contacts the vessel wall. Optionally, element <b>304</b> may be expanded to facilitate positioning of the electrode via the elongated member and/or to block flow through the vessel. The element <b>304</b> can be coupled to the guide or delivery catheter <b>303</b>. Infusate I optionally may be delivered through the catheter <b>303</b> as shown.</p>
<p id="p-0087" num="0086"><figref idref="DRAWINGS">FIG. 8G</figref> is an embodiment of an apparatus <b>860</b> comprising a shaped or self-expanding electrode <b>866</b>. The electrode <b>866</b> may be delivered to a treatment site within catheter <b>303</b>, and then it moves to a preselected shape after it has been removed from the lumen of the catheter <b>303</b>. For example, the electrode <b>866</b> can be removed from the catheter by advancing the catheter <b>302</b> and/or retracting the catheter <b>303</b>. The electrode <b>866</b> contacts the vessel wall for delivery of therapy. Optionally, catheter <b>302</b> may be rotated to rotate the electrode relative to the vessel wall and angularly reposition the electrode. The therapy may be delivered at a singular angular position or at multiple angular positions. Additionally or alternatively, multiple angularly spaced electrodes <b>306</b> may be positioned within the vasculature, as shown in <figref idref="DRAWINGS">FIG. 8H</figref>. In addition to angular spacing, the electrodes may be longitudinally spaced to facilitate treatment over a longitudinal segment of the vessel, e.g., to achieve a circumferential treatment along the longitudinal segment rather than along a cross-section.</p>
<p id="p-0088" num="0087">In addition to extravascular and intravascular systems for thermally-induced renal neuromodulation, intra-to-extravascular systems may be provided. The intra-to-extravascular systems may, for example, have electrode(s) that are delivered to an intravascular position, and then at least partially passed through/across the vessel wall to an extravascular position prior to delivery of a thermal electric field. Intra-to-extravascular positioning of the electrode(s) may place the electrode(s) in closer proximity to target neural fibers for delivery of a thermal electric field, as compared to fully intravascular positioning of the electrode(s). Applicants have previously described intra-to-extravascular pulsed electric field systems, for example, in co-pending U.S. patent application Ser. No. 11/324,188, filed Dec. 29, 2005, which is incorporated herein by reference in its entirety.</p>
<p id="p-0089" num="0088"><figref idref="DRAWINGS">FIG. 9</figref> illustrates one embodiment of an intra-to-extravascular (&#x201c;ITEV&#x201d;) system for thermally-induced renal neuromodulation is described. ITEV system <b>900</b> comprising a catheter <b>922</b> having (a) a plurality of proximal electrode lumens terminating at proximal side ports <b>924</b>, (b) a plurality of distal electrode lumens terminating at distal side ports <b>926</b>, and (c) a guidewire lumen <b>923</b>. The catheter <b>922</b> preferably comprises an equal number of proximal and distal electrode lumens and side ports. The ITEV system <b>900</b> also includes proximal needle electrodes <b>928</b> that may be advanced through the proximal electrode lumens and the proximal side ports <b>924</b>, as well as distal needle electrodes <b>929</b> that may be advanced through the distal electrode lumens and the distal side ports <b>926</b>.</p>
<p id="p-0090" num="0089">The catheter <b>922</b> comprises an optional expandable positioning element <b>930</b>, which may comprise an inflatable balloon or an expandable basket or cage. In use, the positioning element <b>930</b> may be expanded prior to deployment of the needle electrodes <b>928</b> and <b>929</b> in order to position or center the catheter <b>922</b> within the patient's vessel (e.g., within renal artery RA). Centering the catheter <b>922</b> is expected to facilitate delivery of all needle electrodes to desired depths within/external to the patient's vessel (e.g., to deliver all of the needle electrodes approximately to the same depth). In <figref idref="DRAWINGS">FIG. 9</figref>, the illustrated positioning element <b>930</b> is between the proximal side ports <b>924</b> and the distal side ports <b>926</b>, and thus the positioning element <b>930</b> is between the delivery positions of the proximal and distal electrodes. However, it should be understood that the positioning element <b>930</b> additionally or alternatively may be positioned at a different location or at multiple locations along the length of the catheter <b>922</b> (e.g., at a location proximal of the side ports <b>924</b> and/or at a location distal of the side ports <b>926</b>).</p>
<p id="p-0091" num="0090">As illustrated in <figref idref="DRAWINGS">FIG. 9</figref>, the catheter <b>922</b> may be advanced to a treatment site within the patient's vasculature over a guidewire (not shown) via the lumen <b>323</b>. During intravascular delivery, the electrodes <b>928</b> and <b>929</b> may be positioned such that their non-insulated and sharpened distal regions are positioned within the proximal and distal lumens, respectively. Once at a treatment site, a medical practitioner may advance the electrodes via their proximal regions that are located external to the patient. Such advancement causes the distal regions of the electrodes <b>928</b> and <b>929</b> to exit side ports <b>924</b> and <b>926</b>, respectively, and pierce the wall of the patient's vasculature such that the electrodes are positioned extravascularly via an ITEV approach.</p>
<p id="p-0092" num="0091">The proximal electrodes <b>928</b> can be connected to an electric field generator <b>50</b> as active electrodes, and the distal electrodes <b>929</b> can serve as return electrodes. In this manner, the proximal and distal electrodes form bipolar electrode pairs that align the thermal electric field with a longitudinal axis or direction of the patient's vasculature. As will be apparent, the distal electrodes <b>929</b> alternatively may comprise the active electrodes and the proximal electrodes <b>928</b> may comprise the return electrodes. Furthermore, the proximal and/or the distal electrodes may comprise both active and return electrodes. Further still, the proximal and/or the distal electrodes may be utilized in combination with an external ground for delivery of a monopolar thermal electric field. Any combination of active and distal electrodes may be utilized, as desired.</p>
<p id="p-0093" num="0092">When the electrodes <b>928</b> and <b>929</b> are connected to an electric field generator and positioned extravascularly, and with the positioning element <b>930</b> optionally expanded, delivery of the thermal electric field may proceed to achieve desired renal neuromodulation via heating. The electric field also may induce electroporation. After achievement of the thermally-induced renal neuromodulation, the electrodes may be retracted within the proximal and distal lumens, and the positioning element <b>930</b> may be collapsed for retrieval. The ITEV system <b>920</b> then may be removed from the patient to complete the procedure. Additionally or alternatively, the system may be repositioned to provide therapy at another treatment site, such as to provide bilateral renal neuromodulation.</p>
<p id="p-0094" num="0093">Cooling elements, such as convective cooling elements, may be utilized to protect non-target tissues like smooth muscle cells from thermal damage during thermally-induced renal neuromodulation via heat generation. Non-target tissues may be protected by focusing the thermal energy on the target neural fibers such that an intensity of the thermal energy is insufficient to induce thermal damage in non-target tissues distant from the target neural fibers.</p>
<p id="p-0095" num="0094">Although <figref idref="DRAWINGS">FIGS. 3-7</figref> and <b>9</b> illustratively show bipolar apparatus, it should be understood that monopolar apparatus alternatively may be utilized as in <figref idref="DRAWINGS">FIGS. 8A-8H</figref>. For example, an active monopolar electrode may be positioned intravascularly, extravascularly or intra-to-extravascularly in proximity to target neural fibers that contribute to renal function. A return electrode may be attached to the exterior of the patient or positioned in the patient apart from the active electrodes. Finally, a thermal electric field may be delivered between the in vivo monopolar electrode and the remote electrode to effectuate desired thermally-induced renal neuromodulation. Monopolar apparatus additionally may be utilized for bilateral renal neuromodulation.</p>
<p id="p-0096" num="0095">The embodiments of <figref idref="DRAWINGS">FIGS. 3-9</figref> illustratively describe methods and apparatus for thermally-induced renal neuromodulation via delivery of thermal electric fields that modulate the target neural fibers. However, it should be understood that alternative methods and apparatus for thermally-induced (via both heating and cooling) renal neuromodulation may be provided. For example, electric fields may be used to cool and modulate the neural fibers with thermoelectric or Peltier elements. Also, thermally-induced renal neuromodulation optionally may be achieved via direct application of thermal energy to the target neural fibers. Such direct thermal energy may be generated and/or transferred in a variety of ways, such as via resistive heating, via delivery of a heated or chilled fluid (see <figref idref="DRAWINGS">FIGS. 10 and 12</figref>), via a Peltier element (see <figref idref="DRAWINGS">FIG. 11</figref>), etc. Thermally-induced renal neuromodulation additionally or alternatively may be achieved via application of high-intensity focused ultrasound to the target neural fibers (see <figref idref="DRAWINGS">FIG. 13</figref>). Additional and alternative methods and apparatus for thermally-induced renal neuromodulation may be used in accordance with the present invention.</p>
<p id="p-0097" num="0096">With reference now to <figref idref="DRAWINGS">FIG. 10</figref>, an alternative embodiment of an apparatus <b>1000</b> and methods for thermally-induced neuromodulation via direct application of thermal energy is described. In the embodiment of <figref idref="DRAWINGS">FIG. 10</figref>, the electrodes <b>328</b> and <b>329</b> of <figref idref="DRAWINGS">FIG. 9</figref> have been replaced with infusion needles <b>1028</b> and <b>1029</b>, respectively. A thermal fluid F may be delivered through the needles to the target neural fibers. The thermal fluid may be heated in order to raise the temperature of the target neural fibers above a desired threshold. For example, the temperature of the neural fibers can be raised above a body temperature of about 37&#xb0; C., or above a temperature of about 45&#xb0; C. Alternatively, the thermal fluid may be chilled to reduce the temperature of the target neural fibers below a desired threshold. For example, the neural fibers can be cooled to below the body temperature of about 37&#xb0; C., or further cooled below about 20&#xb0; C., or still further cooled below a freezing temperature of about 0&#xb0; C. As will be apparent, in addition to intra-to-extravascular delivery of a thermal fluid, the thermal fluid may be delivered intravascularly (e.g., may inflate and/or be circulated through a balloon member), extravascularly (e.g., may be circulated through a vascular cuff), or a combination thereof.</p>
<p id="p-0098" num="0097">In addition or as alternative to injection of a thermal fluid to the target neural fibers through infusion needles <b>1028</b> and <b>1029</b>, an alternative neuromodulatory agent, such as a drug or medicament, may be injected to modulate, necrose or otherwise block or reduce transmission along the target neural fibers. Examples of alternative neuromodulatory agents include, but are not limited to, phenol and neurotoxins, such as botulinum toxin. Additional neuromodulatory agents, per se known, will be apparent to those of skill in the art.</p>
<p id="p-0099" num="0098"><figref idref="DRAWINGS">FIG. 11</figref> shows another method and apparatus <b>110</b> for thermal renal neuromodulation via direct application of thermal energy to the target neural fibers. The apparatus <b>1100</b> comprises renal artery cuff <b>1102</b> having one or more integrated thermoelectric elements that are electrically coupled to an internal or external power supply <b>1104</b>. The thermoelectric element utilizes the well-known Peltier effect (i.e., the establishment of a thermal gradient induced by an electric voltage) to achieve thermal renal neuromodulation.</p>
<p id="p-0100" num="0099">An electric current is passed from the power supply <b>1104</b> to the thermoelectric element of the cuff <b>1102</b>. The thermoelectric element can comprise two different metals (e.g., a p-type and an n-type semiconductor) that are connected to each other at two junctions. The current induces a thermal gradient between the two junctions, such that one junction cools while the other is heated. Reversal of the polarity of the voltage applied across the two junctions reverses the direction of the thermal gradient. Either the hot side or the cold side of the thermoelectric element faces radially inward in order to heat or cool, respectively, the target neural fibers that travel along the renal artery to achieve thermal renal neuromodulation. Optionally, the radially outward surface of the thermoelectric element may be insulated to reduce a risk of thermal damage to the non-target tissues. The cuff <b>1102</b> may comprise one or more temperature sensors, such as thermocouples, for monitoring the temperature of the target neural fibers and/or of the non-target tissues.</p>
<p id="p-0101" num="0100"><figref idref="DRAWINGS">FIG. 12</figref> shows another method and apparatus <b>1200</b> utilizing the Peltier effect. The apparatus <b>1200</b> comprises an implanted or external pump <b>1202</b> connected to a renal artery cuff <b>1204</b> via inlet fluid conduit <b>1206</b><i>a </i>and outlet fluid conduit <b>1206</b><i>b</i>. The inlet fluid conduit transfers fluid from the pump to the cuff, while the outlet fluid conduit transfers fluid from the cuff to the pump to circulate fluid through the cuff. A reservoir of fluid may be located in the cuff, the pump and/or in the fluid conduits.</p>
<p id="p-0102" num="0101">The pump <b>1202</b> further comprises one or more thermoelectric or other thermal elements in heat exchange contact with the fluid reservoir for cooling or heating the fluid that is transferred to the cuff to thermally modulate the target neural fibers. The apparatus <b>1200</b> optionally may have controls for automatic or manual control of fluid heating or cooling, as well as fluid circulation within the cuff. Furthermore, the apparatus may comprise temperature and/or renal sympathetic neural activity monitoring or feedback control. Although the apparatus illustratively is shown unilaterally treating neural fibers innervating a single kidney, it should be understood that bilateral treatment of neural fibers innervating both kidneys alternatively may be provided.</p>
<p id="p-0103" num="0102">Thermal renal neuromodulation alternatively may be achieved via pulsed or continuous high-intensity focused ultrasound. High intensity focused ultrasound also may induce reversible or irreversible electroporation in the target neural fibers. Furthermore, the ultrasound may be delivered over a full 360&#xb0; (e.g. when delivered intravascularly) or over a radial segment of less than 360&#xb0; (e.g., when delivered intravascularly, extravascularly, intra-to-extravascularly, or a combination thereof). <figref idref="DRAWINGS">FIGS. 13A</figref> and B illustrate an embodiment of an ultrasonic apparatus <b>1300</b> comprising a catheter <b>1302</b>, one or more ultrasound transducers <b>1304</b> positioned along the shaft of the catheter, and an inflatable balloon <b>1306</b> around the transducers <b>1304</b>. The ultrasound transducers <b>1304</b> are coupled to an ultrasound signal generator via conductors <b>1307</b>. The balloon <b>1306</b> can have an acoustically reflective portion <b>1308</b> for reflecting an ultrasound wave and an acoustically transmissive portion <b>1309</b> the wave through which the ultrasonic energy can pass. In this manner, the wave may be focused as shown at a focal point or radius P positioned a desired focal distance from the catheter shaft. In an alternative embodiment, the transducers may be attached directly to the balloon.</p>
<p id="p-0104" num="0103">The focal distance may be specified or dynamically variable such that the ultrasonic wave is focused at a desired depth on target neural fibers outside of the vessel. For example, a family of catheter sizes may be provided to allow for a range of specified focal distances. A dynamically variable focal distance may be achieved, for example, via calibrated expansion of the balloon.</p>
<p id="p-0105" num="0104">Focusing the ultrasound wave may produce a reverse thermal gradient that protects the non-target tissues and selectively affect the target neural fibers to achieve thermal renal neuromodulation via heating. As a result, the temperature at the vessel wall may be less than the temperature at the target tissue. <figref idref="DRAWINGS">FIG. 13A</figref> shows the apparatus <b>1300</b> in a reduced delivery and retrieval configuration, and <figref idref="DRAWINGS">FIG. 13B</figref> shows the apparatus <b>1300</b> in an expanded deployed configuration.</p>
<p id="p-0106" num="0105"><figref idref="DRAWINGS">FIG. 14</figref> shows an alternative embodiment of an ultrasonic <b>1400</b> having a catheter <b>1402</b>, a conductor <b>1403</b>, and concave ultrasound transducers <b>1401</b>. The concave ultrasound transducers <b>1404</b> direct the energy to a specific focal point P. A such, the concave transducers <b>1404</b> are self-focusing and eliminate need of the reflective portion of the balloon <b>366</b> (e.g., the balloon may be acoustically transmissive at all points).</p>
<p id="p-0107" num="0106">The apparatus described above with respect to <figref idref="DRAWINGS">FIGS. 3-14</figref> optionally may be used to quantify the efficacy, extent or cell selectivity of thermally-induced renal neuromodulation in order to monitor and/or control the neuromodulation. As discussed previously, the apparatus may further comprise one or more sensors, such as thermocouples or imaging transducers, for measuring and monitoring one or more parameters of (a) the apparatus, (b) target neural fibers and/or (c) non-target tissues. For example, a temperature rise or drop above or below certain thresholds is expected to thermally ablate, non-ablatively injure, freeze or otherwise damage the target neural fibers to thereby modulate the target neural fibers.</p>
<p id="p-0108" num="0107"><figref idref="DRAWINGS">FIGS. 15A and 15B</figref> classify the various types of thermal neuromodulation that may be achieved with the apparatus and methods of the present invention. <figref idref="DRAWINGS">FIGS. 15A and 15B</figref> are provided only for the sake of illustration and should in no way be construed as limiting. <figref idref="DRAWINGS">FIG. 15A</figref> classifies thermal neuromodulation due to heat exposure. As shown, exposure to heat in excess of a body temperature of about 37&#xb0; C., but below a temperature of about 45&#xb0; C., may induce thermal injury via moderate heating of the target neural fibers or of vascular structures that perfuse the target fibers. For example, this may induce non-ablative thermal injury in the fibers or structures. Exposure to heat above a temperature of about 45&#xb0; C., or above about 60&#xb0; C., may induce thermal injury via substantial heating of the fibers or structures. For example, such higher temperatures may thermally ablate the target neural fibers or the vascular structures. In some patients, it may be desirable to achieve temperatures that thermally ablate the target neural fibers or the vascular structures, but that are less than about 90&#xb0; C., or less than about 85&#xb0; C., or less than about 80&#xb0; C., and/or less than about 75&#xb0; C. Regardless of the type of heat exposure utilized to induce the thermal neuromodulation, a reduction in renal sympathetic nerve activity (&#x201c;RSNA&#x201d;) is expected.</p>
<p id="p-0109" num="0108">As seen in <figref idref="DRAWINGS">FIG. 15B</figref>, thermal cooling for neuromodulation includes non-freezing thermal slowing of nerve conduction and/or nerve injury, as well as freezing thermal nerve injury. Non-freezing thermal cooling may include reducing the temperature of the target neural fibers or of the vascular structures that feed the fibers to temperatures below the body temperature of about 37&#xb0; C., or below about 20&#xb0; C., but above the freezing temperature of about 0&#xb0; C. This non-freezing thermal cooling may either slow nerve conduction or may cause direct neural injury. Slowed nerve conduction may use continuous or intermittent cooling of the target neural fibers to sustain the desired thermal neuromodulation, while direct neural injury may require only a discrete treatment to achieve sustained thermal neuromodulation. Thermal cooling for neuromodulation also may include freezing thermal nerve injury by reducing the temperature of the target neural fibers or of the vascular structures that feed the fibers to temperatures below the freezing point of about 0&#xb0; C. Regardless of the type of cold exposure utilized to induce the thermal neuromodulation (freezing or non-freezing), a reduction in renal sympathetic nerve activity (&#x201c;RSNA&#x201d;) is expected.</p>
<p id="p-0110" num="0109"><figref idref="DRAWINGS">FIG. 16</figref> shows one embodiment of an intravascular pulsed electric field apparatus <b>1600</b> in accordance with the present invention that includes one or more electrodes configured to physically contact a target region within the renal vasculature and deliver a pulsed electric field across a wall of the vasculature. The apparatus <b>1600</b> is shown within a patient's renal artery RA, but it can be positioned in other intravascular locations (e.g., the renal vein). This embodiment of the apparatus <b>1600</b> comprises an intravascular catheter <b>1610</b> having a proximal section <b>1611</b><i>a</i>, a distal section <b>1611</b><i>b</i>, and a plurality of distal electrodes <b>1612</b> at the distal section <b>1611</b><i>b</i>. The proximal section <b>1611</b><i>a </i>generally has an electrical connector to couple the catheter <b>1610</b> to a pulse generator, and the distal section <b>1611</b><i>b </i>in this embodiment has a helical configuration. The apparatus <b>1600</b> is electrically coupled to a pulsed electric field generator <b>1600</b> located proximal and external to the patient; the electrodes <b>1612</b> are electrically coupled to the generator via catheter <b>1610</b>. The generator <b>1600</b> may be utilized with any embodiment of the present invention described hereinafter for delivery of a PEF with desired field parameters. It should be understood that electrodes of embodiments described hereinafter may be connected to the generator, even if the generator is not explicitly shown or described with each variation.</p>
<p id="p-0111" num="0110">The helical distal section <b>1611</b><i>b </i>of catheter <b>1610</b> is configured to oppose the vessel wall and bring electrodes <b>1612</b> into close proximity to extra-vascular neural structures. The pitch of the helix can be varied to provide a longer treatment zone, or to minimize circumferential overlap of adjacent treatments zones in order to reduce a risk of stenosis formation. This pitch change can be achieved by combining a plurality of catheters of different pitches to form catheter <b>1610</b>, or by adjusting the pitch of catheter <b>1610</b> through the use of internal pull wires, adjusting mandrels inserted into the catheter, shaping sheaths placed over the catheter, or by any other suitable means for changing the pitch either in-situ or before introduction into the body.</p>
<p id="p-0112" num="0111">The electrodes <b>1612</b> along the length of the pitch can be individual electrodes, a common but segmented electrode, or a common and continuous electrode. A common and continuous electrode may, for example, comprise a conductive coil formed into or placed over the helical portion of catheter <b>1610</b>. A common but segmented electrode may, for example, be formed by providing a slotted tube fitted onto or into the helical portion of the catheter, or by electrically connecting a series of individual electrodes.</p>
<p id="p-0113" num="0112">Individual electrodes or groups of electrodes <b>1612</b> may be configured to provide a bipolar signal, or all or a subset of the electrodes may be used together in conjunction with a separate external patient ground for monopolar use (the ground pad may, for example, be placed on the patient's leg). Electrodes <b>1612</b> may be dynamically assignable to facilitate monopolar and/or bipolar energy delivery between any of the electrodes and/or between any of the electrodes and an external ground.</p>
<p id="p-0114" num="0113">Catheter <b>1610</b> may be delivered to renal artery RA in a low profile delivery configuration within sheath <b>1650</b>. Once positioned within the artery, the catheter may self-expand or may be expanded actively, e.g., via a pull wire or a balloon, into contact with an interior wall of the artery. A pulsed electric field then may be generated by the PEF generator <b>1600</b>, transferred through catheter <b>1610</b> to electrodes <b>1612</b>, and delivered via the electrodes <b>1612</b> across the wall of the artery. In many applications, the electrodes are arranged so that the pulsed electric field is aligned with the longitudinal dimension of the artery to modulate the neural activity along the renal nerves (e.g., denervation). This may be achieved, for example, via irreversible electroporation, electrofusion and/or inducement of apoptosis in the nerve cells.</p>
<p id="p-0115" num="0114"><figref idref="DRAWINGS">FIG. 17</figref> illustrates an apparatus <b>1720</b> for neural modulation in accordance with another embodiment of the invention. The apparatus <b>1720</b> includes a pair of catheters <b>1722</b><i>a </i>and <b>1722</b><i>b </i>having expandable distal sections <b>1723</b><i>a </i>and <b>1723</b><i>b </i>with helical electrodes <b>1724</b><i>a </i>and <b>1724</b><i>b</i>, respectively. The helical electrodes <b>1724</b><i>a </i>and <b>1724</b><i>b </i>are spaced apart from each other by a desired distance within a patient's renal vasculature. Electrodes <b>1724</b><i>a</i>-<i>b </i>may be actuated in a bipolar fashion such that one electrode is an active electrode and the other is a return electrode. The distance between the electrodes may be altered as desired to change the field strength and/or the length of nerve segment modulated by the electrodes. The expandable helical electrodes may comprise shape-memory properties that facilitate self-expansion, e.g., after passage through sheath <b>1750</b>, or the electrodes may be actively expanded into contact with the vessel wall, e.g., via an inflatable balloon or via pull wires, etc. The catheters <b>1722</b><i>a</i>-<i>b </i>preferably are electrically insulated in areas other than the distal helices of electrodes <b>1724</b><i>a</i>-<i>b. </i></p>
<p id="p-0116" num="0115">It is expected that thermally-induced renal neuromodulation, whether delivered extravascularly, intravascularly, intra-to-extravascularly or a combination thereof, may alleviate clinical symptoms of CHF, hypertension, renal disease, myocardial infarction, atrial fibrillation, contrast nephropathy and/or other cardio-renal diseases for a period of months, (potentially up to six months or more). This time period may be sufficient to allow the body to heal; for example, this period may reduce the risk of CHF onset after an acute myocardial infarction, to thereby alleviating a need for subsequent re-treatment. Alternatively, as symptoms reoccur, or at regularly scheduled intervals, the patient may receive repeat therapy. Thermally-induced renal neuromodulation also may systemically reduce sympathetic tone.</p>
<p id="p-0117" num="0116"><figref idref="DRAWINGS">FIG. 18</figref> shows external renal nerve stimulator apparatus <b>1806</b> connected to the electrode tip <b>1808</b> by the catheter <b>1801</b>. A catheter is inserted via an insertion site <b>1803</b> into the femoral vein <b>1805</b> into the vena cava <b>1802</b> and further into the renal vein <b>1804</b>. The tip <b>1808</b> is then brought into the electric contact with the wall of the vein <b>1804</b>. Hooks or screws, similar to ones used to secure pacemaker leads, can be used to anchor the tip and improve the electric contact. The tip <b>1808</b> can have one, two or more electrodes integrated in its design. The purpose of the electrodes is to generate the electric field sufficiently strong to influence traffic along the renal nerve <b>205</b> stimulating the kidney <b>208</b>.</p>
<p id="p-0118" num="0117">Two potential uses for the embodiment shown on <figref idref="DRAWINGS">FIG. 18</figref> are the acute short-term stimulation of the renal nerve and the implanted embodiment. For short term treatment, a catheter equipped with electrodes on the tip is positioned in the renal vein. The proximal end of the catheter is left outside of the body and connected to the electro stimulation apparatus. For the implanted application, the catheter is used to position a stimulation lead, which is anchored in the vessel and left in place after the catheter is withdrawn. The lead is then connected to the implantable stimulator that is left in the body and the surgical site is closed. Patients have the benefit of mobility and lower risk of infection with the implanted stimulator-lead system.</p>
<p id="p-0119" num="0118">Similar to the venous embodiment, an arterial system can be used. Catheter will be introduced via the femoral artery and aorta (not shown) into the renal artery <b>1807</b>. Arterial catheterization is more dangerous than venous but may achieve superior result by placing stimulation electrode (or electrodes) in close proximity to the renal nerve without surgery.</p>
<p id="p-0120" num="0119">Ablation of conductive tissue pathways is another commonly used technique to control aterial or ventricular tachycardia of the heart. Ablation can be performed by introduction of a catheter into the venous system in close proximity of the sympathetic renal nerve subsequent ablation of the tissue. Catheter based ablation devices were previously used to stop electric stimulation of nerves by heating nerve tissue with RF energy that can be delivered by a system of electrodes. RF energy thus delivered stops the nerve conduction. U.S. Pat. No. 6,292,695 describes in detail a method and apparatus for transvascular treatment of tachycardia and fibrillation with nerve stimulation and ablation. Similar catheter based apparatus can be used to ablate the renal nerve with an intent to treat CRF. The method described in this invention is applicable to irreversible ablation of the renal nerve by electric energy, cold, or chemical agents such as phenol or alcohol.</p>
<p id="p-0121" num="0120">Thermal means may be used to cool the renal nerve and adjacent tissue to reduce the sympathetic nerve stimulation of the kidney. Specifically, the renal nerve signals may be dampened by either directly cooling the renal nerve or the kidney, to reduce their sensitivity, metabolic activity and function, or by cooling the surrounding tissue. An example of this approach is to use the cooling effect of the Peltier device. Specifically, the thermal transfer junction may be positioned adjacent the vascular wall or a renal artery to provide a cooling effect. The cooling effect may be used to dampen signals generated by the kidney. Another example of this approach is to use the fluid delivery device to deliver a cool or cold fluid (e.g. saline).</p>
<p id="p-0122" num="0121">Referring to <figref idref="DRAWINGS">FIGS. 19A and 19B</figref>, variations of the invention comprising detectors or other elements for measuring or monitoring treatment efficacy are described. Variations of the invention may be configured to deliver stimulation electric fields, in addition to denervating or modulating PEFs. These stimulation fields may be utilized to properly position the apparatus for treatment and/or to monitor the effectiveness of treatment in modulating neural activity. This may be achieved by monitoring the responses of physiologic parameters known to be affected by stimulation of the renal nerves. Such parameters comprise, for example, renin levels, sodium levels, renal blood flow and blood pressure. Stimulation also may be used to challenge the denervation for monitoring of treatment efficacy: upon denervation of the renal nerves, the known physiologic responses to stimulation should no longer occur in response to such stimulation.</p>
<p id="p-0123" num="0122">Efferent nerve stimulation waveforms may, for example, comprise frequencies of about 1-10 Hz, while afferent nerve stimulation waveforms may, for example, comprise frequencies of up to about 50 Hz. Waveform amplitudes may, for example, range up to about 50V, while pulse durations may, for example, range up to about 20 milliseconds. When the nerve stimulation waveforms are delivered intravascularly, as in several embodiments of the present invention, field parameters such as frequency, amplitude and pulse duration may be modulated to facilitate passage of the waveforms through the wall of the vessel for delivery to target nerves. Furthermore, although exemplary parameters for stimulation waveforms have been described, it should be understood that any alternative parameters may be utilized as desired.</p>
<p id="p-0124" num="0123">The electrodes used to deliver PEFs in any of the previously described variations of the present invention also may be used to deliver stimulation waveforms to the renal vasculature. Alternatively, the variations may comprise independent electrodes configured for stimulation. As another alternative, a separate stimulation apparatus may be provided.</p>
<p id="p-0125" num="0124">One way to use stimulation to identify renal nerves is to stimulate the nerves such that renal blood flow is affected&#x2014;or would be affected if the renal nerves had not been denervated or modulated. Stimulation acts to reduce renal blood flow, and this response may be attenuated or abolished with denervation. Thus, stimulation prior to neural modulation would be expected to reduce blood flow, while stimulation after neural modulation would not be expected to reduce blood flow to the same degree when utilizing similar stimulation parameters and location(s) as prior to neural modulation. This phenomenon may be utilized to quantify an extent of renal neuromodulation. Variations of the present invention may comprise elements for monitoring renal blood flow or for monitoring any of the other physiological parameters known to be affected by renal stimulation.</p>
<p id="p-0126" num="0125">In <figref idref="DRAWINGS">FIG. 19A</figref>, an apparatus <b>1980</b> to achieve renal denervation including an element for monitoring of renal blood flow is shown. Apparatus <b>1980</b> comprises catheter <b>1982</b> having optional inflatable balloon or centering element <b>1984</b>, shaft electrodes <b>1986</b><i>a </i>and <b>286</b><i>b </i>disposed along the shaft of the catheter on either side of the balloon, as well as optional radiopaque markers <b>1988</b> disposed along the shaft of the catheter, illustratively in line with the balloon. Balloon <b>1984</b> serves as both a centering element for electrodes <b>1986</b> and as an electrical insulator for directing the electric field. Guidewire <b>1950</b> having Doppler ultrasound sensor <b>1952</b> has been advanced through the lumen of catheter <b>1982</b> for monitoring blood flow within renal artery RA. Doppler ultrasound sensor <b>1952</b> is configured to measure the velocity of flow through the artery. A flow rate then may be calculated according to the formula:
<br/>
<?in-line-formulae description="In-line Formulae" end="lead"?>Q=VA<?in-line-formulae description="In-line Formulae" end="tail"?>
<br/>
where Q equals flow rate, V equals flow velocity and A equals cross-sectional area. A baseline of renal blood flow may be determined via measurements from sensor <b>1952</b> prior to delivery of a stimulation waveform, then stimulation may be delivered between electrodes <b>1986</b>, preferably with balloon <b>1984</b> deflated. Alteration of renal blood flow from the baseline, or lack thereof, may be monitored with sensor <b>1952</b> to identify optimal locations for neuromodulation and/or denervation of the renal nerves.
</p>
<p id="p-0127" num="0126"><figref idref="DRAWINGS">FIG. 19B</figref> illustrates a variation of the apparatus of <figref idref="DRAWINGS">FIG. 19A</figref>, wherein Doppler ultrasound sensor <b>1952</b> is coupled to the shaft of catheter <b>1982</b>. Sensor <b>1952</b> illustratively is disposed proximal of balloon <b>1984</b>, but it should be understood that the sensor alternatively may be disposed distal of the balloon.</p>
<p id="p-0128" num="0127">In addition or as an alternative to intravascular monitoring of renal blood flow via Doppler ultrasound, such monitoring optionally may be performed from external to the patient whereby renal blood flow is visualized through the skin (e.g., using an ultrasound transducer). In another variation, one or more intravascular pressure transducers may be used to sense local changes in pressure that may be indicative of renal blood flow. As yet another alternative, blood velocity may be determined, for example, via thermodilution by measuring the time lag for an intravascular temperature input to travel between points of known separation distance.</p>
<p id="p-0129" num="0128">For example, a thermocouple may be incorporated into, or provided in proximity to, each electrode <b>1986</b>, and chilled (i.e., lower than body temperature) fluid or saline may be infused proximally of the thermocouple(s). A time lag for the temperature decrease to register between the thermocouple(s) may be used to quantify flow characteristic(s). A baseline estimate of the flow characteristic(s) of interest may be determined prior to stimulation of the renal nerves and may be compared with a second estimate of the characteristic(s) determined after stimulation.</p>
<p id="p-0130" num="0129">Commercially available devices optionally may be utilized to monitor treatment. Such devices include, for example, the SmartWire&#x2122;, FloWire&#x2122; and WaveWire&#x2122; devices available from Volcano&#x2122; Therapeutics Inc., of Rancho Cordova, Calif., as well as the PressureWire&#xae; device available from RADI Medical Systems AB of Uppsala, Sweden. Additional commercially available devices will be apparent. An extent of electroporation additionally or alternatively may be monitored directly using Electrical Impedance Tomography (&#x201c;EIT&#x201d;) or other electrical impedance measurements, such as an electrical impedance index.</p>
<p id="p-0131" num="0130">Although preferred illustrative variations of the present invention are described above, it will be apparent to those skilled in the art that various changes and modifications may be made thereto without departing from the invention. It is intended in the appended claims to cover all such changes and modifications that fall within the true spirit and scope of the invention.</p>
<?DETDESC description="Detailed Description" end="tail"?>
</description>
<us-claim-statement>We claim:</us-claim-statement>
<claims id="claims">
<claim id="CLM-00001" num="00001">
<claim-text>1. A method for thermally-induced renal neuromodulation of a human patient, the method comprising:
<claim-text>intravascularly positioning a thermal apparatus at least proximate to a neural fiber that contributes to renal function;</claim-text>
<claim-text>delivering pulsed energy via the thermal apparatus to modulate a function of the neural fiber via thermal effects; and</claim-text>
<claim-text>intravascularly removing the thermal apparatus from the patient after renal neuromodulation.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00002" num="00002">
<claim-text>2. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein positioning the thermal apparatus further comprises delivering the thermal apparatus at least proximate to the neural fiber via an intra-to-extravascular approach.</claim-text>
</claim>
<claim id="CLM-00003" num="00003">
<claim-text>3. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein delivering the pulsed energy further comprises directly applying pulsed thermal energy to the neural fiber.</claim-text>
</claim>
<claim id="CLM-00004" num="00004">
<claim-text>4. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein delivering the pulsed energy further comprises indirectly applying pulsed thermal energy to the neural fiber.</claim-text>
</claim>
<claim id="CLM-00005" num="00005">
<claim-text>5. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein delivering the pulsed energy further comprises delivering a pulsed thermal electric field to the neural fiber via at least one electrode.</claim-text>
</claim>
<claim id="CLM-00006" num="00006">
<claim-text>6. The method of <claim-ref idref="CLM-00005">claim 5</claim-ref>, wherein delivering a pulsed thermal electric field to the neural fiber via at least one electrode further comprises delivering the pulsed thermal electric field via at least one wall-contact electrode.</claim-text>
</claim>
<claim id="CLM-00007" num="00007">
<claim-text>7. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref> further comprising monitoring a parameter of at least one of the neural fiber, a non-target tissue or the apparatus during thermally-induced modulation of the function of the neural fiber.</claim-text>
</claim>
<claim id="CLM-00008" num="00008">
<claim-text>8. The method of <claim-ref idref="CLM-00007">claim 7</claim-ref> further comprising controlling the delivery of the pulsed energy in response to the monitored parameter.</claim-text>
</claim>
<claim id="CLM-00009" num="00009">
<claim-text>9. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref> further comprising actively protecting non-target tissue during thermal modulation of the neural fiber.</claim-text>
</claim>
<claim id="CLM-00010" num="00010">
<claim-text>10. The method of <claim-ref idref="CLM-00009">claim 9</claim-ref>, wherein actively protecting the non-target tissue further comprises reducing a degree of thermal damage induced in the non-target tissue.</claim-text>
</claim>
<claim id="CLM-00011" num="00011">
<claim-text>11. The method of <claim-ref idref="CLM-00009">claim 9</claim-ref>, wherein actively protecting the non-target tissue further comprises delivering a thermal fluid to a vicinity of the non-target tissue.</claim-text>
</claim>
<claim id="CLM-00012" num="00012">
<claim-text>12. The method of <claim-ref idref="CLM-00009">claim 9</claim-ref>, wherein actively protecting the non-target tissue further comprises establishing a heat transfer rate discrepancy between the non-target tissue and the neural fiber.</claim-text>
</claim>
<claim id="CLM-00013" num="00013">
<claim-text>13. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein delivering the pulsed energy further comprises delivering pulsed high intensity focused ultrasound to the neural fiber.</claim-text>
</claim>
<claim id="CLM-00014" num="00014">
<claim-text>14. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein delivering the pulsed energy further comprises heating the neural fiber via the pulsed thermal energy.</claim-text>
</claim>
<claim id="CLM-00015" num="00015">
<claim-text>15. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein delivering the pulsed energy further comprises cooling the neural fiber via the pulsed thermal energy.</claim-text>
</claim>
<claim id="CLM-00016" num="00016">
<claim-text>16. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein intravascularly positioning a thermal apparatus comprises intravascularly positioning the thermal apparatus within a renal artery proximate to the neural fiber.</claim-text>
</claim>
<claim id="CLM-00017" num="00017">
<claim-text>17. A method for catheter-based renal denervation, the method comprising:
<claim-text>positioning a catheter having an energy delivery element within a renal artery of a human patient;</claim-text>
<claim-text>delivering pulsed energy via the energy delivery element to reduce renal sympathetic nerve activity; and</claim-text>
<claim-text>removing the catheter from the patient after treatment. </claim-text>
</claim-text>
</claim>
</claims>
</us-patent-grant>
